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 Three studies are presented; the first epidemiological study was a survey of Baton 
Rouge/New Orleans physicians who manage osteoporosis.  When the respondents’ answers were 
compared to selected guidelines, they displayed poor knowledge regarding osteoporosis 
prevention, diagnosis, and treatment (X2=39.88; P<0.0001).  Rheumatologists and 
endocrinologists scored globally better on osteoporosis management when compared to ObGyn 
(OR= 6.98) (CI=2.4; 22.8).  Physicians with more years of experience were more knowledgeable 
of osteoporosis care (OR=1.04) (CI=1.014; 1.071). 
The second epidemiological study was a case referent study looking at osteoporosis 
treatment and patient adherence of selected women in Baton Rouge.  Results showed that 
osteoporosis management depended partly on patient adherence. Barriers to patient’s adherence 
varied from physiological to psychological reasons.  Physicians need to provide more 
explanation and motivation to the patients.  Spine was the area most affected and showed more 
improvement with treatment than the femur (P<0.01).  Bisphosphonates were the most effective 
treatment for the spine (P<0.05).  In patients with osteoporosis, being on just calcium and 
exercise is not enough to counteract bone resorption.  They also need to be on an anti-resorptive 
therapy.  Low body mass index, genetics, and history of fractures were negatively correlated to 
bone mineral density (BMD) increase (P<0.05).   
The third interventional pilot study was a non-randomized controlled study done on 
osteopenic postmenopausal women to examine the effect of calcium supplements and core/lower 
back strengthening exercises on lumbar density and muscle strength.  Repeated measures 
analysis showed that both groups increased in isometric lumbar strength with time (P=0.02).  
When fosamax and exercise were taken as treatments, with baseline BMD as a covariable, the 
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one-tailed P value of the two-way ANOVA showed a numerically positive but not significant 
increase in the exercise group (yearly change=2.373 ± 2.625; T value=0.9; P=0.21).  Also, the 
exercise group showed increased feelings of well-being as opposed to the control group who 
showed no change or worsening.  One woman in the control group fractured a bone.  Ultimately, 
osteoporosis management relies on physicians’ knowledge, involvement, and patient adherence.  
Calcium, exercise and anti-resorptive treatments are needed in case of osteoporosis.  Calcium 






 According to the National Institute of Health (NIH), “osteoporosis is defined as a skeletal 
disorder characterized by compromised bone strength” predisposing a person to an elevated 
fracture risk (NIH, 2001). It has been estimated that osteoporosis affects approximately 25 
million people in the United States, and most are women (McCoy, 2001). An average of one 
million Americans suffer from fractures per year and the total estimate cost is over 14 billion 
dollars according to Riggs et al., (1998) and is about $17 billion annually according to the 
National Osteoporosis Foundation (NOF, 2002).  Albeit osteoporosis is both “preventable and 
treatable” (Eastell, 1998), yet, according to McCoy (2001) it is often “undiagnosed and 
untreated”.  Because the number of treatment options is escalating, the decision-making process 
is becoming a hard task.  There is even some controversy regarding the active treatment of 
osteoporosis (Speroff, 1999).  Moreover, there has been no general consensus with respect to the 
exact type and amount of exercise that would be beneficial to patients with osteoporosis (Watts 
NB, 1994; Henderson et al., 1998). 
 This dissertation starts by a literature review of osteoporosis (Chapter II).  The definitions 
and the different types of this disease are presented at first.  The review then gives a brief 
overview about the pathogenesis, prevalence of osteoporosis, the risks associated, as well as the 
management procedures currently applied.  Then, it presents the conflicting results of the 
previous research that had studied the relationship between osteoporosis and physical activity, 
osteoporosis and muscle strength in postmenopausal women.  The studies are summarized and 
presented according to their design, i.e. randomized controlled trials, non-randomized controlled 
trials, and descriptive studies.  An analysis of the disparities in the literature will accrue, along 
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with comparison with other studies in the literature as well as two other meta-analyses.  The 
review concludes with exercise guidelines, summary and future studies’ suggestions. 
 The problem of low bone mineral density (BMD) in postmenopausal women in Baton 
Rouge is addressed by a three-pronged approach: two epidemiological studies (Chapters III and 
IV) and one interventional study (Chapter V). 
 Chapter III is a survey about physicians who manage osteoporosis in Baton Rouge and 
New Orleans areas.  The purpose of the survey is to collect descriptive information on how 
physicians who treat osteoporosis in Baton Rouge/New Orleans communities diagnose, prevent, 
treat, and follow up with osteoporosis patients, and how the physicians’ recommendations 
compare with standards World Health Organization (WHO) and National Osteoporosis 
Foundation (NOF) according to their area of specialty and their years of experience. 
Chapter IV is a case-referent study.  The goal of this study is to investigate the types of 
interventions for osteopenia/osteoporosis offered to a population-based case-referent of 
postmenopausal women with osteopenia/osteoporosis, and then to look at the outcome of these 
methods, including patient adherence to the treatment protocol.  The objectives were to answer 
the following questions: 1) Based on the treatment followed, what kind of response is seen on the 
patients upon the second/third year of treatment? What is the best treatment for osteoporosis in 
practice? 2) Are patients compliant with the physician’s prescribed treatment? If not, what are 
the barriers to compliance? 3) Does optimal osteoporosis management lie exclusively on patient 
adherence? 
Chapter V is a pilot non-randomized controlled trial.  The goal of the study is to design 
an appropriate, convenient, and cheap home exercise program for postmenopausal women 
suffering from low bone density (osteopenia) in the lower back.  The program consists of site-
 3
specific core/lower back strengthening exercises.  The primary objective is to prevent the 
accelerated bone loss induced by menopause via the core/lumbar strength exercises.  Secondary 
objectives are to improve isometric lumbar strength and overall quality of life. 
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Osteoporosis can be broken down into two words; the term “osteo” means bone and the 
term “porosis” means porous or having pores.  Osteoporosis refers to a disease causing the bone 
structure to become more open and porous resulting in fractures.  According to National Institute 
of Health (NIH), osteoporosis is defined as “a skeletal disorder characterized by compromised 
bone strength predisposing a person to an increased risk fracture; bone strength reflects the 
integration of two main features: bone density and bone quality” (NIH Consensus Development 
Panel, 2001).  Bone strength primarily implies the combination of bone density and bone quality.  
Bone density is expressed as grams of mineral per surface (g/cm2) or volume (g/cm3).  Bone 
quality refers to the integrity, remodeling, architecture, and geometry of the bone.  Currently, 
there is no accurate measure of global bone strength.  Bone mineral density (BMD) is often used 
as an estimate measure for bone strength while it only accounts for 70% of bone strength.  The 
World Health Organization (WHO) operationally defines osteoporosis as “bone density 2.5 S.Ds 
below the mean for the young white adult women”.  The WHO definition of osteoporosis was 
established for Caucasian women, because of paucity of data for other population groups 
(Sanborn and Simmonds, 2002).  The term osteopenia is a less advanced stage of bone loss as 
compared to osteoporosis; it reflects BMD values “between 1 and 2.5 standard deviations below 
the mean of young adults of the same race and sex”(Khan et al., 2002).  BMD results are 
represented as T-scores and Z-scores.  The main difference between the two scores is the age 
variable, where the T uses the mean value of young adults of the same gender as a reference and 
the Z score uses the mean value of the people of the same age and gender.  Z-score is a more 
appropriate measure for children and young adults, who haven’t yet achieved their peak bone 
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mass (PBM).  However, the reference “young adults” population used in the T score is assumed 
to represent a standard PBM (Gourlay and Brown, 2004).  Each standard deviation reflects a 10- 
to 12% difference in BMD (McGarry et al., 2003) and each 1 SD decrease in BMD reflects a 
doubling of fracture risk (NIH, 2001).  Regardless of the BMD scores, a patient with history of 
fractures is considered to have severe osteoporosis (Lane et al., 2003). 
  Strength exercise refers to the type of exercise designed to increase the ability of the 
muscle to move and perform functions of daily activity such as lifting, carrying, pushing, pulling, 
sitting, standing, walking, and climbing stairs.  Strength exercise can be performed with weights 
(progressive resistance training; isokinetic resistance training) or without weights (isometric 
strength training).  “The gain in strength can be either static (isometric) in which no observable 
changes occur in muscle fiber length, or dynamic in which the muscle action produces 
movement of the skeleton” (ACSM’s guidelines, 2000).   
Muscle strength refers to “the maximal force (properly expressed in Newtons, or Kg) that 
can be generated by a specific muscle or muscle group at a given velocity”.  Static or isometric 
strength can be measured conveniently using different instruments, such as cable tensiometers 
and handgrip dynamometers.  “Dynamic strength can also be measured using the direct 1-
repetition maximum test (1-RM), the heaviest weight that can be lifted only once using good 
form” (ACSM’s guidelines, 2000).  
2.2. Types of Osteoporosis 
Although bones might appear as non-living materials due to their rigid structure, they are 
actually made of 5% of living materials.  Osteoblasts (bone building cells) and osteoclasts (bone 
scavenger cells) are the two major types of cells that form the bone living material.  Bearing this 
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information in mind, it becomes important to differentiate between the two types of osteoporosis, 
primary and secondary.   
 There are two types of primary osteoporosis: Type I and type II.  Type I occurs only in 
women due to decreased estrogen and increased osteoclast activity, typically in the years 
following menopause, from age 50 to 70.  Type II most commonly affects men and women over 
the age of 75 due to decreased osteoblast activity and decreased bone formation (Gruver, 2004).    
Secondary osteoporosis, as its name indicates, it is secondary to other underlying 
diseases, we will state but a few: secondary hyperparathyroidism, diabetes, glucocorticoids 
intake, excessive thyroid hormone therapy, hypogonadism, hypoestrogenemia, and tamoxifen 
(Shephard, 2002; McGarry et al., 2003).   
2.3. Pathogenesis 
Bone is a living tissue, and the cells in the bones are constantly changing.  They go 
through a remodeling cycle that starts with bone resorption by osteoclasts, followed by bone 
formation by osteoblasts.  Bones increase in length up till about 20 years of age and keep on 
increasing in mass up till about 30 years of age.  This is why an adequate intake of calcium 
during growth is needed to achieve adequate bone mineralization.  Peak bone mass is a chronic 
effect and is attained at 30 years of age.  Therefore, bones can be compared to a saving account: 
the more we store calcium in them, the higher the peak bone mass will be at 30 to 35 years old, 
and the higher the prevention against risk fractures will be for later years (Shils et al., 1998).  
After 30 years of age, bone resorption exceeds bone formation, and this negative calcium balance 
is accentuated in postmenopausal women who stop secreting estrogen, leading to a decrease in 
calcium absorption and an increased osteoclast activity (Hughes et al., 1996).  The trabecular 
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bone found mainly in the vertebras has a larger surface area and remodels more rapidly than the 




Osteoporosis is considered one of the most common skeletal disorders in elderly.  The 
bone loss process can occur with no symptoms and the individual feels fine until a fracture 
occurs; therefore the attribute “silent” given to the disease.  If untreated, it can lead to suffering, 
dysfunction, and death in the elderly population (Goldmann and Horowitz, 2000).  An estimate 
of 44 million Americans is affected by the bone loss.  More specifically, 34 million suffer from 
osteopenia (low bone mass) and 10 million have osteoporosis (Kenny et al. 2003).  More than 47 
million are expected to have low bone mass by the year 2020 (NOF, 2004). 
 
2.5. Risks and Costs Associated 
 
According to the investigators of the National Osteoporosis Risk Assessment trial 
(NORA), women suffering from osteoporosis have a relative risk of sustaining a fracture that is 
four times that of women free from the disease; as for women with osteopenia, their relative risk 
doubled (Siris et al., 2001).  Fractures occurring as a result of osteoporosis constitute a serious 
and escalating threat to our aging population (Melton, 2000). These threats vary from diminished 
quality of life to its complete loss (Hertel and Trahiotis, 2001).  Estimates of one out of two 
women and one out of eight men have an osteoporosis-related fracture in their lifetime (Gruver, 
2004).  In the United States, over half a million of women suffer from vertebral fractures, over ¼ 
million women suffer from hip fractures, and another ¼ million men suffer from osteoporotic 
fractures each year.  The total estimated cost of the one million Americans suffering from 
fractures is over 14 billion dollars according to Riggs et al., (1998) and is about $17 billion 
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annually according to the National Osteoporosis Foundation (NOF press release, 2002).  
Although less prevalent than vertebral fracture, hip fracture is the predominant cause of death 
and accounts for the major share of the medical cost (Melton, 2000).  According to the NIH, 
(NIH, 1992), patients die within six months of hip fractures in 12 to 20% of the cases, but since 
the population at risk of osteoporosis is enormous, the potential cost of preventing those fractures 
is also high.  Consequently, there is continuous argument about the relative cost-effectiveness of 
various management strategies (Melton, 1999), albeit the social benefit and the cost efficiency in 
treating these high-risk individuals seem to be very clear (Cuddihy et al., 2002).  Although 
osteoporosis can be prevented and treated, its efficient management is still underutilized among 
postmenopausal women who experience a fracture (McCoy, 2001; Cuddihy et al. 2002).  A 
myriad of variables affecting bone, balance, and muscle strength will in turn affect fracture risk 
(Rutherford, 1999).  Age is a great example; in fact, given the same bone density, fracture risks 
increase from 8- to 10-fold from age <45 years to>80 years (Hui et al.,1988).  Knowing that the 
most common cause of hip fractures is falling (Cummings et al., 1995), it is more useful to 
engage the elderly in safe physical activities that would strengthen their muscles and reduce 
falling than increasing their bone mineral density per se (Shephard, 2002). 
2.6. Prevention 
The prevention starts as early as childhood because calcium is needed during childhood 
through adulthood until the peak bone mass is reached.  The first 30 years of a person act like 
they are storing calcium like a reservoir; the more calcium stored, the less the likelihood of a 
later fracture.  A plethora of lifestyle interventions can be very beneficial to osteoporosis 
prevention such as the following: 
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-Having a healthy and varied diet with adequate calcium and vitamin D daily intake:  Common 
sources of calcium are milk and dairy products.  Common food sources of vitamin D are egg 
yolk, fatty fish, and cod liver oil.  While an intake of 1000-1500 mg calcium is recommended 
daily, it is still deficient among more than 90% of the women and more than 50% of the men in 
the United States.  Similarly, while an intake of 400 to 800 IU of vitamin D is recommended 
daily, its deficiency is prevalent, resulting in poor calcium absorption, increased bone loss, and 
decreased mineralization elderly (Gruver, 2004).   
-Leading an active lifestyle:  Growing evidence suggests that weight bearing, resistance and 
strength exercises stimulate bone growth and muscle strength (Silverwood, 2003) and improve 
balance.   
-Cutting down on smoking: Smoking affects the bone negatively by lowering the estrogen levels 
in the blood (Papazian, 1991) and it has shown to increase the risk of hip fracture in the aging 
population (Silverwood, 2003). 
-Controlling alcohol intake: Excessive consumption of alcohol (>2cups/day) suppresses calcium 
absorption (Papazian, 1991) and increases the risk of falls. 
-Controlling caffeine intake: It is speculated that excess caffeine consumption increases urinary 
excretion of calcium as well as rates of bone loss.  Results are still controversial.  Patients who 
consume a lot of caffeinated beverages are advised to have an adequate intake of calcium to 
counterbalance the urinary calcium loss (Follin and Hansen, 2003). 
-Avoiding excessive weight loss: Thin women [Body Mass Index (BMI) <18.5] are at higher risk 
because they lose muscle mass, become susceptible to falling and are less able to sustain the 
impact of falls. 
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-Exposing the body to sunrays: This would encourage the synthesis of vitamin D precursors by 
the skin via exposure to UV light. 
-Being aware of the risk factors of osteoporosis: Turner et al. (2003) has shown that an 
osteoporosis prevention program for a group of middle-aged women may help promote 
osteoporosis prevention behaviors. 
-Undergoing a therapy if needed, either anti-resorptive therapy (bisphosphonates, estrogen, 
calcitonin, Selective Estrogen Receptor Modulator SERM) or bone formation therapy (Para 
Thyroid Hormone –PTH- such as Forteo). 
2.7. Diagnosis 
Diagnosis of osteoporosis should include a thorough medical history identifying the risk 
factors for low bone density among other tests such as a physical examination for any indications 
of fractures, a bone mineral density (BMD) testing, and a routine lab tests to rule out secondary 
causes (Follin and Hansen, 2003).  Risk factors are the ones that increase the likelihood of 
developing osteoporosis.  The risk of osteoporosis is determined by the amount of calcium 
deposited during adulthood and by the loss rate of the bone mass.  According to the National 
Osteoporosis Foundation (NOF) Guidelines, the following risk factors have been identified:  
-Advanced age: The aging process leads to loss of muscle mass, deficit in estrogen, and 
weakening of the bones.  
-Gender: The risk of developing osteoporosis is greater for women than for men.  An estimate of 
one-third of postmenopausal women will undergo an osteoporotic fracture in their lifetime 
(Melton, 2000).  In fact, women are at a greater risk of osteoporosis than men because they have 
a smaller body size, they have less bone, they are thinner, they have less muscle mass, and they 
lose bone more rapidly because of the hormonal changes during menopause.  Postmenopausal 
 11
estrogen deficiency is the chief culprit for osteoporosis in women because estrogen enhances 
calcium absorption and has an anti-resorptive effect on bones.   
-Race: Race and gender play an important role in the prevalence of osteoporosis and the 
incidence of fracture.  White (Caucasian and Asian) postmenopausal women have the highest 
age-adjusted fracture incidence.  Nevertheless, African American women, Hispanic women, 
men, and children are also at a significant risk of fracture.  Among men, white men appear to be 
at greater risk.  These differences are mainly due to discrepancies in peak bone mass and rate of 
bone loss.  Other reasons are greater total body potassium and thus higher muscle mass (Pollitzer 
and Anderson, 1989), as well as differences in bone geometry. 
-Bone structure and body weight: Women with a small frame size and low BMI (<18.5) have 
less muscle mass and tend to have weaker bones; thus they are more prone to develop the 
disease. 
-History of bone fractures: Previous fractures are an indication of low bone mass. 
-Family history of osteoporosis (heredity): Young women whose mothers have osteoporosis are 
at a greater risk of developing the disease.  Genetic factors relating to bone mass acquisition, 
bone remodeling, or bone structure are also being identified. 
-Menopause/Menstrual history: Having menopause at an early age because of either surgery or 
natural reasons increases the risk of developing osteoporosis because of lack of estrogen at an 
early age.  Moreover, women who stop menstruating before menopause because of excessive 
exercise or disordered eating may also lose bone tissue and develop osteoporosis (female athletic 
triad). 
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-Hypogonadism: it is defined as “low production of the male sex hormone testosterone”, and it 
increases the risk of developing osteoporosis in men.  In fact, sex steroids secreted during 
puberty increase peak bone mass and bone mineral density. 
-Removal of ovaries: Estrogen production stops after removal of the ovaries. 
-Lifestyle: Excessive alcohol, caffeine, and tobacco use, low intake in calcium and vitamin D, 
and lack of exercise are all factors that are negatively correlated to bone health. 
-High Phytate, high oxalate, high protein, and high sodium: Phytate (in whole wheat bran) and 
oxalate (in spinach and rhubarb) inhibit calcium absorption; high protein or high sodium intake 
increase urinary calcium excretion. 
-Certain medications: Prolonged usage of steroids to treat asthma or arthritis, anticonvulsants, 
certain cancer treatments and aluminum-containing antacids interfere with calcium homeostasis 
or absorption. 
-Certain diseases: Cystic fibrosis, celiac disease, and inflammatory bowel disease lead to 
secondary osteoporosis by inhibiting calcium absorption among other nutrients.  Also, 
hyperthyroidism and hyperparathyroidism increase the rate bone resorption and lead to 
osteoporosis. 
2.7.1. Guidelines for Bone Mineral Density Testing 
The NOF has established guidelines for BMD testing in postmenopausal women that can 
be useful for physicians to identify candidates for screening.  According to NOF, all 
postmenopausal women who are less than 65 years of age with one or more additional 
osteoporosis risk factors, all women above 65 years of age, all postmenopausal women who 
sustain a fracture, all women considering osteoporosis therapy, and all women who have been on 




2.8.1. Patient Beliefs and Medication Use 
 Cline and coworkers (2005) developed a health belief model associated with the decision 
of using a newer antiresorptive therapy (bisphosphonates and calcitonin) as compared to no 
prescription therapy.  They found in their cross sectional survey on 983 postmenopausal women 
that constructs such as “perceived susceptibility to the disease”, “perceived benefits and barriers 
to the use of antiresorptive” treatment, and BMD screening were all associated with the use of 
antiresorptive therapy.  These results were concordant with other prospective studies that showed 
that previous knowledge of low bone mass was positively correlated to the positive changes in 
exercise habits and to the increase in calcium and vitamin D supplements (Jamal et al., 1999).  In 
a similar vein, Hsieh and Turner (2001) reported that women who showed more concern about 
osteoporosis were more likely to commit to treatments such as hormone therapy, weight-bearing 
exercise, or calcium and vitamin D supplements.  Congruent with these results, Blalock and 
colleagues showed that women who expressed fewer barriers and more benefits to exercise were 
more likely to engage in weight-bearing exercises (1996).  These findings highlight the 
importance of the dissemination of osteoporosis management knowledge to both physicians and 
patients.   
2.8.2. Nutrition 
 Osteoporosis is a multi-factorial disease.  There is a plethora of factors that affect the risk 
of osteoporosis, such as age, sex, race, exercise, diet, stature, and hormonal status; among these 
factors, only nutrition and exercise can be manipulated by the individual (Kuntze et al., 1989).  
The chief nutrients affecting the bone are calcium and vitamin D.   
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2.8.2.1. Calcium and Vitamin D 
Bone is a connective tissue.  It is composed of (5%) living materials (lining cells, 
osteocytes, osteoblasts, osteoclasts) and of (95%) non-living materials (protein matrix encrypted 
with minerals, which give the mechanical functions of the bones, such as stiffness; rigidity; 
resilience).  The non-living material is formed of 50% protein and 50% minerals.  Among the 
proteins, 90% is collagen and 10% is non-collagen, such as osteocalcin.  Among the minerals, 
around 55% is phosphorus, 40% is calcium, and 5% is carbonate and other trace minerals (Shils 
et al., 1998).  A simple algebra of the numbers above suggests that 19% of the bone tissue is 
made of calcium.  Knowing that the total body calcium is around 0.9 to 1.5 Kg, 99% of body 
calcium is in the skeleton. 
  During adult life, bone grows in length and keeps on growing in mass until 30 to 35 
years of age.  Dietary calcium needs to be adequate during this critical period (10-35 years of 
age) to attain a high PBM.  The RDA of calcium is 1000-1500 mg; the higher range is 
recommended for elderly and post-menopausal women.  Adequate calcium intake is considered 
standard care for all postmenopausal women, either alone or in combination with other 
pharmacological treatments (McGarry et al., 2003).  Food sources of calcium are milk and dairy 
products, sardines, broccoli, nuts, fortified beverages (orange juice), and sesame seeds.  Calcium 
supplements are available in the form of calcium carbonate and calcium citrate.  The latter is 
better absorbed than calcium carbonate in the body (Lin and Lane, 2004). 
 Vitamin D maintains serum calcium and phosphorus homeostasis by stimulating their 
absorption from the gut; thus vitamin D, taken with calcium, slows bone loss in postmenopausal 
women.  The RDA of vitamin D is 400-800 IU.  Sources of vitamin D include egg yolk, liver, 
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fatty fish, cod liver oil, and fortified milk and dairy products and skin production of vitamin D 
with sun exposure. 
Literature has shown that supplements of calcium and vitamin D combined decrease the 
risk of non-vertebral fractures and increase the total-body BMD in elderly men and women with 
no osteoporosis (Dawson-Hughes et al., 1997).   
 While Wymelenberg (among other researchers) recommended in the Harvard Health 
Letter in 1994 that women suspecting to have menopause should increase their calcium intake up 
to 1500 mg daily owing to the upcoming decrease in estrogen production and the subsequent 
decrease in calcium absorption, Cumming and coworkers (1997), on the other hand, argued 
against this high calcium intake.  They thought that daily calcium recommended intakes of 1-
1.5g would accentuate rather than attenuate fracture risk.  Excess calcium may suppress PTH 
secretion and thus hamper the natural bone turnover. 
2.8.2.2. Calcium and Exercise  
 Research on calcium effects in interaction with exercise on the bone has been 
controversial.  This conflict may arise from the fact that calcium may be essential to skeletal 
integrity but may not be enough to prevent osteoporosis on its own (Heaney, 1987).  In a critical 
review of the literature, Specker (1996) concluded that exercise can only be beneficial to bone 
density if complemented with a minimum calcium intake of 1000 mg; moreover, calcium 
supplements can only be beneficial to bone health if complemented with adequate physical 
activity.  In fact, several researchers have argued that calcium is crucial for bone development; 
yet, its intake alone cannot suppress bone loss and replace a disintegrating matrix (Kreiger et al., 
1992).  Congruent with this argument, Heaney (1992) mentioned that calcium should be viewed 
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as a nutrient and not as a drug per se; thus, its supplementation will be useful to alleviate calcium 
deficiency.  
2.8.2.3. Other Nutrients 
 While an excess of nutrients such as sodium, caffeine, phosphorus, or protein potentially 
affect bone mineral through increased calcium excretion, phytoestrogens in soy foods may 
attenuate bone loss through estrogen like activity (Lewis and Modlesky, 1998).   
2.8.3. Pharmacologic 
 Osteoporosis reversal can be achieved by either decreasing bone turnover (anti-
resorption), and/or increasing bone mass formation (anabolism) (WHO guidelines, 1994).  All 
the following treatments listed below have been approved by the US Food and Drug 
Administration (FDA). 
2.8.3.1. Anti-resorptive 
 Anti-resorptive drugs are those that decrease resorption of the bones, such as estrogen, 
bisphosphonates, and calcitonin.  These drugs decrease the rate of bone formation as well.  The 
only difference is that this last happens in a few months, whereas the decrease in bone resorption 
happens within weeks.  Thus the ultimate result is that the decreased resorption is larger than the 
decreased formation, leading to a net increase in bone. Yet, it takes two to three years for the 
bone density to change (Eastell, 1998). 
2.8.3.1.1. Estrogen 
 Estrogen used for the alleviation of postmenopausal symptoms did receive approval from 
FDA in 1988 as a treatment for osteoporosis.  It has been shown that its usage decreases the odds 
of hip fracture by 4% if taken alone and by 11% if taken with progestin (Michaelsson, 1998); 
yet, a positive correlation has been shown between estrogen use and breast cancer and 
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endometrial cancer.  Adding progestin to it may lower the risk of uterine cancer, but also 
increase a woman’s risk of developing breast cancer (Papazian, 1991).  Once estrogen therapy is 
stopped, it is followed by rapid bone loss (Speroff, 1999); thus, other treatments need to be 
implemented to counteract this effect.  Some women might not respond to hormone therapy and 
the reason is unknown.  Some theories can be ruled out such as compliance, calcium and vitamin 
D deficiency, renal and hepatic problems, eating disorders, high intake of alcohol, and smoking 
(Papazian, 1991).  A recent review in the literature has highlighted that estrogen was not 
recommended for osteoporosis treatment because the health risks outweighed the benefits (Lin 
and Lane, 2004).  According to the Women’s Health Initiative Writing Group, although there 
were 5 fewer hip fractures per 10,000 person years in persons taking conjugated equine estrogens 
plus progestin, the number of each of coronary heart disease events, stokes, pulmonary 
embolisms, and invasive breast cancers increased by 7; 8; 8; and 8 respectively (Rossouw et al., 
2002).  On another note, Minelli et al. (2004) have shown that women with no menopausal 
symptoms were at increased risk of breast cancer from (HRT) use.  Thus, even for women with 
menopausal symptoms, a tailored individual-based approached would be more adequate than a 
population-based approach for decision-making. 
2.8.3.1.2. Bisphosphonates 
 Interestingly, hormones and drugs affect different regions in the body with different 
magnitude (Eastell, 1998); for prevention and treatment of osteoporosis, bisphosphonates are the 
most potent and effective class of drugs.  They act by inhibiting osteoclast activity (Lin and 
Lane, 2004).  Alendronate (Fosamax), risedronate (Actonel), and etidronate (Didronel), are all 
compounds of the bisphosphonates family (Papazian, 1991).  However, the first 2 are the most 
popular and they are known to decrease hip and vertebral fractures (Lin and Lane, 2004).   
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 Alendronate administration was shown to increase bone density in both the spine and the 
hip in women who already have osteoporosis (Speroff, 1999);   
 Similary, Harris et al. (1999) showed in a randomized controlled trial that risedronate 
administration to women with osteoporosis reduced new vertebral fractures by 65% after 1 year 
and by 41% after 3 years; and non-vertebral fractures by 40% in 3 years.  Moreover, it 
significantly increased BMD at the lumbar spine (4.3%), femoral neck (2.8%) and trochanter 
(4%).   
 Etidronate is a non-hormonal drug, proven to slow down the process of bone resorption 
in the spine (Papazian, 1991). 
 Adverse effects were reported upon the oral intake of bisphosphonates such as abdominal 
pain, GI inflammation, and ulcers.  To circumvent this problem, patients have to remain upright 
for the first 30 minutes after the ingestion of the medication. 
2.8.3.1.3. Selective Estrogen Receptor Modulators (SERMS) 
 Raloxifene (EVISTA) and Tamoxifen are selective estrogen receptor modulators.  They 
both appear to have an oestrogenic activity on the bone.  Both appear to be protective against 
breast cancer (WHO guidelines).  Raloxifene works by binding to estrogen receptors and works 
as an estrogen agonist on bone (anti-resorption), lipids (deep vein thrombosis), and blood 
clotting (pulmonary embolism), and as an estrogen antagonist on the breast (cancer risk) and 
uterus.  Studies have shown a decrease in vertebral fractures of 68%, 46%, and 41% at 1, 2 and 3 
years respectively upon daily ingestion of 60 mg raloxifene.  However, there was no hips’ 
fracture protection (Maricic et al., 2002).  Yet, Raloxifene (EVISTA)’s effect on the increase on 




 The effects of calcitonin are better documented on the spine and the forearm rather than 
the hip in women with osteoporosis in a dose-dependent manner (WHO guidelines).  In a 5-years 
randomized controlled trial, a 200 IU daily intake of calcitonin was shown to increase lumbar 
BMD (1-1.5%) and to decrease new vertebral fractures by 33% when compared with placebo 
(Chestnut et al., 2000); nevertheless, no hip fracture protection was shown (Martens, 2003; 
Silverman, 2003).  Although approved by the FDA for osteoporosis treatment, calcitonin is not 
approved for osteoporosis prevention (Murphy et al., 2003). 
2.8.3.2. Anabolic Agents 
The other alternative treatment is bone formation medication such as a PTH hormone 
(Forteo), which, in contrast to the anti-resorptive agents mentioned above, stimulates new bone 
formation, restores bone architecture (McClung, 2003) and significantly increases BMD.  Forteo 
received FDA approval in November 2002.  It was shown that PTH reduced the risk of new non-
vertebral fractures by 35 to 40% in a dose-dependent manner (daily 20 to 40 µg respectively); 
vertebral fractures were also significantly reduced by 60-70% after 21 months of treatment (Neer 
et al., 2001).  PTH is an attractive alternative for patients who are intolerant of the other anti-
resorptive treatments.  
2.8.3.3. Combination Treatments  
Data comparing bone density increments in men and postmenopausal women showed 
that PTH hormone acted better than PTH and alendronate combined, which in turn acted better 
than alendronate alone (Black et al., 2003; Finkelstein et al., 2003).  However, other studies have 
shown that the combination of PTH and estrogen produced greater gains on lumbar and femoral 
BMD than estrogen alone (Cosman et al., 2001).  Other studies have shown that the combination 
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of estrogen and bisphosphonates together had a greater impact on BMD gains as compared to 
either agent alone (Bone et al., 2000).  Moreover, the combination of calcium, exercise and HRT 
was evaluated in some studies, where it was shown that estrogen combined with weight-bearing 
exercises (Kohrt et al., 1995) or resistance exercise (Notelovitz et al., 1991) or even weight 
bearing plus calcium (Prince et al., 1991) acted better than either treatment alone.   
An attractive combination to increase bone strength would be to increase BMD by one of 
the anti-resorptive agents and to improve bone geometry and architecture by exercise (Uusi-Rasi 
et al., 2003). 
 Further studies with fractures as an endpoint need to be implemented before 
recommending combination therapy to patients with osteoporosis.  It is important to note that 
HRT is no longer viewed as the ‘gold standard’ therapy for osteoporosis (Compston, 2000) 
owing to the other emerging anti-resorptive and anabolic treatments. 
2.8.4. Exercise  
 Exercise is an important component for a healthy well-being throughout the life cycle; 
from maximizing peak bone mass during childhood and adolescence, to maintaining or 
increasing BMD in pre and postmenopausal women, to increasing muscle strength, muscle mass 
and improving balance in elderly, exercise should be incorporated in everyone’s daily routine.  
Weight-bearing and resistance training appear to be the first-line exercises that show benefits on 
BMD in the aging population.  Yet, weight-bearing activities (walking) that decrease the risk of 
trauma may represent a more adequate regimen for elderly males and females who cannot afford 
lifting weights.  Regardless of changes in BMD, the overall benefits of physical activity on the 
muscles may end up reducing the risk of falling (Lewis and Modlesky, 1998).  Toned muscles 
may also prevent trauma to the bones (Kuntze et al., 1989).  Conversely, excessive exercise can 
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be detrimental in premenopausal women especially in cases of excessive weight loss and 
secondary amenorrhea (Bubbear and Keen, 2003).  According to Wallace and Cumming (2000), 
optimal training programs to maximize peak bone mass and preserve skeletal integrity are yet to 
be determined. 
2.9. Exercise and Bone Mineral Density (BMD)  
 According to Turner and Robling (2003), BMD or BMC should not be used as a 
surrogate measure for bone strength.  It should be emphasized that bone strength is a 
combination of BMD and bone geometry.  This being said, albeit the effect of exercise on BMD 
might be modest, the authors showed in their loading study on rats that it actually resulted in 
favorable alterations in bone geometry, leading to a great increase in bone strength.  Bearing this 
idea in mind, we reported some of the studies done on postmenopausal women according to the 
design followed: randomized controlled trials; non-randomized controlled trials; and descriptive 
studies. 
Table 2.1. Randomized Controlled Trials (RCT) 
Source Intervention Participants BMD assessment 
1-Chan et 
al., 2004 
-Tai Chi Chun (TCC), 45 
min/day; 5x/week for 12 
months 
-TCC=low impact weight 
bearing exercises 




women (mean age 
54 yr) 
-CG (n=67);  
-TCC (n=65);  
 
A 2.6 to 3.6 fold retardation 
bone loss in tibia (cortical + 
trabecular) in TCC group 
2-
Verschueren 
et al., 2004 
Whole body vibration 
(WBV) training; for 6 
months 
-Postmenopausal 
women (58-74 yrs)  
-WBV (n=25);  
-Resistance(n=22); 
-CG (n=23)  
-BMD of the hip increased 
(+0.93%, P<0.05) but not 
total BMD nor lumbar; 
-Isometric + dynamic muscle 
strength increased 




DT et al, 
2003 
-Exercise Group (EG): 
Physical therapy; 
resistance; endurance 
-Home Exercise (HE): 
Physical therapy; for 9 
months 
-1200 mg Calcium 
supplements (Ca Supp) + 
800 IU vitamin D/day for 
both groups 
-Men and women 
(≥78 yrs) 
-EG(n=650);  
-HE (n=47)  
 
No significant differences in 






Training (PRE): hi (HI)- 
or (80% of 1 RM)  lo- 
intensity (LI) 
-For 6 months; 3x/wk 
-Elderly men and 
women  




-BMD for femoral neck 
increased by 1.96% in HI 
group. 
-Total strength increased in 





-Strength (SG): 3 sets of 
exercises + progressive 
increased loading;  
-Fitness (FG): 3 sets of 
exercises + bike riding;  
-Both groups: 3x/wk for 2 
years; 600 mg Ca 
Supp./day 
-Postmenopausal 






-A 0.9% increase in BMD 
the S group at the hip site. 
-No difference in forearm, 
lumbar, and whole body 
BMD between the 2 groups 






-High Intensity Resistance 
Training (HI) 
-Moderate weight training 
(MI) 
-For 6 months, 3x/wk 
 
-Older men and 
women with no 
ERT (52-54 years)  
-HI: n=27  
-MI: n=27 
  
-Lumbar BMD increased in 
HI in men 
-Hip BMD increased in HI 
and MI in men 




-PRE: 3 sets of 8 reps for 
large muscle groups; 1 
hour session; 3x/wk; for 1 
year. 
-Healthy sedentary 





-No significant changes in 
BMD between both groups 
-Increase in muscle strength 
in EG. 
-Significant correlations 
between strength gain 
(quadriceps) and BMD 
(lumbar) in EG. 
8-Hakkinen 
et al., 1999 
-Dynamic Strength 
Training (DS); 2x/wk; for 
12 months + Recreational 
physical activity (RP) 





-EG increased in muscle 
strength but not significant 
changes in BMD 
-Subjects on glucocorticoids 
had lower femoral BMD 
 
   (Table continued) 
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9-De Jong 
et al., 1999 
-A 17-week: supplements 
(S); exercise (E); both 
(SE); none. 
-Frail elderly 






-S showed increase in BMD, 
bone mass, and calcium 





- One year PRE.  
-Strength (SG)=3x8 RM; 





women (mean age 
56-58) 
-En G: n=28 
-SG: n=28 
 
-BMD increased site 
specifically in the SG but not 
in the En G. 
-Muscle strength increased in 
both groups. 
-Peak load is more important 






stretching); 1 hour session; 
2x/wk; 







-EG: increased strength and 
sway but not BMD 
-Overall fracture risk 
decreased in EG 
12-Pruitt et 
al., 1995 
-12 month resistance 
training program: 10 
exercises; 3 days/wk; 
-High Intensity (HI): 80% 
of 1-RM 
-Low-Intensity (LI):  







-No significant changes in 
BMD among the 3 groups 
-Muscular strength increased 
in the HI and LI. 
13-
McCartney 
et al., 1995 
-42 weeks of progressive 
weight-lifting 
-EG: 2x/wk at 50-80% of 
1-RM 
-CG: usual daily activities 
-Males and females 
(60-80 years) 
-EG: 37 females + 
39 males 
-CG: 42 females + 
24 males 
-No change in BMD 
-Increase in dynamic muscle 
strength; muscle size; and 
functional capacity. 
14- Nichols 
et al., 1995 
-High-intensity resistance 
program: 8 exercises; 3 
sets; 10-12 reps; at 80% 
1RM 3x/wk-1 for 1 yr 
-17 Active elderly 
women (≥ 60 yrs) 
-EG: n=9 
-CG: n=7 
-No significant increases in 
BMD were found in EG 
15-Nelson 
et al., 1994 
-High Intensity strength 
training (SG); 2x/wk; 5 
different exercises; 









-Femoral neck and lumbar 
BMD increased in SG (0.9%; 
1% respectively) 
-Muscle strength; mass; 
dynamic balance increased in 
SG 




et al., 1991 
-Variable-resistance 
weight training (E) ± 
estrogen therapy (EST) 






-Lumbar, total, and radial 
midshaft BMD increased in 
E+EST (8.3%; 2.1%; 4.1% 
respectively) and was 
maintained in EST. 
17-Beverly 
et al., 1989 
-Squeezing a tennis ball as 
hard as possible for 30 
seconds each day for 6 
weeks. 
-99 women (30 had 
a fractured forearm)
-BMC and strength increased 
(3.4%; 14.5% respectively) 
in the stressed forearms 
-After 6 months of no 
exercise, only the injured 
women kept on gaining 
strength and BMC.  All the 
rest lost previous gains. 
18-Sinaki et 
al., 1989 
-Non-loading exercises for 
back extensor muscles, 
1x/day, 5x/week; with a 
backpack containing 
sandbag weights 
-Duration 2 years 









-Back extensor muscle 
strength increased in both 
groups, but more in EG 
-Mean rate of bone loss was 
the same in both groups 
19- Dalsky 
et al., 1988 
-Weight-bearing exercises; 
walking; jogging; stair 
climbing 
-Duration of 9 months 
-Postmenopausal 
women (55-70 yrs) 
 
-EG increased in BMD 
(+5.2%); CG decreased in 
BMD (-1.4%) 
-No correlation between 
VO2 max and BMC in EG 
  
 Randomized intervention trials are the best studies to show causal inferences (Wolff et 
al., 1999).  Among the 19 studies reported above, 9 of them (3; 7; 8; 9; 11; 12; 13; 14; 18) did 
not show significant increase in BMD at neither the hip nor the spine area.  Ten of them (1; 2; 4; 
5; 6; 10; 15; 16; 17; 19) showed a significant increase in BMD in at least one of the skeletal areas 
(hip or spine).   
 A myriad of reasons exist to interpret the conflicting results.  Some of them are the 
duration of the study (6 months up to 2 years); the age of the participants (early post-
menopausal, late postmenopausal women, or frail); the type of physical activities; the frequency, 
duration, and intensity of the exercise regimen; the initial BMD of the participants; the estrogen 
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deficiency; calcium and vitamin D supplementation; the sites and the techniques used to measure 
BMD; as well as the sample size.  Moreover, according to Drinkwater (1994), disparities arise 
due to the different nomenclature used in specifying the types of the exercise regimen.  For 
instance, “weight bearing or non-weight bearing; loading or non-loading; resistance or 
endurance”; this makes it hard to determine which kind of exercise is in fact osteogenic.  In fact, 
what is a weight-bearing activity for an individual may or may not be a sufficient loading 
exercise, owing to the initial BMD and fitness level of the individual.  For this purpose, Caldwell 
J. (1996) has identified these different types of exercises to circumvent this problem:  
Table 2.2: Caldwell’s Definitions of Different Exercise Types. 
Exercise type Implication  
Passive Performed by someone else on the subject’s limbs 
Active Performed by the subject him/herself 
Isometric active Contraction of the muscle for a short period with no movement 
Isokinetic Joint motion 
Aerobic At least 15 to 20 minutes of prolonged activity 
Anaerobic Small number of reps with a short time till exhaustion 
  
 Based on the RCT studies that showed a significant effect on the BMD, it is suggested 
that high-intensity exercise (high magnitude with fewer reps) is more efficient in increasing the 
site specific BMD than the low intensity exercise.  This is concordant with the findings of Skerry 
(1997) who recommended the long-term, progressive high-load with few reps exercises in order 
to promote osteogenesis.  This phenomenon could be explained by the versatile strain 
distributions that are created throughout the bone.  However, according to Karlsson et al., (2001), 
none of these trials considered fracture rates as an end-point.  This might be due to the difficulty 
in conducting a randomized controlled trial that would last for several years to ascertain fracture 
incidence.   
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 Congruent with the finding of Villareal et al., (2003), Beck and Snow (2003) reported 
that to induce increase in bone mass, the impact of the exercise has to cause a bone load that 
overrides the one resulting from the regular daily activities.  Likewise, Westerlind et al. (1997) 
have shown in a study on ovariectomized (OVX) female rats that mechanical strain (such as 
treadmill exercise) balances bone formation and bone resorption in OVX rat, while bone loss 
occurs in OVX rats in sites with low strain.  Nevertheless, for individuals with osteoporosis, 
strenuous high impact activities may be detrimental to their skeletal health.  Examples of such 
activities to be avoided include jumping, running, or even trunk flexion activities such as toe 
touches, rowing, and full sit-ups (Meeks, 1999).   
 Drinkwater (1994) has provided a logical interpretation of the literature based on the five 
basic principles of the physical training, which are: (1) Specificity, which implies that an 
exercise should be designed to target a specific target bone; (2) Overload, which means that an 
exercise should cause an overload on the bone which exceeds a certain remodeling threshold in 
order to stimulate osteogenesis; (3) Reversibility, which means that if the exercise is stopped, the 
increase in BMD is reversed or lost; (4) Initial values, which suggests that the baseline BMD or 
fitness level does affect the subsequent results of the exercise on the BMD, where people with a 
lower baseline value are more prone to see improvement than those who have a higher baseline 
values; and (5) diminishing returns, which suggests that early responses of the bone are more 
marked than the subsequent responses, may be because the subject would be approaching his/her 
“biological ceiling.” 
 A recent meta-analysis of randomized trials between 1977 and 1996 was conducted by 
Wallace and Cumming in 2000.  They classified the exercises under 2 categories: “Impact” 
(walking, running, aerobics, and heel drops) and “non-impact” which reflects to all kind of 
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strength training with weights (free weights, weight machines, or weighted backpacks) also 
known as resistance training, weight lifting, and strength training.  Yet, they did not examine the 
impact of exercise frequency or duration in their meta-analysis.  The meta-analysis found that the 
impact exercises yielded a significant increase in lumbar BMD (1.5%) and femoral neck BMD 
(1%) in both pre- and postmenopausal women.  As for the non-impact exercises, they had a 
positive effect on the lumbar spine (1%) regardless of the menopausal status, but conclusions 
could not be drawn on their effect on the femoral neck BMD owing to the paucity of the studies.  
 Although some researchers concluded from their study in rats that increasing load 
frequency was more important that increasing load intensity in order to promote osteogenesis 
(Hsieh and Turner, 2001; Turner and Robling, 2003), other authors have showed the opposite.  
Vincent and Braith (2002) (study 4) concluded that 1 set of high resistance training was effective 
in increasing BMD in elderly men and women; likewise, Kerr et al (1996) (study 10) showed 
that the peak load with low reps was a more important factor in achieving bone gain than the low 
load endurance exercise.  Similarly, Martin and McCulloch (1987) stressed more importance on 
the intensity rather than the frequency of the stimulus.  Congruently, Snow-Harter et al., (1992) 
found significant increases with a similar program in postmenopausal women.  Strikingly, two 
other studies have found no significant increases on BMD upon high resistance exercise (Nichols 
et al., 1995; Pruitt et al., 1992).  In both of these studies, however, selected subjects were healthy 
and had a good baseline BMD. 
Table 2.3. Non Randomized Controlled Trials (NRCT) 




exercise; at 50% VO2 
max; for at least 1 
hour; 4x/week;  




-EG (n=32);  
-CG (n=18);  
-Lumbar BMD increased 
in the EG and did not 
change in CG 




-Intense exercise: 2 
group sessions and 2 
home sessions per 
week 
-Calcium supplements 
and cholecalciferol to 
all 
-Duration of 2 years 
-Early postmenopausal 
osteopenic women 
-EG (n=50);  
-CG (n=33);  
 
-Lumbar BMD increased 
in EG (0.7%) 
-Decrease in rate of hip 
bone loss in the EG  
(-0.3%) vs. CG (-1.7%) 
3-Wu et al., 2000 -Swimming; 1 hour; 
1.5 sessions per week; 
-Duration of 2 years 
-Post menopausal 
women 
-EG: n=22 (mean age 
59.5) 
-CG: n=19 (mean age 
59.3) 
-EG had higher BMD in 
hip region but had 
decreased BMD in spine 
-Muscle leg strength 
increased in EG 
4-Humphries et 
al., 2000 
-Short term high 
intensity strength 
training (weights):60-
90% 1RM; or 50-min 
low intensity walking ± 
HRT; 2x/wk 
-Duration of 24 weeks 




-Weights+ HRT: n=14 
-Walking+ HRT: n=9 
 
-No difference in lumbar 
BMD among groups. 
-Muscular strength 
increased in Weights and 
Weights+ HRT groups 
5-Pruitt et al., 
1992 
-Weight training; 1 
hour session (warm-up-
weights-stretching); 






-Lumbar BMD increased 
in EG (+1.6%) 
-No changes in hip or 
distal wrist BMD in EG 
6-Sinaki et al., 
1984 
-Flexion (F) vs. 
Extension (E) exercices
or None (N) 










occurred mostly in F: 
89%; N: 67%; E+F: 
53%; E: 16%. 
-Flexion exercises are 
not appropriate. 
  
 As for the non-randomized controlled trials, study 4 did not show a significant change in 
BMD, studies 3 and 5 showed some site-specific effects on BMD, and the rest of the studies did 
show a significant increase in BMD. Again, these conflicting results go back to the same reasons 
mentioned above.  In fact, according to Wolff et al., (1999), non-randomized controlled trials 
tend to positively bias the results by magnifying the effects to more than what they should be, 
owing to the non-randomization confounding bias. 
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 In a recent meta-analysis of randomized and non-randomized controlled trials between 
1966 and 1996 conducted by Wolff and his coworkers in 1999, they concluded that the exercise 
training program did in fact suppress or reverse bone loss rate by almost 1% per year, 
irrespective to the menopausal status.  Yet, specific exercise recommendations could not be 
developed owing to the variety of the exercise type, duration, intensity, and frequency used in 
these studies. 
Table 2.4. Descriptive Studies 





and osteoporosis;  
-Cross sectional 
study 
-171 physiotherapists;  
-Response rate 39 %; 
 
 
-45% used manual therapy  
-91% had concerns such as 
vertebral and rib fractures 
owing to manual therapy in 
osteoporotic patients  
2-Kemmler 






(PMW) (mean age 55.5) 
-Weak relationship between 
habitual physical activity/non 
athletic exercise on bone 
parameters in early PMW 
3-Devine et 
al., 2004 
-Cross-sectional -1363 older women 
(mean age 75) 
-Hip BMD was higher by 5.1% 
in those who achieved physical 
activity (4 hrs of walking or 
more/wk) and dietary calcium 
intake (>800mg/day) 
4-Greendale 
et al., 2003 
-Cross sectional  
-Adjusted linear 
regression 
N =544 African 
American 
N =1044 Caucasian 
N =230 Chinese 
N =239 Japanese 
-Higher sport and home 
physical activity (PA) were 
associated with higher lumbar 
and hip BMD. 
-Work PA or active living were 





50 older women and 29 
older men; healthy; not 
doing resistance training 
-Correlation between hip BMD 
and muscle strength of the 
lower joints depends on body 




-Cross sectional -36 women with 
osteoporosis (47-84 
years) 
-There was a negative 
correlation between: 
-Back extensor strength and the 
number of vertebral 
compression fractures (VCF) 
- BMD and number of VCF 
   (Table Continued) 
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7-Heinonen 
et al., 1993 
-Cross-sectional 
-ANOVA 
30 female orienteers; 
28 cross-country skiers; 
29 cyclists; 
18 weight lifters; 
25 reference group 
-BMD was higher in weight 
lifters than in referents 
-Of the endurance athletes, only 




-Cross-sectional 78 healthy subjects (>50 
years) 
-Weight-bearing exercise (up to 
300 min/wk) was strongly 
correlated with lumbar BMD in 
women 
-Extremely vigorous exercise 




-Cross-sectional 46 postmenopausal 
subjects among 84 
Caucasian (age 20-75 
yrs) 
-Fitness predicted femoral neck 
BMD and fitness and weight 
predicted lumbar BMD in the 
46 postmenopausal women 
10-Stillman 




or very sedentary 
to very active 
-Women aged 30-85 yrs: 
High active groups: n=28 
Moderate active: n=36; 
Low active: n=19 
-BMC was higher in high active 
groups than the low active 
group; No difference between 
moderate and low active groups.
  
 Descriptive studies can never show causality.  They only show correlations and they also 
generate hypotheses that need to be tested by controlled trials.  They are also subject to selection 
bias (Wolff et al., 1999).  In general, most of these studies summarized in the table above (3; 4; 
7; 8; 9; 10) reflect a relationship between weight-bearing physical activity and resistance training 
with BMC or BMD.  The notion of site-specificity is also remarkable where the BMD increases 
only in the specific bones attached to the muscles engaged in the physical activity.  The 
drawback of descriptive studies is that we can never prove which factor lead to the other.  For 
instance, did BMD increase because of physical activity or did a healthy skeletal bone lead to a 
physically active lifestyle?  These questions can be answered by the controlled clinical trials. 
2.10. Exercise and Muscle Strength 
 Clark (1996) gave details in his book about strength training for the aging adult.  He 
defined muscle strength as “the ability of the muscle to perform some tasks of daily living such 
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as lifting, carrying, pushing, pulling, sitting, standing, walking, and climbing stairs”.  According 
to Clark, exercise can influence some fitness parameters such as muscle strength, range of 
motion, and balance.  Luckily, muscle strength does not decline exponentially as bone does 
owing to the lack of estrogen after menopause (Sinaki, 2003).  The loss of muscle strength 
occurs gradually with aging as muscle mass declines (Rogers and Evans, 1993) and as the result 
of lack of physical activity.  Thus, skeletal deformity occurs and the incidence of falls accrues 
(Sinaki, 2003).  When the strength of the trunk is lost, specifically the back extensor strength, 
vertebral fractures may result (Hertel and Trahiotis, 2001).  The studies related to exercise and 
muscle strength in postmenopausal women were reported according to the design followed: 
Table 2.5. Randomized Controlled Trials (RCT) 




-EG: 6 months exercise 
(phase 1) + 6 months self-
maintenance (phase 2) 
-CG: 6 months self 
maintenance (phase 1) + 6 




(mean age 81), 





-In phase 1, EG had higher 
extension strength than CG;  
-In phase 2, CG had significant 
changes in trunk strength from 
baseline. EG did not maintain 
their improved trunk strength. 
2-Kemmler 
et al., 2004 
-Modified cross-over 
-G1: 12 wks high intensity 
(HI) multiple 
set + 5 wks low intensity 
training + 12 weeks HI single 
set; 
-G2:12 wks HI single  
set + 5 wks low intensity +12 
weeks HI multiple set; 
-Well trained early 
post-menopausal 





-Multiple set HI trainings resulted 
in higher strength increases (3.3-
5.5%) 
-Single set HI training resulted in 
significant decreases (-1.1 to -2%) 
-Multiple set protocols HI 
increase muscle strength more 
than single set HI protocols 
3-Vincent 
et al., 2002 
-high intensity (HI): 80% 
of 1 RM; 8 reps; 
-low intensity (LI): 50% of 
1 RM; 13 reps;  
-1 set of 12 exercises. 
-Duration for 6 months 
-Adults aged 60 




-Significant improvements in 
strength, endurance, and stair 
climbing time in both groups. 
-HI or LI have similar strength 










-Twice weekly exercise 
class for 20 wks 





-Improvement in dynamic 
balance (3.3%) and strength 
(7.8%) in the EG, i.e. reduced 
risk factor for falls 
5-Bemben 
et al., 2000 
-High intensity (HI) (80%1 
RM; 8 reps) 
-Low intensity (LI) (40% 1 
RM; 16 reps) 
-Duration: 6 months; 
Volume: 3 sets, 3d.wk-1 
-12 exercises that load 
spine and hip 











-HI and LI had similar 
increases in muscle strength 
(biceps; lower body; hip; 
rectus femoris).   
-HI had higher upper body 
strength than LI. 
-Neither group had increase in 












-Back extensor strength 
increased significantly in both 
groups. 
-EG had less thoracic 
kyphosis. 
7-Morgan 
et al., 1995 
-Aerobics exercise (A) ± 
strength training (S) (3 sets 
of 8-12 reps of knee 
exercises; 80% 1RM); 
Duration: A=8 months; 








-A+S group had highly 
significant increases in knee 
flexion and extension strength. 
-Resistance is a crucial 
supplement to aerobics to 
increase muscle strength. 
8-Morganti 
et al., 1995 
-Progressive Resistance 
training (PRT) at ≥ 80% of 
1 RM; 2x/wk; 
-Duration of 1 yr 
-Older healthy 




-In all exercises, PRT had 
substantial, continual strength 
gains, with the greatest gains 
in the first 3 months of training 
9-Charette 
et al., 1991 
-12 wk Resistance training: 
7 exercises for the lower 
extremeties 
-Older women 
(mean age 69 yr) 
-EG: n=13 
-CG: n=6 
-EG had significant increases 
in muscle strength (28-115%) 
and in cross-sectional area of 
type II muscle fibers (20.1%) 
as compared to baseline values 
  
 Most of the above mentioned RCT (3; 5) suggested that high intensity (HI) or low 
intensity (LI) strength exercises had similar effects on increasing muscle strength; study 2 
showed that HI single set strength training resulted in a decrease in strength as compared to HI 
multiple set strength training, contrary to what study 3 has showed, where one set of HI did 
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actually improve muscle strength. These inconsistencies may stem from the difference in the 
baseline values of the individuals, where in study 2 they were well trained and in study 3 they 
were not.  Similarly, study 5 showed that HI and LI strength training had similar increases on 
muscle strength, and again, the authors used a different number of sets in the exercises.  The 
same five basic principles of the physical training explained above apply in the discussion of the 
discrepancies of the results.  Yet, this empirical evidence converges to the same conclusion, 
which is that the resistance training with different intensities can significantly improve muscle 
strength, and thus reduce the risk of falls.  According to Sinaki (2003), proper rehabilitation 
programs can significantly reduce the musculoskeletal deformities owing to osteoporosis.  This 
non-pharmacologic intervention is based on empirical evidence resulting from controlled trials. 
Table 2.6. Non Randomized Controlled Trials (NRCT) 
Source Intervention Participants BMD assessment 
1-Belanger 
et al., 2000 
-Functional electrical 
stimulation (FES) ± 
Resistance training 
(RT) 
-1 hour a day; 5 
days/wk for 24 weeks 
- Spinal Cord injured 
individuals with osteopenia 
(mean age 33 yrs) 
-SCI with FES±RT: n=14 
(left-resisted vs. right-
unresisted quadriceps) 
-CG (no SCI; no FES): 
n=14 
-SCI with the FES 
treatment showed 
increased BMD (in muscle 
with or without RT) and 
strength (in resisted 
muscle) in femur and tibia 







calisthenics; 3x/wk for 
30 min; against gravity 
or with bands or 
gymnastic balls for 9.7 
to 10 yrs 
-33 postmenopausal  
women (45-75 yr) with a 
history of at least 1 fracture 
and BMD  ≤-1SD below 
the age adjusted mean 
-EG: n=19 
-CG: n=6 
-No significant differences 
in fracture rate, falling 
episodes, and BMD were 
observed. 
-HEP not efficient for this 
population. 
  
 These 2 NRCT suggest that electrical stimulation might be beneficial to treat or reverse 
osteoporosis by increasing BMD with or without applying resistance.  However, muscle strength 
was only increased when resistance training was performed and not under electrical stimulation.  
The other study (2) suggested that HEP are not enough to decrease fracture rate in 
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postmenopausal women; therefore, a more involved exercise regimen needs to be performed by 
these women to counteract the effects of osteoporosis. 
Table 2.7. Descriptive Studies 






-Cases: n=55 osteoporotic 
women (40-85 yrs) 
-Controls: n=25 healthy 
women (40-85 yrs) 
-After adjusting for age, 
osteoporotic women had 
significantly lower back extensor 
strength (BES) than the normal 
women; this might lead to skeletal 








menopausal women (n=68) 
-A significant positive correlation 
between lumbar BMD and BES, 
even after adjusting for age 
-Positive correlation between 
BMD and body weight. 
-High BES may benefit lumbar 
BMD 
  
 These 2 studies suggested a negative correlation between skeletal deformities and BES 
(study 1) and a positive correlation between a high BES and lumbar BMD (study 2).  Yet, due to 
the type of the descriptive studies, one cannot confirm which one happens first; is it the 
weakening of the muscles or the skeletal deformities? Or is it the strength of the muscles or the 
healthy skeletal?  Although these studies do not provide confirming answers, strength training 
does not seem unfavorable for individuals with osteoporosis (Hertel and Trahiotis, 2001).   
2.11. Exercise Guidelines  
 Every physical exercise should include 3 parts: aerobics (walking, cycling, and running), 
strength, and flexibility.  Ideally, the strength component should target all the muscle groups 
necessary for our daily functional activities (upper body strength, lower body strength, and 
core/lower back strength).  The American College of Sports Medicine (ACSM, 1998) has 
established some guidelines for the healthy adult suggesting that this latter should perform a 
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minimum of 8 to10 exercises for the major muscle groups with a volume of 1 set of 8-12 reps or 
near fatigue for 2-3 days a week.  As for the elderly, Pollock et al. (1994) gave some resistance 
training guidelines for elderly.  He suggested that elderly should perform 8 to 10 exercises for 
the major muscle groups (chest, back, biceps, triceps, shoulders, hips, legs, and abdominals) with 
a volume of 1 set of 10 to 15 reps with a frequency of 2 days a week.  Nevertheless, no one has 
yet examined the effect of these exercises on the BMD in elderly men and women (Vincent and 
Braith, 2002). 
Table 2.8. Exercise Guidelines 
Source Group # of sets # of reps # of exercises # d.wk-1 
Pollock et al., 
1994 
Elderly 1 10-15 8-10 2 





Rhea et al., 
2003 
Untrained 4 sets/muscle 
group 
60% 1 RM All muscle 
groups 
3 (each muscle 
group) 
Rhea et al., 
2003 
Trained 4 sets/muscle 
group 
80% 1 RM All muscle 
groups 
2 (each muscle 
group) 
  
 As a follow-up to the previous statement, the ACSM conducted a subsequent statement 
saying that as the training proceeds, the volume (number of sets) and the intensity (% of 1 RM) 
of the workout have to gradually increase in order to stimulate the neuromuscular system.  The 
amount of increase in strength was not given with specific volume and intensity.  As a corollary, 
Rhea et al. (2003) came up with a formula out of a meta-analysis of 140 studies.  This formula 
calculated the effect size (ES) to quantify the dose-response relationship for strength accrual.  
Accordingly, they came up with the guidelines for trained and untrained individuals.  Thus, to 
elicit maximum strength gain in trained individuals, they should perform 4 sets for each muscle 
groups at 80% 1RM 2 days a week.  Whereas untrained individuals should perform 4 sets for 
each muscle groups at 60% 1RM 3 days a week.  Further studies need to be implemented to test 
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whether these recommendations of dose-response relationship for muscular strength 
development can be applied in patients with osteopenia/osteoporosis. 
2.12. Summary 
 To sum up, osteoporosis is a skeletal disorder that predisposes the person to an increased 
risk of fracture.  The trabecular bone is more susceptible to osteoporosis than the cortical bone.  
Fractures occurring as a result of osteoporosis can be life threatening to the patient.  Management 
of this disease depends on its prevention, diagnosis, and treatment.  Prevention starts at an early 
age by having an appropriate calcium intake and adopting an active lifestyle; it continues through 
adulthood by avoiding excessive alcohol, caffeine, and cigarette smoking among other factors.  
Diagnosis identifies the risk factors of osteoporosis and prompts a DXA scan if the disease is 
suspected.  Treatment of osteoporosis includes pharmacological and non-pharmacological 
agents.  The former (pharmacological) includes anti-resorptive therapy such as hormones, 
bisphosphonates, SERM, calcitonin, as well as anabolic agents such as the PTH Forteo.  The 
latter (non-pharmacological) includes calcium intake and exercise. 
 Results have been inconsistent with respect to the protective effect of exercise on bone 
loss at the spine and hip.  This is partly due to the difference in the study design (RCT, NRCT, 
and descriptive studies) as well as the complex interaction of the bone with different factors 
(diet, age, genetics, hormones).  However, all of the studies have been consistent with respect to 
the weight bearing exercise and resistance training imparting an increase in muscle strength.  
Consequently, exercise should be included in everyone’s lifestyle in order to maximize peak 
bone mass, maintain muscle balance and strength, optimize bone geometry and strength (Beck 
and Snow, 2003), reduce or suppress bone loss, and thus minimize the propensity to fall.  Albeit 
the strength training effect on BMD might be modest, exercise still plays an important role in 
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decreasing the incidence of fractures by optimizing the skeletal health.  Therefore, an optimal 
exercise prescription for elderly should target exercises that focus on increasing muscle strength, 
balance, and agility, as well as the bones involved in weight bearing activities, yet, without 
causing a high stress threatening their bones.  In fact, The American Geriatrics Society (AGS, 
2001) recommends in a published guide that elderly people engage in physical activities that 
optimize their balance and they should avoid the potential hazards that would cause them to fall 
in the home (loose carpets, misplaced items, dim lighting).   
2.13. Future Studies’ Suggestions 
 Future research should focus on conducting long-term, large randomized controlled trials 
to study the effect of novel exercise modalities, with conjunction of calcium and vitamin D 
supplementation, on fracture risk reduction in patients with osteoporosis.  Further research must 
test the dose-response relationship in muscle strength gain in trained and untrained people and 
check if this principle applies in elderly with osteopenia/osteoporosis.  Moreover, there is a 
definite need to adopt a standardized nomenclature to the different exercises used and the 
different sites measured, bearing in mind the concept of the baseline BMD values as well as the 
concept of the regression to the mean for participants with extreme scores.  Ultimately, exercise 
recommendations for elderly subjects with osteoporosis should focus more on reducing the risk 
of falls and lowering the exercise intensities. 
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CHAPTER III 





According to the National Institute of Health (NIH), “osteoporosis is defined as a skeletal 
disorder characterized by compromised bone strength” predisposing a person to an elevated 
fracture risk.  Bone strength primarily reflects the integration of bone density (grams of calcium 
per unit area or volume of bone) and bone quality (micro architecture of bone) (NIH, 2001).    
The World Health Organization (WHO) operationally defines osteoporosis as “bone density 2.5 
S.Ds below the mean for the young white adult women”. 
It has been estimated that osteoporosis affects approximately 25 million people in the 
United States and mostly women (McCoy, 2001).  If untreated, “osteoporosis can be one of the 
leading causes of suffering, disability, and death in elderly people” (Goldmann and Horowitz, 
2000).  Osteoporotic fractures represent a major and escalating “threat to our aging population” 
(Melton, 2000).   
Osteoporosis is both “preventable and treatable” (Eastell, 1998), yet, according to McCoy 
(2001) it is often “undiagnosed and untreated”.  Cuddihy et al. (2002) have shown that “effective 
osteoporosis interventions are underutilized among postmenopausal women” who experience a 
fracture due to osteoporosis.  The WHO and the National Osteoporosis Foundation (NOF) of the 
United States have both established guidelines for the physicians to prevent, diagnose, and treat 
osteoporosis.  However, there are some discrepancies between both guidelines, and according to 
some studies (Wilkin and Eastell, 1999; Hui et al., 1988) osteoporosis diagnosis has been 
controversial.  Nevertheless, osteoporosis diagnosis depends to a greater extent on the knowledge 
of the physicians (Werner and Vered, 2002). 
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3.1.1. Purpose 
The purpose of the survey was to collect descriptive information on how physicians who 
treat osteoporosis in Baton Rouge/New Orleans communities diagnose, prevent, treat, and follow 
up with osteoporosis patients, and how the physicians’ recommendations compare with standards 
(WHO; NOF) according to their area of specialty and their years of experience. 
3.2. Materials and Methods 
Four hundred questionnaires (Appendix 1) were distributed to a stratified sample of 
physicians.  The sample was selected according to physician’s specialty and geographic location.  
The specialties that were targeted were rheumatology (Rheum), family medicine (FP), 
orthopedics (Ortho), internal medicine (IM), obstetrics and gynecology (ObGyn), endocrinology 
(Endo), and others.  The questionnaires were first drafted, pre-tested, and modified after a pilot 
survey on a small sample of physicians.  The questionnaires were then delivered to different 
locations in Baton Rouge and New Orleans, along with a cover letter and a self-addressed 
stamped envelope.  Once completed, the questionnaires were mailed back, faxed to LSU school 
of Human Ecology, or picked up from their location by the investigator.  For analysis purposes, 
physician’s specialty was divided into 5 broad categories: internal medicine, obstetrics and 
gynecologists, family practitioner + nurse practitioners, orthopedics + others, and 
endocrinologists + rheumatologist.  Physicians’ years of experience ranged between 1 year and  
≥ 25 years.  Overall, 106 questionnaires were returned back, and five were removed because the 
physicians didn’t treat osteoporosis, therefore, the overall response rate was 25%. 
The structured questionnaire was comprised of the following information: 
1. Physicians’ demographic information and professional background: area of specialty, 
years of experience, place of work, number of patients seen per month. 
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2. Knowledge about osteoporosis prevention:  One multiple choice closed-ended question 
was used. 
3. Knowledge about osteoporosis diagnosis: four multiple choice closed ended questions 
were used. 
4. Knowledge about osteoporosis treatment: two multiple choice questions were used, of 
which one had 6 subheadings. 
5. Knowledge about osteoporosis follow-up: two multiple choice questions were used.  
Another two questions regarding follow-up were dropped out of the analysis because of 
the missing values.  
6. Patients’ demographic information: age range, distribution of sex and race, areas mostly 
affected. 
Correct answers to the knowledge items were based on the guidelines published by WHO 
and NOF, as well as other published references, and are summarized in appendix 2 
3.2.1. Data Analysis and Statistical Methods 
Data were analyzed in several steps.  First, descriptive statistics, which include 
percentages of correct answers and proportions of variables, were computed.  Second, 
comparative statistics, which includes hypothesis testing about osteoporosis management; 
Osteoporosis management included the three questions corresponding to prevention, diagnosis, 
and treatment of osteoporosis.  Each question consisted of a set of multiple choice answers where 
the physicians had to mark the correct answers.  The participants received a score of “1” for a 
correct answer and a score of “0” for an incorrect answer.  A total score was calculated across 
the different questions to determine knowledge about osteoporosis management on a 3 subscales: 
prevention, diagnosis, and treatment.  A cut-off point was chosen where if 80% of the answers 
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were marked right, then the corresponding question would be marked as correct.  Thus, each of 
the three responses was treated as a binary outcome.  The two independent variables were area of 
specialty and years of experience.  Area of specialty was treated as a categorical variable and 
years of experience was kept as a continuous variable.  The three binary responses were treated 
as a repeated measure on each subject.  Repeated measures analysis with discrete data using the 
SAS system (Proc Genmod) was used to test whether the knowledge among physicians varied 
according to their area of specialty and their years of experience.  Conditional odds ratio (OR) 
with associated 95% confidence intervals (95%CI) were used to test the significance of the 




3.3.1. Descriptive Analysis  
 Table 3.1 indicates that 35% of the respondents’ specialty was Internal Medicine and 95 
were endocrinologists and rheumatologists. 
Table 3.1: Characteristics of the responding physicians according to area of specialty 
Specialty  Percentage 
Internal Medicine  35 
Obstetrics and Gynecologists 25 
Family Practitioner + Nurse Practitioner  16 
Orthopedics and Others* 15 
Endocrinologist + Rheumatologist 9 
*Others include nephrologists, oncologists, and pain management specialists. 
 
Mostly Caucasian females suffer from osteoporosis.  In this study, osteoporosis started as 
early as 28 years of age and as late as 89 years of age.  The area that is mostly affected is the 
spine (62%), followed by the hip (35%).  It will be shown in chapter IV that people suffer from 
low bone mineral density mostly in the spine area. 
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Table 3.2: Patients’ information 
Gender Age 
Mean % females 80% ± 18.1 Mean maximum age 89 ± 10.4 
Mean % males 20% ± 18.1 Mean minimum age 28 ± 17.6 
Race Areas mostly affected 
 Caucasian 54.2% ± 25 Spine  62% ± 23.9  
 African American 39.2% ± 24.4  Hip  35% ± 22.9  
 Hispanic 5.63% ± 10.5 Wrist  5% ± 12.0  
Native American 1.97% ± 10.1 Other (femur, feet, ribs) 0.84% ± 4.9  
 
Table 3.3:  Percentage of physicians recommending specific strategies for osteoporosis 
prevention 




High calcium diet and exercise* 98% Yes 
Control of alcohol and smoking* 75% Yes 
Gonadal steroids in men and women if hypogonadal‡§ 45% Yes 
Control of caffeine intake 40% Yes 
Control of salt intake 21% Yes 
Others (calcium supplements, exercise, screening, 
bisphosphonates, PTH assessment)  
19% ---- 
Control of protein intake 12% Yes 
*Recommended by WHO; ‡ Recommended by WHO in women with ovarian failure;  
§ Recommended by published reference (Snyder et al., 1999); †correct responses are provided in 
boldface type 
  
 The majority of physicians reported high calcium diet and exercise, as well as control of 
alcohol and smoking as preventive measures for osteoporosis.  Only 45% reported the usage of 
gonadal steroids in both hypogonadal men and women. 
 Fracture, loss of height, curved back, family history, smoking, low body weight, and 
frailty were among the most reported signs of osteoporosis presence by the respondents. 
 The majority of the respondents reported the usage of DXA scans as a detection before 
fractures occur.  Others also reported history taking and physical examination for osteoporosis 
diagnosis.  Surprisingly, 41% of the respondents reported the usage of X-ray.  
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Tables 3.4 (a; b; c): Percentage of physicians recommending specific strategies for 
osteoporosis diagnosis 
Table 3.4a: 
Signs of osteoporosis presence % physicians Correct responses 
Fracture* 90 Yes 
Loss of height* 88 Yes 
Curved back* 84 Yes 
Family history* 83 Yes 
Smoking* 80 Yes 
Low Body Weight* 75 Yes 
Frailty 71 Yes 
Low Peak Bone Mass (PBM) at early ages 53 Yes 
Pain 52 Yes 
Other (steroid use, white race, post-menopausal, 
amenorrhea)* 
34 ---- 
*Recommended by WHO  
Table 3.4b: 
Detection methods before fractures occur % physicians Correct responses 
DXA* 90 Yes 
History taking 61 Yes 
Physical examination 44 Yes 
X-ray† 41 No 
Blood and urine tests for bone markers 7 Yes 
Quantitative ultrasound for bone density 6 Yes 
None 2 No 
* Recommended by WHO (Delmas and Fraser, 1999); † X-rays will only detect bone loss by the 
time 25 ± 40% of bone mass has already gone (Delmas and Fraser, 1999)  
  
 Physicians demonstrated poor knowledge with respect to DXA scan usage upon gluco-
corticoid usage and for all women above 65 years of age. 
 Most of the physicians recommended non-pharmacological treatments for osteoporosis 
such as exercise, dietary changes, and calcium supplements, as well as pharmacological 
treatments such as bisphosphonates, hormone therapy, and nasal calcitonin.  
 Walking and resistance training were the priority choices among the majority of the 





Bone density scan recommendation % physicians Correct 
responses 
When osteoporosis is suspected, before fractures occur‡ 82 Yes 
When see clinical risk factors (premature menopause…) ‡ 71 Yes 
To assess effectiveness of a given treatment‡§ 60 Yes 
When fractures have already occurred‡ 54 Yes 
Upon gluco-corticoid use*‡ 43 Yes 
All postmenopausal women† 39 No 
All women above 65 years of age*‡ 29 Yes 
All post-menopausal women not on hormones† 27 No 
Others (women at menopause) † 7 No 
All men above 65 years of age† 2 No 
*Recommended by NOF; ‡Recommended by WHO; † Not recommended by WHO unless presence 
of other risk factors; § Recommended by published references (Miller et al., 1999; Bonnick SL, 
2000) 
 
Tables 3.5(a- -c): Percentage of physicians recommending specific strategies for 
osteoporosis treatment: 
Table 3.5a: 
Treatment % physicians Correct responses 
Supplements* 100 (Ca 100% ; vitamin D 89%)  Yes 
Exercise* 95 Yes 
Bisphosphonates‡ 92 (Fosamax 90%; Actonel 42%; Etidronate 15%)   Yes 
Hormone therapy† 87  Controversial 
Diet change*  82 (more dairy 61% and fortified milk 51% ) Yes 
Nasal calcitonin‡ 47 Yes 
*Recommended by WHO; ‡ Recommended by WHO: shown to decrease rate of bone loss in 
postmenopausal women; † Not recommended by the FDA 
 
 Most of the respondents reported estrogen and evista as the types of hormones they 
would use for osteoporosis treatment. 
 Fifty percent of the physicians reported that patients came back for a follow-up every 2 
years, while 28% reported that patients came back every one year. 
 Eighty eight percent of the physicians thought that the patients did not follow their 
prescription (partially 87% or fully 1%), and only 4% thought that the patients followed 




Exercise kind % physicians Correct responses 
Walking* 85 Yes 
Resistance* 51 Yes 
Swimming** 33 Controversial 
Running‡ 20 Yes 
Non weight bearing‡‡ 19 No 




*Recommended by NOF; ** The effect of swimming on human bone skeleton is still controversial; 
‡Not advised according to Shephard, 2002; ‡‡Non weight bearing (bicycling) is not recommended 
by NOF  
  
Table 3.5c: 
Types of hormones* % physicians 
Estrogen 68 
Evista 50 




*87% of the physicians prescribed HRT as a treatment of osteoporosis  
Table 3.6: Frequency of patients coming back for follow-up based on physicians’ 
estimation 
Frequency of patients coming back for follow-up % based on physicians’ 
estimation 
Every 2 years 50 
Every 1 year 28 
Other (never, 3-4 years, no access for DXA) 15 
Every 6 months 7 
  
Table 3.7: Physicians’ opinion about whether patients follow their prescription 










3.3.2. Comparative Analysis 
Generalized Estimating Equations (GEEs) methodology (Gordon Johnston, SAS  
Institute, http://www.ats.ucla.edu/stat/sas/library/gee.pdf)  was used to test whether the 
knowledge among physicians varied according to their area of specialty (S) and their years of 
experience (E).  Our survey has a moderate number of repeated measures on many subjects.  
These repeated measures are treated as binary discrete responses (T), which makes the data look 
like a cross-sectional time series (Liang and Zeger, 1986).  When the responses are discrete and 
correlated, the method of GEEs provides a practical way with reasonable statistical efficiency to 
analyze such data.  The “exchangeable” correlation matrix with Proc Genmod in SAS, along 
with the “repeated” statement, will account for of the correlation among the responses.  As a 
result, the “population averaged coefficient” or the beta parameters will be estimated.  Based on 
the analysis of deviance (∆G2) of the nested models shown in Table 3.8, model (4) was the most 
appropriate model, where each of the main effects showed significance without any significant 








∏ = probability of having a correct answer. 
1- Π = probability of not answering correctly. 
α= intercept 
T
iβ = slope for the categorical variable T (time), representing the 3 binary responses.  
S
jβ = slope for the categorical variable S (specialty) 
γ  = slope for the continuous variable E (experience) 
 The analysis of deviance compares the deviances between two models (one is full and the 
other is reduced) by taking their difference.  Model (1) is the fullest model and has the 2 two-
way interactions (E*S) and (E*T) as well as the main effects (E, S and T).  Model (2) has one 
two-way interaction (E*S) and the main effects.  The null hypothesis suggests that these two 
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models have the same goodness of fit.  If the resulting P value of this test is greater than 0.05, 
this means there is failure of rejection of the null hypothesis, which means that the two models 
have the same goodness of fit and thus we choose the simpler model (2).  This analysis is 
reiterated several times until we come up with the simplest model that is not significantly 
different from the full model.  In our case, model (4) was the chosen model (P=0.1), because it is 
not significantly different from its previous more complex model (3)  
Table 3.8: Analysis of deviance to come up with the best fit model 
Model Predictors Deviance G2 df Models Compared ∆ G2 ∆ df P value 
(1) E*S; E*T 
E; S; T 
288.07 268 ------- -----  --- --- 
(2) E*S 
E; S; T 
292 270 (2)-(1) 3.93 2 0.2 
(3) E*T 
E; S; T 
296.03 272 (3)-(2) 4.03 2 0.1 
(4) E; S; T 300.6 274 (4)-(3) 4.57 2 0.1 
E= Years of Experience; S= Area of Specialty; T=Time, which corresponds to the three different 
questions; prevention, diagnosis, and treatment. 
  
 The test of the significance of each effect in model (4) appeared to be significant as 
shown from the score test in table 3.9.  This suggests that there is difference in the correct 
responses obtained based on the type of question asked (prevention, diagnosis, or treatment), on 
the area of specialty, and on the years of experience. 
Table 3.9: Score statistics for Type 3 GEE analysis 
Source DF Chi-Square P>ChiSq 
T 2 39.88 <0.0001* 
S 4 11.85 0.0185* 
E 1 6.47 0.0110* 
* Significant at P<0.05 
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For fixed Specialty and years of experience, the conditional odds of a wrong answer to 
the prevention question are 10 times more as compared to the treatment question (Table 3.10).  
Similarly, the conditional odds of a wrong answer to the diagnosis questions are 2.56 times more 
as compared to the treatment question.  Thus, given specialty and years of experience, 
participating physicians answered best on the treatment question, followed with the diagnosis 
question, then with the prevention question. 
Table 3.10: Conditional Odds Ratio (OR) of incorrect answers to the three questions 
Correct Answer OR C.I. 
Prevention% Treatment  10* (4.76; 21.7) 
Diagnosis % Treatment 2.56* (1.38; 5) 
Prevention% Diagnosis 3.86* (2; 8.33) 
* Significant at P<0.05 
For fixed years of experience and for a specific question, the conditional odds of 
responding right is 6.98 times higher in Rheum + Endo as compared to the baseline ObGyn; 4.24 
times higher in IM as compared to the baseline; 4.06 times higher in FP+NP as compared to the 
baseline; and 3.74 times more in Ortho+Others as compared to the baseline ObGyn (Table 3.11).  
Thus, given the years of experience and the question asked, the knowledge about osteoporosis 
management went in a descending order from ‘Rheum + Endo’ to ‘IM’ to ‘FP + NP’ to ‘Ortho + 
Others’ to ‘ObGyn’. 
Table 3.11: Conditional Odds Ratio (OR) of correct answers based on area of specialty as 
compared to the baseline (ObGyn) 
Correct Answer compared 
to baseline (ObGyn) 
OR* C.I. 
Rheum + Endo 6.98* (2.4; 22.8) 
IM 4.24* (1.76; 10.19) 
FP+ NP 4.06* (1.53;10.8) 
Ortho + Others 3.74* (1.3; 10.72) 
* Significant at P<0.05; Rheum=Rheumatologist; Endo=Endocrinologists; IM=Internal Medicine; 
FP=Family Practitioner; NP=Nurse Practitioner; Ortho=Orthopedics. 
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For fixed area of specialty and for a specific question, the conditional odds ratio of 
responding right is 4% higher as years of experience increases by one unit (Table 3.12).  Thus, 
given the area of specialty and the question asked, the knowledge of osteoporosis increased as 
the number of years of experience increased. 
Table 3.12: Conditional Odds Ratio (OR) of correct answers based on years of experience 
Correct Answer  OR* C.I. 
(Year+1) % (Year) 1.04* (1.014; 1.071) 
* Significant at P<0.05 
 
3.4. Discussion  
 
3.4.1. Osteoporosis Prevention 
 
The majority of the respondents (98%) prescribed a high calcium diet as well as exercise 
as a preventive measure before osteoporosis occurs (Table 3.3).  19% of the bone is made of 
calcium mineral and 99% of total body calcium is in the bones (Shils et al., 1998).  Calcium is 
crucial for the formation and remodeling of bones as well as for calcium homeostasis.  Vitamin 
D increases calcium absorption from the gut.   
75% of the physicians would control for alcohol and smoking.  Alcohol, if consumed in 
excess (>2cups/day), can directly affect direct bone tissue by inhibiting calcium absorption, and 
smoking decreases calcium absorption and the therapeutic effect of estrogen (Papazian, 1991).    
Most of the physicians (55%) were reluctant about prescribing hormones as a preventive 
measure for osteoporosis in men and women who are hypogonadal (Table 3.3).  According to 
specialty, the percentages of physicians were 44% of the IM, 27% of the ObGyn, 9% of the 
rheumatologists, and 9% of the family practitioners.  However, it is known that sex steroids 
secreted in the body during puberty increase the bone mineral density (BMD) and the peak bone 
mass (NIH concensus, 2001).  Thus any delay in the menarche (such as in strenuous exercise or 
under emotional stress or low body weight) will be reflected in the attainment of the peak bone 
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mass, and preventive measures such as prescribing gonadal steroids in this scenario are crucial to 
prevent osteoporosis.  According to the literature, some studies have shown that hormone 
replacement therapy such as estrogens with or without progesterone can reduce the risk of hip 
fracture.  Moreover, this reduction in the risk is proportional to the quantity and the duration of 
estrogen usage (Michaelsson et al., 1998).  In a similar vein, Lindsay (1993) has favored the 
usage of hormone replacement therapy –estrogen, in addition to progestin only if the uterus was 
not removed- in order to prevent osteoporosis.  Lindsay emphasized in his article the importance 
of patient monitoring; this includes bone mass measurement after 1 year of treatment, annual 
mammography, blood pressure measurement after 3 months of treatment, and lipoproteins 
profile because it is known that oral administration of estrogen increases HDL and decreased 
LDL (Barrett-Connor; 1993).  In contrast, Minelli et al. (2004) have shown that the usage of 
hormone replacement therapy (HRT) as a prevention against osteoporosis in women without the 
menopausal symptoms is not recommended, namely in women with a baseline risk of breast 
cancer.  Thus, the authors suggest an individualized approach tailored to the case of every 
individual in order to make a clinical decision.  The WHO on the other hand recommends the use 
of HRT for prevention of osteoporosis in women with ovarian failure.  The benefits of HRT 
outweigh their risks if given for a period of 10 years.  It is important to inform women about the 
pros and the cons of HRT so to make an informed decision about its usage (WHO guidelines, 
1994).  On the other hand, the FDA recommends the minimum usage of HT for the shortest 
duration possible and with a minimum dosage only when other alternatives are not feasible 
(Stephenson, 2003); this is in congruence with NOF among other societies.  Additionally, other 
evidence suggested that HRT was not recommended by FDA to treat osteoporosis (Lane et al., 
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2003).  These conflicting results are still reflected among the participants in the survey where 
only 45% of the physicians recommend HRT in hypogonadal patients. 
 Coffee intake in relation to osteoporosis was underestimated, where only 40% of the 
physicians were aware of the caffeine effect on calcium absorption (Table 3.3).  Studies have 
shown that coffee intake has been associated with increased risk of hip fracture in elderly women 
(Kiel et al., 1990).  This could be explained by the calciuretic effect of caffeine (Bergman et al., 
1990) leading to a negative calcium balance (Hernandez-Avilla et al., 1991). However, Barrett-
Connor et al (1994) have shown in their cohort study of 980 postmenopausal women that 
caffeine intake was associated with reduced BMD only in women who had marginal calcium 
intakes.  Similarly, another longitudinal study found no association between caffeine intake and 
bone loss in postmenopausal women (Lloyd et al., 2000).  Further studies comparing the timing 
of caffeine intake with milk or a few hours after milk consumption need to be conducted in order 
to understand the role of the timing of caffeine intake with respect to calcium. 
3.4.2. Osteoporosis Diagnosis 
 
The majority of the professionals who responded had indicated fracture as a risk factor 
for osteoporosis (Table3.4a).  This is concordant with previous data, which have shown that 
independent of bone mass, previous fractures of the spine are predictive of the risk of future 
spine fractures.  One explanation may be that once a vertebra is damaged, it will change the 
mechanical loading on the remaining vertebrae, and thus make them susceptible to further 
fractures (Johnston and Slemenda, 1993).   
 Only 53% of the respondents considered low peak bone mass at early ages to be a sign of 
osteoporosis presence (Table 3.4a), while it has been suggested in 1984 that the peak bone mass 
reached in the third decade is “the most important factor that determines how much of the bone 
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will be lost before fractures occur” or a “low bone mass is reached” (Wahner et al., 1984).  
Additionally, a 2-year randomized controlled trial in young women (20-35 years) showed that a 
combined regimen of aerobics and weight training had a positive effect on the BMD of the hip, 
spine, and calcaneus in the participants and thus on their peak bone mass (Friedlander et al., 
1995). 
 Clearly, most physicians (90%) responding to the survey recommended the usage of Dual 
Energy X-Ray Absorptiometry (DXA) as a detection method before fractures occur (Table 4b), 
which is concordant with the WHO guidelines (1994) and with Marshall et al (1996) who 
declared that a DXA scan was a great predictor of fracture risk.  However, only 29% of them 
recommend a DXA scan for all women above 65 years of age (Table 3.4c), although this is 
recommended by the guidelines set by both WHO and NOF.  According to Morris et al. (2004), 
some of the barriers to BMD testing are the lack of uniformity in the content of the screening 
guidelines.  Nevertheless, controversy exists among experts about whether BMD alone is enough 
as a diagnostic criterion (NIH consensus statement, 2000).  Not only are there concerns about   
“region-specific reference ranges”, as well as “intre-and inter-manufacturer differences in 
hardware and software algorithms” (Formica, 1998), but also it is suggested that relying on just a 
single measurement of bone mass is an underestimation of the actual risk of fracture occurrence.  
In fact, previous low-trauma fractures may be indicative of a poor bone quality and are correlated 
with increased risk of fracture, independent of bone mass (Wasnich, 1993).   
Appropriate referral of patients at risk is crucial for the optimal management of 
osteoporosis.  This survey suggests that appropriate referral occurred in only 51% of the 
respondents who answered “yes” when asked if DXA should be used as a screening tool; 
however, 37% thought that DXA should be only for women at risk for osteoporosis because they 
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believed that BMD measurement was too expensive.  3% never considered DXA as a screening 
tool, most probably because they had no idea about who should have this procedure.  10% 
complained about the unavailability of a DXA machine at their facility, although they were 
aware of its importance as a diagnostic tool for osteoporosis.  This should draw the attention of 
the health care community to make the DXA machine more accessible to the physicians at some 
hospitals.  In fact, it has been shown in the literature that low-cost BMD screening is highly 
effective in motivating the patient in seeking medical consultation for osteoporosis prevention 
and treatment (Anastasopoulou and Rude; 2002); likewise, Cline et al. (2005) concluded from 
their cross sectional survey of postmenopausal women residing in Minnesota that BMD 
screening encourages the patient to engage in exercises (weight-bearing) and the physician to 
initiate a drug therapy.  Recent evidence showed that if Medicare expanded by 10% the BMD 
testing for women for osteoporosis prevention, it could have saved billions (collated from 
Disease Management Advisor, 2003). On the other hand, according to the physicians’ estimation, 
a mean of only 23% of patients would do the bone scan if they were not insured.  All these 
current and previous findings corroborate the importance of a BMD screening; consequently, this 
should draw the attention of the health agencies to authorize this reimbursement.   
Specifically striking is the fact that as many as 41% of the respondents suggested the 
usage of X-ray as a detection method before fractures occur (Table 3.4b), despite the fact that X-
rays will only detect bone loss by the time 25 ± 40% of bone mass has already gone (Delmas, 
1999).  Herein, the lack of knowledge of some of the physicians is a problem towards a good 
osteoporosis management.  Another deceiving fact was that only 43% of the physicians 
recommended a bone scan upon gluco-corticoid use (Table 3.4c), despite the fact that the NOF 
recommends a DXA scan in this particular scenario.   
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3.4.3. Osteoporosis Treatment 
 
The majority of respondents had a global knowledge about osteoporosis treatment where 
all of them (100%) recommended calcium and most of them (89%) recommended vitamin D 
supplements as well (Table 3.5a).   95% of the respondents advised exercise.  According to 
WHO, the effects of exercise on bone mass have been inconsistent; however, carefully designed 
exercises for women with osteoporosis have shown to optimize well-being, muscle strength, 
postural stability, and thus decrease the risk of subsequent fracture (WHO, 1994).  While NOF 
recommends walking and resistance training for patients with osteoporosis, 85% of the 
respondents advised walking, and only 52% recommended resistance training (Table 3.5b).  On 
the other hand, some studies have shown that swimming (Hart et al., 2001; O’Neil et al., 2002) 
increased bone density in OVX rats, but the effect on human is still controversial.  In this survey, 
33% of the respondents recommended swimming.  Moreover, sports activities that include 
repetitive impact on the spine (running) may cause damage to the lumbar spine and are thus not 
favorable to people with osteoporosis (Shephard, 2002).  Surprisingly, a few of the respondents 
demonstrated poor knowledge to the kind of exercise suitable for osteoporosis, where 20% 
recommended “running” and a few others recommended “non weight bearing activities” such as 
“bike riding”, albeit not recommended by NOF as a treatment for osteoporosis.  In 1993, 
Heinonen et al. reported that the cyclist female athletes had relatively low lumbar and hip BMD 
when compared to other weight-bearing activities such as skiing or weight lifting.  This may be 
explained by the fact that cycling does not include vertical weight-bearing activities.  Sometimes, 
the nomenclature of the exercise regimens might be misleading to physicians and even to the 
patients themselves.  There are a variety of non-weight bearing exercises that can be beneficial to 
osteopenia patients, as will be shown in Chapter IV, such as site-specific strengthening exercises 
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that target a specific area in the body, e.g. the lower back.  These exercise can be beneficial to 
the bone mineral loss, although they are not all weight bearing or resistance exercises per se.  
Other longitudinal studies need to be done to test whether these type of exercises benefit patients 
who have osteoporosis, which is a more advanced stage in bone loss, as compared to osteopenia.  
On the other hand, other non-weight bearing exercises such as bike riding are known to be non 
beneficial for treating bone mineral loss.  Consequently, physicians need to be more specific and 
consistent in prescribing exercises regimen to treat osteoporosis, by first increasing their 
knowledge about it, and by using a common nomenclature that does not confuse the patient.  As 
for the physical therapy, 16% of the physicians answered “yes”.  Their answer was considered 
correct, but more clarification needs to be mentioned about this technique.  Emerging evidence 
has cautioned against the use of manual therapy in individuals with osteoporosis for fear of 
causing rib or vertebral fracture (Maitland et al., 2001).  On the other hand, some physical 
therapists prescribe appropriate strengthening exercises when treating individuals with 
osteoporosis, which is considered a safe and adequate treatment. 
As for exercise frequency, the majority of the respondents (58%) recommended a 
frequency of 3 times per week (Table 3.5c), and 61% reported a duration of 16-30 minutes each 
time (Table 3.5d).  Although hormones were recommended by 45% of the respondents for 
osteoporosis prevention in hypogonadal patients (Table 3.3), 87% of the respondents 
recommended the usage of HRT as a treatment of osteoporosis (Table 3.5a), either estrogen 
alone (68%), or Evista (50%), or a combination of progesterone and estrogen (46%), or even 
testosterone (15%) as shown in Table 6e.  The pros and cons of HRT in osteoporosis patients 
have been discussed above.  To summarize those, we note that recent emerging evidence 
highlighted that the risks of long-term HRT in healthy postmenopausal women by far 
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outweighed the benefits in chronic health maintenance (Schulman et al., 2002); therefore, these 
substantial findings should prompt the cessation of its usage for this purpose.  Additionally, it is 
important to note that most of the respondents recommended the usage of bisphosphonates 
(92%), with Fosamax being the favorite prescribed drug recommended by the physicians (90%), 
followed with Actonel (42%), then with Etidronate (15%).  The issue of discussing what seems 
to be the best treatment for osteoporosis will be discussed in the next chapter (Chapter IV).   
3.4.3.1. Best Treatment for Osteoporosis 
 
No physicians recommended diet/supplements as the sole treatment for osteoporosis but 
69% included diet/supplements in their combination treatment.  The most commonly 
recommended treatment was the combination of diet/supplements + exercise + biphosphonates 
(44%) with some adding hormone replacement therapy or calcitonin to this combination.  
As a single best treatment, Biphosphonates was the first choice by 16% of the physicians. 
According to the responding physicians, they considered that bisphosphonates would 
mostly improve BMD in 55.32% of the cases; second, hormones in 32.81% of the cases; third, 
calcitonin (18% of the cases), and last, diets and supplements (in 15.3 % of the cases) are 
recommended.  
3.4.4. Osteoporosis Follow-up 
 
 Based on the physicians’ estimation, 78% of the patients come back for a follow-up for 
another DXA every 1 to 2 years (Table 3.6).  As for the rest, they either reported the 
unavailability of DXA, which should raise some red flags to the health authorities; or they said 
“every 3 to 4 years”, which is too long of a period to follow-up with an osteoporosis patient; or 
they said “every 6 months”, which is too short to show a change on the bone mineral density, 
taking into consideration the random error coming from the machine itself; or they said “never”, 
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which is the worst case scenario for osteoporosis management.  According to the literature, 
patients receiving HRT, calcitonin, or Selective Estrogen Receptor Modulator (SERM) should 
have a repeat BMD scan every 2 to 4 years; while patients receiving bisphosphonates should 
repeat it every 1 to 2 years (McGarry et al., 2003).  In all cases, DXA scans should be more 
available to physicians in order to follow-up appropriately with osteoporosis patients, physicians 
should be aware that patients need to come back for a follow-up for another scan every 1 to 2 
years.  Conversely, Wei et al. (2004) reported in their paper that neither BMD nor bone turnover 
markers were substantially correlated to fracture rate reduction; consequently, the best optimal 
way to monitor a treatment efficacy remains unknown.  Nevetheless, physicians should put more 
effort into explaining to the patients the importance and the seriousness of the disease and its 
follow-up in order to enhance patient compliance.  Chapter IV will show the low percentage of 
patients’ adherence to physicians’ prescription; interestingly, 88% of the physicians are fully 
aware that the patients do not fully comply with their prescription (Table 3.7).  This being said, 
physicians do need to take serious and sustained steps and be more involved in optimizing the 
management of patients with osteoporosis to enhance their compliance. 
3.4.5. Comparative Analysis Discussion 
  
 Physicians’ knowledge about osteoporosis management varied with the type of question 
answered.  Physicians answered best on the treatment question, followed by the diagnosis, and 
then by the prevention question.  It also turned out that rheumatologists and endocrinologists 
scored the best as compared to other specialties.  This might be due to the fact that 
rheumatologists are more specialized in diseases related to the bones and the joints, and they deal 
with elderly people most of their time.  Similarly, endocrinologists deal most of the time with the 
hormonal problems, which are very linked to the osteoporosis in post-menopausal women.  
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According to the WHO published summary, it is recognized that several medical specialties deal 
with osteoporosis patients; including “rheumatology, orthopedics, general practice, 
endocrinology, metabolic medicine, geriatrics, and obstetrics and gynecology”.  These specialties 
deal with osteoporosis, albeit they are not equally “professionally trained” in metabolic bone 
diseases.  This should draw the attention of the “relevant Royal Medical Colleges” and 
encourage them to include the osteoporosis management as a training component to all the 
relevant disciplines (WHO, 1994).  In addition, it appeared that physicians with more years of 
experience scored higher in general.  This might also be due to the fact that some of the 
respondents were residents (1 or 2 years of experience), and thus they are not expected to know 




Knowing that physicians are a very busy population, they barely have time to read and 
fill out a questionnaire.  Therefore, the response rate was not very high (25.2%); and thus the 
sample size was not fully representative of the target population of physicians.  There may also 
have been a sampling bias where only physicians interested in osteoporosis filled the 
questionnaire.  Another limitation is that there were a couple of questions in the questionnaire 
that were not very clearly understood by the respondents, and thus, they would skip the answer.  
This has lead to some missing values in some of the variables.  Therefore, the summary statistics 
should be interpreted with caution, taking into consideration the sampling errors and the 





 Respondents displayed poor knowledge regarding osteoporosis prevention with gonadal 
steroids in hypogonadal patients; control of caffeine intake because of its calciuretic effect; 
osteoporosis diagnosis with X-rays; DXA scan recommendation upon glucocorticoid use; DXA 
scan recommendation for all women above 65 years of age; and the appropriate kind of exercise 
for osteoporosis treatment.  Rheumatologists and endocrinologists scored globally better on 
osteoporosis management.  Physicians with more years of experience were more knowledgeable 
of osteoporosis care. 
3.6. Recommendations 
 
There is a need to equally expand the knowledge among physicians with different areas 
of specialties, who deal with osteoporosis patients in Baton Rouge and New Orleans, with 
respect to prevention, diagnosis, and treatment of osteoporosis.  Physicians need to convey the 
osteoporosis message to the patients in a sustained way that will improve adherence to the 
regimen.  The health agencies should recognize DXA scan reimbursement and broaden its 
policy.  There is clearly a need for greater availability of the diagnostic tool (DXA machine) in 
more hospitals in Louisiana.  This will improve the standard care of osteoporosis and thus result 
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OSTEOPOROSIS TREATMENT AND PATIENT ADHERENCE: A CASE-REFERENT 
STUDY OF POST-MENOPAUSAL WOMEN IN BATON ROUGE 
 
4.1. Introduction  
 
Prior to 1990, estrogens and calcitonin (a thyroid hormone; injectible form) were the only 
two drugs authorized by the Food and Drug Administration (FDA) for osteoporosis treatment. 
Postmenopausal women were reluctant to use estrogen due to the concern about the continuation 
of their menstruation cycle, as well as the connection of estrogen to breast cancer (Papazian, 
1991).   
The major inconvenience of salmon calcitonin (injectible) is its cost: it is 10 times more 
expensive than estrogen therapy (Watts, 1994).  On the other hand, nasal calcitonin has shown to 
decrease vertebral fracture frequency (WHO, 1994), albeit some unfavorable reactions such as 
nasal discomfort, nausea, and flushing were shown (Eastell, 1998; Watts, 1994).   
For women diagnosed with osteoporosis, newer drugs such as bisphosphonates 
alendronate (Fosamax) and risedronate (Actonel) can help strengthen bone and prevent 
subsequent bone loss (Siris et al., 2004).  Yet, the use of bisphosphonates is not recommended in 
individuals with hypocalcemia, persons with esophagus complications, and people who are 
unable to sit or stand for 30 minutes after each dose (McCoy, 2001).  
Other varieties of new medications include the selective estrogen receptor modulator 
(SERM) Raloxifene (Evista) and more recently, intermittent parathyroid hormone (PTH) 
(Forteo).  Although there has been a debate in the literature about whether pharmacological 
treatments can actually suppress bone resorption or add up bones, PTH was shown to add bone 
instead of just reducing the rate of bone loss (Siris et al., 2004).   
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Calcium alone may be partly effective in decreasing the rate of bone loss, particularly in 
elderly women and those who are deficient in calcium.  Vitamin D increases calcium absorption, 
which may lead to beneficial effects on the bone (Eastell, 1998). 
Because the number of treatment options is escalating, the decision-making process is 
becoming a hard task.  There is even some controversy regarding the active treatment of 
osteoporosis (Speroff, 1999).  According to Speroff, the ideal treatment for early postmenopausal 
women is hormone therapy.  However, it is questionable that this applies to all post-menopausal 
women.  Moreover, a lot of studies have looked into the different treatment approaches for 
management of osteoporosis; yet, none of the studies have looked into the patient’s adherence to 
treatment protocol.  So, does optimal osteoporosis management lie in the type of treatment 
prescribed or in the patient adherence to the treatment protocol?  
4.1.1. Purpose 
The goal of this study was to investigate the types of interventions for 
osteopenia/osteoporosis offered to a population-based case-referent of postmenopausal women 
with osteopenia/osteoporosis, and then to look at the outcome of these methods, including patient 
adherence to the treatment protocol. 
The objectives were to answer the following questions: 
1- Are patients compliant with the physician’s prescribed treatment? If not, what are the barriers 
to compliance? 
2- Based on the treatment followed, what kind of response is seen on the patients upon the 
second/third year of treatment? What is the best treatment for osteoporosis in practice? Does the 
treatment work equally on the spine and the femur? 
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3- Does optimal osteoporosis management lie exclusively on patient adherence? 
4.2. Materials and Methods 
 Study Design: This study used a case-referent design.  In a case-referent study design, “a 
series of people with and another without the illness are enrolled and their profiles with respect 
to the exposure, past or present, are ascertained and compared.  The same population that gives 
rise to the case-series, gives rise to the referent series.  The referent series are not people without 
the condition, but they are a sample of the population from which the cases came” (Olli 
Miettinen, 1976).  The study consisted of 223 postmenopausal women who suffered from low 
bone mineral density in the femur, the spine, or in both. 
 Target population: Post-menopausal women, diagnosed with osteopenia or osteoporosis, 
who had followed a prescribed treatment for osteoporosis along with two dual-energy X-ray 
absorptiometry (DXA) bone scans taken within a time frame of three years prior to the time of 
the study.   
 Sample size: A total of 223 medical records were examined for this study. 
 Case series:  Post-menopausal women who showed a positive response to treatment.  This 
was determined by comparing the two DXA scans taken within the 3-year time frame.  1.  The 
first DXA scan should show a BMD at least 1 SD below the mean.  2.  The second DXA scan 
should show an increase in the bone density with respect to the previous measurement.  3.  The 
case-series should be free from evidence of deterioration of bones for the previous 3 years of the 
study. 
 Referent series: They are women who showed no response to treatment.  This was 
determined as follows: 1. The first DXA scan should show a BMD at least 1 SD below the mean.  
2. The second DXA scan should show a decrease in the bone density.  3.  Referent-series are 
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women who showed any of the following end-points: fractures, loss of height, curvature of spine, 
rounding of the back, falls, and broken bones during the study timeline. 
 Measurement of exposures, and covariates: In this study, subjects may have been exposed 
to different treatments for different periods of time within the 3-year time frame of the study.  
For the purpose of this study, a cut-off point of 1 year was set to classify subjects as exposed or 
non-exposed.     
 Data collection methods: Medical records of the subjects were reviewed for demographic 
data (age, race), behavioral data (cigarette smoking, alcohol use, exercise habits), allergies, 
history of present illness, past medical history, medications taken, family medical history, social 
history, and a variety of clinical information including review of systems (chest, breath, thyroid 
problems, diabetes, allergy, abdominal problems), physical examination results, and all medical 
correspondence with each patient.  Record reviews were restricted to all post-menopausal 
women aged 45 years or older.  Physician comments were followed gathering information on 
specific recommendations for osteoporosis interventions including medications and referral for 
BMD testing.  Bone densitometry measurements were made using DXA scans. 
An attempt to obtain information not available from the medical records was done 
through a patient phone interview; however only a subsample of 100 randomly selected patients 
was interviewed.  Patients were called over the phone from Ochsner clinic.  The Ochsner’s 
Institutional Review Board for the protection of human subjects reviewed/approved the 
telephone script that was used for the study.  A formal verbal consent of the patients to have 
access to this information was obtained.  This information included actual treatment followed 
(adherence), the length of time of the treatment followed, as well as current assessment of 
exercise habits.  Please refer to the attached script (Appendix 3) used for telephone interviews. 
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 Inclusion criteria: Post-menopausal women diagnosed with osteoporosis or osteopenia in 
the femur and/or the spine area, and who have had at least two DXA scans within the previous 3 
years.  Some of the women should be accessible at the time of the study.  Verbal informed 
consent was obtained prior to subject subscription for the interview. 
 Exclusion criteria: Women who were unreachable at the time of the study for medical 
reasons (death) or geographical reasons (migration) were not included in the sample size that was 
randomly selected to check about patient adherence. 
4.2.1. Statistical Methods 
 
A descriptive comparison between the physician prescription (obtained from the medical 
records) and what the patient said (obtained from the interview) was done to estimate the 
percentage of adherence and identify the barriers for non-compliance.  Analysis of variance was 
used to test if the treatment means were equal in the spine and the femur areas.  A Chi-square 
analysis (X2) was done to estimate the odds of recovery while being on bisphosphonates in each 
site.  Repeated Measures Anova using Proc Mixed was used to test if the treatment was 
consistent for both sites femur and spine, taking into consideration the repeated measures in 
space on the same subject as one variable “site”.  To avoid complexity of the model, only the 
two-way interactions were kept in the model.  Higher order interactions have lead to empty cell 
sizes and have made the analysis unable to run.  Logistic regression using Proc Genmod was 
used to compare between the different treatments’ combinations that were followed.  Ultimately, 
a modeling approach using a regression analysis with backward elimination was used to control 
for the different confounding variables and estimate their correlation with the change in bone 
mineral density in the spine and the femur.  Only the main effects without any interaction were 
used in the model.  All the confounding variables such as such as smoking, exercise, body mass 
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index (BMI), steroid therapy, history of osteoporotic fractures, genetics, milk intolerance, and 
illnesses such as cancer, thyroid disease, kidney failure, liver disease, and bowel disease were 
controlled for by including the significant variables in the model and removing the non 
significant variables.  The statistical analyses were done using SAS (version 9). 
4.3. Results 
 
 Two hundred and twenty three medical records were reviewed (Table 4.1).  The subjects 
included had a low bone mineral density in either the spine or the femur or both.  Of these 223 
subjects, some of them had a low BMD in the spine only, others had a low BMD in the femur 
only, and others had low BMD in both areas.  For the purpose of this study, we will first do a 
separate analysis for each of the spine and the femur.  Among the 223 subjects, 208 subjects (143 
cases and 65 referents) had a low bone mineral density in the spine and 201 subjects (107 cases 
and 94 referents) had a low bone mineral density in the femur (Table 4.1), knowing that some of 
the subjects in both groups are the same because they have low BMD in both areas. The mean 
BMI was in the range of 24 to 25 kg/m2.  The majority of the sampled women with low bone 
mineral density were Caucasian.  When a sample of 100 women was interviewed over the phone, 
it appeared that only 37-38% was fully adhering to the physician’s prescription, while 62-63% 
was partially adhering or not adhering at all. 
Table 4.1: Descriptive characteristics of the study population 
 Spine Cases Referents Femur Cases Referents 
Total (n=223) 208 143 65 201 107 94 











































*Others: Hispanic; African American; Native American; †Includes “partially” and “not at all”; 
BMI= Body Mass Index. 
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 Table 4.2 shows the number of subjects who became cases (recovery from the disease) or 
controls (no recovery from the disease) in each of the femur and the spine.  The percentage of 
people who recovered in the spine area (68.75%) was higher than in the femur area (53.23%) 
suggesting that the spine area is more responsive to the treatment.  When the last DXA scan was 
assessed, it turned out that more women had osteoporosis in the spine (59%) and osteopenia in 
the femur (54.5%) suggesting that the spine was the area that was most susceptible to lose bone 
mineral mass.  These results are also confirmed with the percentage mean changes in BMD in 
each area.  The yearly change in BMD can go as low as -6.28 or -6.09 in each of the femur and 
spine respectively, and as high as 6.5 or 13.9 in each of the mentioned areas respectively.  Here 
again the mean change per year in BMD was higher in the spine area.   
Table 4.2: Descriptive characteristics at the end of the study 
  Femur Spine 







Normal (at the end)           
Osteopenia (at the end)      







∆BMD*/yr  min 
                         max  






1.11± 2.56  
* Change in Bone Mineral Density (BMD) per year in g/cm2 
The subjects were on different kinds of treatments, whether a single treatment (e.g., 
dietary supplements, antacids, fosamax, actonel, evista, fortero, premarin, calcitonin, exercise), 
or a combination of two, three, or four treatments of the ones previously mentioned (Table 4.3).  
The number of subjects per treatment followed varied between a minimum of two and a 
maximum of 29 subjects.  For the purpose of the analysis, treatments were collapsed into for 
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single groups (Fig4.1) such as “Calcium” (calcium and vitamin D supplements; or one 
multivitamin and one antacid); “Bisphosphonates” (fosamax; actonel); “Hormones” (premarin; 
evista; fortero; calcitonin); and “Exercise” or a combination of 2; 3; or 4 of these single groups.  
Note that the majority of the subjects who were taking bisphosphonates were taking mostly 
fosamax, and those who were on hormones were mostly on premarin (estrogen); nevertheless, to 
avoid bias, the broader name was chosen to indicate treatment groups. 
Table 4.3: Mean yearly change in lumbar BMD and number of subjects per treatment 
followed  
Treatment N Mean spine BMD ± SD 
B 3 8.64 ± 6.85 
BE 2 3.72 ± 1.60 
CaBE 29 2.17 ± 2.85 
CaBH 13 1.97 ± 2.57 
CaBHE 15 1.92 ± 1.89 
CaB 23 1.61 ± 2.06 
BH 2 1.59 ± 0.84 
H 7 1.51 ± 1.44 
CaHE 22 1.09 ± 1.92 
CaH 29 0.65 ± 1.74 
Ca 29 0.53 ± 2.29 
E 3 -0.04 ± 3.08 
CaE 28 -0.17 ± 2.32 
HE 3 -0.89 ± 1.26 
Ca=Calcium; B=Bisphosphonates (Fosamax/Actonel); H=Hormones (Premarin; Evista; Fortero; 
Calcitonin); E=Exercise; CaB =Calcium + Bisphosphonates etc…;  
   
Analysis of Variance (ANOVA) of the mean yearly change in BMD in the femur showed 
that subjects who were on BH; B; CaBH; CaBHE; CaBE; BE; CaB; CaH; or H had higher 
increasing values of BMD as compared to CaHE; Ca; CaE; E; or HE, albeit these former were 
not significantly different among each other.  Note that the bar graphs in Fig.4.1 with the same 
letter are not significantly different.  It is also important to note that the ANOVA is unbalanced 
and the cells do not have equal size.  Numerically, the treatment group of BH scored the highest 
increase per year in femur BMD but there was only one subject in that group.  These results 
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should be discussed with caution.  Subjects who were on either calcium alone, or calcium and 
exercise, or exercise alone, or hormone and exercise showed a decrease in femur bone mineral 
density.  When comparing subjects who were on bisphosphonates vs. those who were not, the 
odds of recovery in the femur area (or being a case) was 2.08 times more in subjects taking 
bisphosphonates either alone or in combination with other therapies (X2=5.29; P=0.02; 
OR=2.08). 
Table 4.4 represents the mean yearly change in the femur BMD as well as the cell size 
per treatment followed.  There was only one subject under the treatment combination of 
bisphosphonate and hormone.  Analysis of variance of the mean change in BMD in the spine 
showed that subjects who were on Bisphosphonates had a significantly highest increase in spine 
BMD as compared to the rest of the treatment combinations (Fig4.2).  Subjects who were on 
either exercise alone, or calcium and exercise, or hormone and exercise showed a decrease in 
spine bone mineral density.  Chi-square analysis revealed that the odds of recovery in the spine 
area (or being a case) was 1.96 times more in subjects taking bisphosphonates either alone or in 
combination with other therapies (X2=5.28; P=0.02; OR=1.96). 
When the variables (femur and spine) were combined into one variable (site), repeated 
measures ANOVA was used to compare if both sites reacted similarly to the treatments 
followed, and to test which treatment appeared to have an overall increasing effect on the bone.  
Table 4.5a displays the significant main effects and interactions obtained from the repeated 
measures ANOVA.   
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Fig. 4.1: Mean yearly change in BMD in the femur according to different treatment combinations 
*Means with the same letter (A; B; or C) are not statistically different. 
 
Table 4.4: Mean yearly change in femur BMD and number of subjects per treatment 
followed  
Treatment N Mean femur BMD ± SD 
BH 1 2.35 ± . 
B 3 1.49 ± 0.79 
CaBH 13 1.37 ± 2.02 
CaBHE 14 1.24 ± 1.28 
CaBE 27 0.80 ± 1.49 
BE 2 0.52 ± 1.68 
CaB 21 0.30 ± 2.01 
CaH 27 0.21 ± 1.89 
H 9 0.19 ± 1.15 
CaHE 23 0.07 ± 1.63 
Ca 28 -0.40 ± 2.15 
CaE 25 -0.56 ± 1.30 
E 5 -0.6 ± 1.52 
HE 3 -1.72 ± 3.37 
Ca=Calcium; B=Bisphosphonates (Fosamax/Actonel); H=Hormones (Premarin; Evista; Fortero; 
Calcitonin); E=Exercise; CaB =Calcium + Bisphosphonates etc; 
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Fig. 4.2: Mean yearly change in BMD in the spine according to different treatment combinations 
*Means with the same letter are not statistically different; ‡ Bisphosphonates had significantly the 
highest mean yearly change in BMD in the spine 
 
 Table 4.5b shows in more details where this significance comes into play; it indicates that 
the spine showed more response to the treatment than the femur; this can be also seen in Fig4.3 
below, where the mean yearly change in BMD was higher in the spine as compared to the femur, 
for almost all the treatment protocols followed.  Fig4.1 and Fig4.2 are both depicted in Fig4.3. 
Table 4.5a: Repeated measures ANOVA with two-ways interactions 
Type 3 tests for fixed effects 
Effect  F value Pr>F† 
Site 28.35 <0.0001
Site*Calcium 4.15 0.04 
Bisphosphonates 8.45 0.005 
Exercise 7.04 0.01 
Ca*Exercise 8.86 0.0031 
Ca*Hormones 7.63 0.008 
† Only significant results were reported 
 
In addition, Table 4.5b shows that calcium acted better in the spine than on the femur; 
Moreover, it also appeared that being on bisphosphonates was better than not being on them, yet, 
exercising alone was not statistically different from not exercising; being on calcium alone was 
 85
worse than being on a combination of calcium and exercise, or calcium and hormones, or even 
on hormones alone.   
Table 4.5b: Repeated measures ANOVA: significant main effects and interactions 




1.80 ± 0.25  





1.24 ± 0.17 





1.79 ± 0.37 





0.47 ± 0.34 






0.88 ± 0.2 
0.72 ± 0.2 







1.03 ± 0.21 
0.57 ± 0.19 




†Means with the same letter are not statistically different; A is better than B; B is better than C; 











































Fig. 4.3: Mean yearly change in BMD in Femur & Spine vs. Treatment  
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 Taking the subjects who were just on calcium as a baseline (Table 4.6), the logistic 
regression analysis showed that the odds of recovery while being on CaBHE is 5.68 times the 
odds of being on just Ca for the spine.  As for the rest of the combinations, no significant 
difference was seen among the treatments. 
Table 4.6:  Logistic regression results for the spine comparing the odds of being on CaBHE 
vs. being on Ca 
Analysis of Parameter Estimates 
    Parameter  DF Estimate  OR Wald X2 P>X2 
Intercept 1 0.2076     ----- 0.31 0.5782 
CaBHE 1 1.7383     5.68 3.87 0.039* 
Ca 1 0.00    ----- . . 
*Significant at P<0.05 
 
 Table 4.7 displays the significant odds ratio of the different treatments in the femur.  The 
analysis showed that odds of recovery while being on CaBE were 3.16 times the odds of being 
on just Ca in the femur.  Similarly, the odds of recovery while being on CaBHE were 5.33 times 
that of being on just Ca.  In addition, the odds of recovery while being on CaBHE were 1.68 
times than being on just CaBE (OR=1.68), however, this synergistic effect of the hormones was 
not significant CI= (0.3; 7.05).  
Table 4.7:  Logistic regression results for the femur comparing the odds of being on 
CaBHE vs. being on Ca and the odds of being in CaBE vs. being on Ca 
      Analysis of Parameter Estimates  
    Parameter  DF  Estimate     OR  Wald X2 P>X2 
Intercept 1 -0.2877 ----- 0.57 0.4513 
CaBE 1 1.1527  3.16 4.11 0.04* 
CaBHE 1 1.674   5.33 4.42 0.025* 
Ca 1 0.00 ----- . . 
*Significant at P<0.05 
 
Another modeling approach was tried in order to control for the different confounding 
variables and to include them in the analysis.  Table 4.8 shows the results of the stepwise 
regression with backward elimination procedure.  The variables that were eliminated were 
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illnesses, smoking, milk intolerance, exercise, and steroid.  As for the remaining variables, they 
were significant at the 0.1 level or the 0.05 level as the table indicates. 
Table 4.8: Summary of stepwise regression with backward elimination showing the 





Type II SS F value Pr>F 
BMI* 0.04496      0.02090    20.55778     4.63   0.0321 
Genetics -0.40889     0.22942    14.10733     3.18   0.0755 
HistFx -0.39983     0.21844    14.87897     3.35   0.0680 
Site* -0.96684     0.21363    90.96672   20.48   <.0001 
Ca -0.58356     0.34666    12.58528     2.83   0.0931 
B* 1.62289      0.22508    230.88011   51.99   <.0001 
H 0.36350      0.21848    12.29339     2.77   0.0970 
†All variables kept in the model are significant at the 0.1 level; * P<0.05; BMI=Body Mass Index; 
HistFx= History of fractures; Ca=Calcium; B=Bisphosphonate; H=Hormones;  
 
 It appeared that BMI, bisphosphonates, and hormones had a positive slope.  This suggests 
a positive correlation between these variables and the change in BMD.  As for the remaining 
variables such as genetics, history of fractures, and calcium taken alone, these had a negative 
slope.  This suggests a negative correlation between these variables and the change in BMD.  
“Site” was coded as a binary indicator 0 or 1, with 0 referring to spine and 1 referring to femur.  
The negative slope obtained for “site” simply indicates that the change in BMD is less in the 
femur as compared to spine. 
 Table 4.9 shows barriers to adherence to the various treatments prescribed by the 
physicians.  For calcium and vitamin D supplements, some women complained about stomach 
bloating and constipation problems.  For bisphosphonates, the identified barriers were cost, rash, 
digestive problems for “fosamax” and intolerance for “actonel”.  For hormones, the main barriers 
were the risk of cancer, the continuation of menstruation, and the indecision among physicians 
for use of premarin, and the cost of “evista”.  As for the recommendations of exercise or 
smoking cessation, the barriers were lack of motivation and will from the patients to do so. 
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Table 4.9: Barriers towards subjects’ compliance  
Non Adherence to: Causes 
Calcium + vitamin D ? Stomach bloating/problems; 
? Constipation 
Exercise ? No motivation; No will 
Fosamax ? Cost; 
? Digestion, stomach, esophagus, swallowing problems; 
Diarrhea;  
? Rash;  
? “Not know about it”. 
Actonel ? “can’t tolerate” 
Evista ? Cost 
Hormones (Premarin) ? Ovarian/ colon cancer risk; 
? Menstruation;  
? Indecision among physicians 




 Dietary factors such as calcium intake in childhood, adolescence, and later in life, 
estimate intake of salt, caffeine, and alcohol; smoking; physical activity in childhood and 
adolescence; age at menopause (premature menopause); amenorrhea; small skeletal frame, low 
BMI, steroid therapy, history of osteoporotic fractures, illnesses such as cancer, thyroid disease, 
kidney failure, liver disease, and bowel disease might affect the development of osteoporosis 
later in life” (Goldmann and Horowitz, 2000).  Thus, these variables might bias our results in 
comparing groups that might be different inherently for reasons other than the treatment or 
“exposure” factor.  Getting the information from the medical records before hand is one way of 
controlling these confounding variables.  However, variables such as previous calcium intake 
and exercise habits since childhood will be assumed to have a diluted effect for the three years 
time frame of the study.  In practice, it is hard to collect such detailed information related to 
childhood lifestyle habits from the medical records or even from interviewing the women 
themselves. 
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 Sixty two to 63% of the phone interviewed patients did not partially or fully adhere to the 
prescribed regimen.  Among the remaining 38% who adhered, they adhered mostly to the 
combination of calcium, exercise, and bisphosphonates.  This being said, the reality was not far 
away from the physicians’ estimation as shown is chapter III, where 88% of the surveyed 
physicians thought that the patients did not partially (87%) or fully (1%) follow their 
prescription.  The result of this case referent study suggests that osteoporosis management 
depends to a certain extent on patient adherence.  The survey conducted in chapter III suggests 
on the other hand that osteoporosis management relies in the treatment prescription or the 
physician’s knowledge about it per se.  Adding these two studies together, the answer will be that 
osteoporosis management relies on both factors: patient adherence and treatment prescription.   
 The spine was more responsive to treatment than the femur area (Fig4.3).  It also showed 
that not only were there more subjects who recovered from the disease in the spine as compared 
to the femur, but also there were more people who had more osteoporosis in the spine than the 
femur in their most current DXA scan.  This suggests that the spine area is a more susceptible 
area for bone turnover, and it is also more sensitive to treatment.  One possible explanation 
behind this mechanism might be a regression towards the mean, where the weaker area is the one 
that shows more improvement.  This finding is consistent with previous findings where it was 
stated that the femur and the spine are two different types of bone.  The femur is predominantly 
cortical “appendicular skeleton” and the vertebra is predominantly trabecular “axial skeleton”.  
There is a differential bone loss not only between the two kinds of bone, but also among different 
trabecular bone sites (Wahner et al., 1984).  It was also suggested that the vertebral trabecular 
sites were more susceptible to bone loss and had a higher turnover rate as compared to other 
bone sites, whether cortical or non-vertebral trabecular sites.  This might be due to the greater 
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surface area of the vertebra upon which osteoclasts can function (Lane et al., 2003) or the greater 
blood supply towards the trabecular bone surfaces because of its proximity to the bone marrow 
(Mazess, 1983).  As far as the different responses seen among patients, the yearly percent change 
in BMD in both areas varied from negative to positive.  In other words, the kind of response 
upon a treatment can be a decrease, maintenance, or an increase in BMD.  According to Wilkin 
(1999), it is believed that an increase or maintenance in bone density with treatment is a good 
indication that treatment is effective.  Similarly, according to Cooper (2000), osteoporosis cannot 
be eliminated, but the medications can slow down the bone turnover and rebuild some of the 
bone.   
 It appears that bisphosphonates and hormones or bisphosphonates therapy alone result in 
the highest mean response numerically, but it is not statistically different from B; H; CaB; CaH; 
BE; CaBH; CaBE; or CaBHE.  These treatments have the same letter “A” on Fig4.1.  Note that 
the analysis of variance that generated these results was unbalanced.  For instance, there was 
only one subject that was under BH, and this subject had the highest numerical value in change 
in femoral BMD.  Thus, conclusions should be drawn with reservation.  Surprisingly, it appeared 
that bisphosphonates alone had the highest effect in the spine as compared to the rest of the 
treatments (Fig4.2).  These results are similar to the findings Follin and Hansen (2003) where 
they suggested that when it came to pharmacological therapy, bisphosphonates showed the 
greatest benefit in bone loss prevention and fracture risk lowering.  On the other hand, other 
studies were conducted to evaluate several combination therapies, but the results were 
conflicting.  In some randomized controlled trials, combination therapy showed greater increases 
on BMD than either agent alone (Johnell et al., 2002) but the results on the fracture risk are still 
unknown.  Further studies need to be implemented in order to test the validity of this 
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observation.  The negative effects of CaE; E; HE in the femur and spine and Ca in the femur can 
be explained by three reasons.  First, these negative numbers were not statistically different from 
other positive numbers observed under other treatments (as seen in the letters indicated on the 
bar graph in figures 4.1 and 4.2).  Second, the target population chosen for this study was 
postmenopausal women who suffered from low bone mineral density, with the cut-off chosen 
being the one for osteopenia.  Third, the design is unbalanced and the sample size is relatively 
small as compared to the myriad of combination treatments in the study.  This being said, there 
were a number of subjects who started off with osteoporosis and if these patients were put on just 
calcium, or exercise, or calcium and exercise, they didn’t show improvement in their bone 
mineral density.  It appears that if the stage of the disease is advanced, patients need to be on an 
anti-resorptive therapy such as bisphosphonates.  Yet, for postmenopausal women who have 
osteopenia, calcium and exercise alone might be enough to counterbalance the bone turnover.  
Congruent with our findings, Siris et al. (2004) stated that for osteopenia, non-pharmacologic 
treatments such as resistance training exercise and adequate calcium intake were advised to 
counterbalance the bone turnover.  But in more advanced situations such as osteoporosis, an anti-
resorptive therapy was needed to prevent fractures.  It is important to explain why the target 
population was chosen to be patients who had the disease or the condition of low BMD; in 
chronic disease epidemiology, incident (new) rather than prevalent (already established) cases 
are enrolled.  In case of a prevalent case (i.e. a person who responded to treatment before the 3 
years time frame), one should be excluded from the computation of the population-time of 
experience, otherwise, it will be necessary to assume that the duration of illness (response to 
treatment) is unrelated to exposure.  To avoid this dilemma, the recruited subjects were chosen in 
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a way they all had the disease, in this case, low bone mineral density in either femur, spine, or 
both. 
The results of the repeated measure ANOVA confirm that the spine is more responsive to 
treatment as compared to the femur (P<0.01) (Table 4.4b).  This is also shown in fig4.3.  
Exercise did not improve the BMD when compared to non exercise since exercise alone is not 
enough for people with advanced stage of the disease.  The combination of calcium and exercise 
was more significant that calcium alone.  This is congruent with the finding of Specker (1996) 
who concluded that calcium supplements can only be beneficial on bone health if complemented 
with adequate physical activity.   
 The combination of the four treatments of Ca, B, H, and E had higher odds of recovery 
from the disease as compared to being on one sole treatment such as calcium.  However, when 
another mono-therapy is taken as a reference, the odds of recovery were not significantly 
different as compared to being on a combination of 2; 3; or 4 drugs.  The literature regarding this 
matter has been conflicting.  On one hand, some studies discouraged the use of combination 
therapy suggesting there is no substantial evidence to recommend such a treatment for 
osteoporosis (Comptson and Watts, 2002); on the other hand, McGarry et al (2003) suggested 
that the combination of alendronate and raloxifene produced significantly higher gains than 
either drug alone.  While table 4.6 suggests that adding hormones onto CaBE was not 
significantly any better than just CaBE, Eastell (1998) has likewise shown that there was no 
evidence that combining ERT onto bisphosphonates was more effective than either treatment 
alone.  Due to the unbalanced design and the small cell size in some of the treatment 
combinations, there was surprisingly no significant difference among the remaining treatment 
combinations.  The odds ratio in this case is an estimate of the incident-density ratio, “without 
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the need of the rare disease assumption’ (main characteristic of the case-referent studies) 
(Miettinen, 1976).  The incidence density ratio tells the risk of development of case (in this case 
recovery) in relation to the exposure (treatment followed) for various time periods.  However, 
due to the complexity of the treatment combinations followed by patients, the unavailability of 
the exact information of the length of time under which they were following a certain treatment, 
and their recall bias even when they were verbally asked about the length of time they have been 
on a certain treatment, all these reasons have made the estimation of the exact time periods 
impossible to the estimation of the incident density ratio.  To solve the problem of exposure or 
non exposure, a cut-off point of one year was chosen to define exposure to a specific treatment.  
This being said, the OR calculated in tables 4.5 and 4.6 are an estimation of the incident density 
ratio for an average of a one year period of time.   
 None of the analyses mentioned above were able to control for all the variables that are 
known to influence the response to the treatment.  The stepwise regression (Table 4.7) eliminated 
the non-significant variables and kept the significant ones.  Again, it appeared that the correlation 
between calcium alone and the change in BMD was negative.  This might be explained by the 
same reasoning that calcium alone is not enough to compensate for the bone turnover at the 
advanced stage of the disease.  Bisphosphonates showed the highest slope estimate, which is 
consistent with the literature.  This analysis also confirms that spine is more responsive to 
treatment than femur because of the negative slope obtained for “site”.  The intake of hormones 
was positively correlated to an increase in BMD.  BMI was positively correlated to the increase 
in BMD as well.  It is possible that the heavier the body, the more weight the bones have to bear, 
and thus the stronger the bone density.  Genetics and history of fractures were both negatively 
correlated to BMD.  Studies have shown that if a previous fracture occurs, then it is more likely 
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that another one happens subsequently, independently of bone mass (Johnston and Slemenda, 
1993). 
 A weight of evidence suggested that subjects who had suboptimal dietary calcium intake 
were the ones who reported higher barriers as compared to those receiving adequate amounts 
(Wallace, 2002) and subjects who reported lower barriers to exercise were the ones more likely 
to engage into a regular weight bearing exercise (Blalock et al., 1996).  Table 4.9 displays the 
barriers to adherence as mentioned by the interviewed patients.  Some of these barriers can be 
overcome by finding an array of medications or anti-resorptive therapy that can be tailored to 
different individuals with different tolerance levels.  For instance, if some women cannot tolerate 
“fosamax”, they need to be switched to “actonel” or to another kind of treatment.  On another 
note, the inconsistency among physicians about the usage of a certain therapy, say hormones, 
might lead the patients to confusion and might hinder their adherence.  Moreover, congruent with 
the findings of the survey in chapter III, it is suggested that physicians need to be more involved 
into explaining to the patient about each treatment prescribed.  Interestingly, Hsieh and 
coworkers (2001) reported that women who expressed worry about osteoporosis were more 
likely to adhere to hormone therapy, weight-bearing exercise, calcium or vitamin D supplements.  
This being said, physicians need to discuss with the patient the seriousness of the disease and 
how important it is to follow the prescribed regimen, whether it is exercise, or cessation of 
smoking, or any other behavior modification.  In fact, studies have shown that although 
Americans might be aware of the exercise health benefits (Morrow et al., 1999), their behaviors 
indicate that they are probably unaware of how to become physically active to achieve a health 
benefit (Morrow et al., 2004).   Behavior modification requires a lot of psychology, motivation, 
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education, and persistence from both sides; so it is the role of the physicians to play this role as 
much as possible to enhance positive feedback from the patient. 
4.4.1. Limitations 
 
The present study provided data from a 3 year population-based sample, with correlation 
to medical record information.  This was done in order to minimize misclassification bias. The 
confounding variables such as previous dietary habits and exercise habits were considered as 
diluted within the 3 years time frame of the study. 
Other sources of biases:  
 Selection bias:  the establishment of the inclusion and exclusion criteria already created a 
selection bias.  There is also a survival bias where only those who survived were included 
because it is a retrospective study.  It is not known whether the cause of death of some patients 
was related to osteoporosis or to other reasons.  Besides, the sampling frame for selecting cases 
and controls were restricted to one location.  Thus, it is questionable whether the sample selected 
really represented the target population (cases of women outside the location of the study). 
 Misclassification bias: Recall bias; this is shown especially while interviewing the 
patients about their actual treatment followed and their current level of physical activity.  
However, to control for this source of bias with respect to the other variables and exposures, the 
duration of the study is confined to a period of 3 years. 
The carry over effect of the medications that were taken within the previous six months 
prior to the time frame of the stuffy and not during the study might affect the BMD changes.   
4.5. Conclusion 
 
Osteoporosis management relies partly on patient adherence.  62% of the patients didn’t 
fully adhere to the prescribed regimen.  Barriers to adherence varied from physiological reactions 
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to a specified treatment to a lack of motivation from the patient.  Physicians need to be more 
involved in monitoring compliance.  The change in BMD under a specific treatment can vary 
from a decrease, to maintenance, or to an increase in BMD, without necessarily achieving the 
normal BMD range.  Spine, the area mostly affected, showed more improvement with treatment 
than the femur.  Bisphosphonates acted best on the spine statistically and on the femur 
numerically.  Combining calcium with exercise or calcium with hormones was better than either 
one alone, but may not be enough if the patient had osteoporosis.  An anti-resorptive medication 
medication might be needed if the disease was advanced.  Ultimately, low BMI, genetics, and 
history of fractures were negatively correlated to the increase in BMD.  Thus, these risk factors 
for osteoporosis are also risk factors for further progression of the disease as seen by decreased 




Novel means of osteoporosis management should be approached by physicians to 
overcome the barriers for patients’ adherence.  Moreover, criteria for monitoring adherence 
should be established.   
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THE EFFECT OF CALCIUM SUPPLEMENTS AND SITE-SPECIFIC 
STRENGTHENING EXERCISES ON LUMBAR MINERAL DENSITY AND MUSCLE 




There has been no general consensus with respect to the exact type and amount of 
exercise that would be beneficial to patients with osteoporosis (Watts, 1994; Henderson et al., 
1998).  Moreover, it is still not known whether bone in the elderly can be maintained with 
slightly above the average habitual activity or with some non-athletic exercises with low to 
moderate intensity levels (Kemmler et al., 2004).  Walking 20 to 30 minutes three times per 
week (Watts, 1994) or walking 30 minutes daily in one to three bouts in addition to resistance 
training two times per week (Asikainen et al., 2004) has been suggested to be of a benefit.  Any 
activities that might lead to falling need to be avoided (Watts, 1994). 
 Recently, researchers have focused on determining whether different forms of physical 
activities targeting critical skeletal sites can enhance the BMD in postmenopausal women.  
Generally speaking, the major muscle groups are easily targeted in everyday life (leg and arm 
muscles), yet at the expense of neglecting other areas in the body that need to be specifically 
targeted such as the lower back.  Not only is this area often neglected in people, but also it can be 
damaged by some kind of repetitive impact activities (e.g.running) or weight lifting at the end of 
a range of motion (Shephard, 2002).  Yet, a recent meta-analysis of randomized trials (15 
studies) has shown that both impact (e.g. aerobics) and non-impact (e.g. weight-training) 
exercises had a positive impact on the lumbar spine mass in post-menopausal women (1.6% bone 
loss prevented vs. 1% bone loss prevented respectively) (Wallace and Cumming, 2000).  
According to Rutheford (1999), most studies do not detect a difference between the impact of 
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both types of exercises (endurance and strength training) on the lumbar mineral density.  In all 
cases, however, the lower back along with the abdominal muscles should be targeted in every 
exercise activity, because they both represent the core of the body and they keep this last under 
balance and control (www.spine-health.com).  In a similar vein, Sinaki et al. (1993) have 
emphasized the importance of assessing the safety and effectiveness of exercise programs 
designed to strengthen the lower back muscles and to improve the posture in postmenopausal 
women because of the higher vulnerability of the spinal trabecular bone to mineral loss as 
compared to other areas. 
Moreover, recent researches have suggested that inactivity can be detrimental to the 
muscles of the lower back and it can lead to a longer recovery period or even worsen the 
condition.  In 1991, Limburg et al. mentioned that weaknesses in the lower back muscle group 
(extensors and flexors) can lead to vertebral compression in people with osteoporosis in the 
spine.  Similarly, in 1989, Sinaki noted that strengthening the back extensor muscles that are 
already weak can help in maintaining good posture and vertical alignment.   
According to White (2001), osteopenia can be managed primarily by exercise and 
adequate nutrition; there is no evidence that a pharmacological treatment is needed at this stage.  
On the other hand, other literature negates the fact that a treatment for osteoporosis can actually 
restore bones, although (unlike calcium supplements) antiresorptive therapy has been shown to 
prevent bone resorption (Peel et al., 1995). 
 According to the American College of Sports Medicine guidelines (ACSM, 2000), 
“muscular strength is best achieved by the use of weights, but it can also be developed by static 
or dynamic exercises”; this means that muscular strength can be improved without using any 
external object for extra resistance. 
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 In the literature, strength training has always been related to weights.  In this study, 
however, no weights were involved due to the possibility that some people with bone problems 
might not be able to lift any weights.  The site-specific strength exercises that were given only 
utilized the body weight of the subject.  In fact, there has been some concern in the literature 
about the efficacy, practicality, safety, and compliance of elderly to resistance training, 
especially if they haven’t had any previous experience in regular weight training (Petranick and 
Berg, 1997).  It is also cumbersome for elderly to go to the gym or to be obliged to use some 
equipments for the long term.   
This being said, the idea of developing a safe site-specific exercise program, easily 
accomplished by elderly people suffering from low bone density (T score <-1 SD) has emerged.  
These exercises target the core and lower back muscles attached to the lumbar spine, without 
using any extra weights or any instruments.  In fact, Hsieh and Turner (2001) concluded from 
their interventional rat study that increasing load frequency can lead to osteogenesis.  Home 
based exercises are becoming an attractive alternative to clinical therapies, knowing that the 
health care resources are limited (Hakkinen et al., 1999). 
5.1.1. Purpose 
 
The goal of the study was to design an appropriate, convenient, and inexpensive home 
exercise program for postmenopausal women suffering from low bone density.  The program 
consisted of site-specific core/lower back strengthening exercises.   
The primary objective was to prevent the accelerated bone loss induced by menopause 
via the core/lumbar strength exercises.  Secondary objectives were to improve isometric lumbar 
strength and overall quality of life. 
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5.2. Materials and Methods 
 
 Study design: The experimental design was a pretest-posttest control group design.   
 Subjects and procedures: Medical records of postmenopausal women from Ochsner clinic 
were examined.  Forty women who fit the criteria were contacted by phone by the investigator.  
They were verbally asked if they were interested in being a participant in the study.  At first, 20 
women showed interest and accordingly, they were mailed the informed consent form to be 
signed.  Only 11 women returned the signed informed consent.  They were then assigned 
appointments for measurements.  Five women were in the exercise group and another 6 women 
were in the control group.  However, one woman dropped out of the exercise group during the 
study for personal reasons unrelated to her physical skeletal health.  The final sample size was 10 
women.  The 10 women gave their informed written consent before the testing and after all 
procedures were explained to them.  All methods and procedures were approved by the 
Institutional Review Board of Ochsner Clinic Foundation in New Orleans.  The treatment 
allocation was made by the participants’ choice.  The women in the exercise group were assigned 
the core/lower back strengthening exercises for a period of one year, 3 times a week, 40 minutes 
each time; The control group were either not active (2 subjects), or already involved in a physical 
activity such as weight lifting (n=1), walking (n=1), working in the yard (n=1), aerobics (n=1) 
but not doing the exercises designed for this pilot study.  The women assigned to the control 
group were asked to maintain the same pattern of their dietary intake and physical activity 
throughout the study.  Both groups were asked to attend the three meetings for isometric lower 
back strength measurement (pre, mid, and post study) and the two meetings for the Dual Energy 
X-ray Absorptiometry (DXA) scan measurements of the spine (L1-L4) (pre- and post study).  All 
measurements were done by the same subjects on the same machines.  All the women were on 
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calcium supplements except for two: one in the exercise group where her total daily calcium 
intake was 800 mg and another woman in the control group where her total daily calcium intake 
was 1000 mg.  One subject who completed the study was excluded from the analysis due to her 
low calcium intake and high intake of synthroid, which would confound the results. 
 Inclusion criteria: Participants had to meet the following criteria to be enrolled in this 
study: 
-Be psychosocially, mentally, and physically able to fully comply with the exercise protocol 
including adhering to the follow-up schedule and requirements and filling out forms. 
-Have medical clearance to begin a physical exercise program. 
-Provide a signed informed consent 
-Be postmenopausal women, and do not exceed 75 years of age. 
-Suffer from osteopenia: low bone density (-2.5 SD<T score< -1SD) 
-Have a bone scan taken at the time of the beginning of the study or three months prior to the 
study. 
 Exclusion criteria: Women with the following criteria were excluded from the study: 
-Osteoporosis, (if DXA bone density is less or equal to –2.5 (The World Health Organization 
definition of osteoporosis) 
-Frail women above 75 years of age 
-Morbid obesity defined as Body Mass Index (BMI)>40 or weight more than 100 lbs over ideal 
body weight. 
-Systematic disease including AIDS, HIV, hepatitis. 
-Back pain of unknown etiology 
-Under hormonal replacement therapy  
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-Underweight women (BMI< 18.5) 
-Previous hip or vertebral fracture (Fracture risk drastically increases following the first fracture, 
according to some literature (Watts, 1994). 
-On daily steroids. 
-Undergoing exercises different from the ones assessed at baseline. 
-Contraindication to participation in back strength measurement and back exercises.  
-Previous spinal operation 
-Deficiency in calcium and vitamin D (<800 mg/day) 
Data collection strategy: The data of the different variables were collected as follows: 
-Height and weight and body mass index for all subjects were recorded 
-Physical activity readiness for each participant will be identified by the Physical activity 
readiness questionnaire (PAR-Q) (Appendix 4) (www.csep.ca/pdfs/par-q.pdf) 
-Level of physical activity.  The participants were asked to complete the Aerobic Center 
Longitudinal Study Physical Activity Questionnaire (ACSM, 2005) at the beginning and at the 
end of the study to monitor changes. This Questionnaire is designed to conduct physical activity 
pattern, including leisure and household, during the past three months. Information regarding 
walking, stair climbing, jogging, swimming, weightlifting, aerobic dance, and household 
activities were acquired.  All kinds of physical activity were accepted besides the specific 
core/lower back strengthening exercises (Appendix 5) 
-Baseline calcium/vitamin D intake: Subjects were asked to complete a food frequency 
questionnaire focusing on the calcium rich, calcium rich food, high-protein foods, caffeine 
containing beverages, and alcoholic beverages food pre- and post-study to monitor calcium 
deficiency or changes if any (Appendix 6) 
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-Global health assessment variables were measured such as global strength, global pain, and a 
general well-being, using the short form 36 (www.swin.edu.au/victims/resources/assessment) 
pre- and post-study to monitor any changes in the feelings of well-being (Appendix 7)  
-Medical history and health related behaviors were measured using the health status 
questionnaire (www.ncsf.org/pdf/downloads/Health_Status_Questionaire) (Appendix 8) 
-BMD: Lumbar BMD determined by DXA (GE Lunar Prodigy a) was assessed at baseline and at 
the end of the study (gemedicalsystems.com).  All subjects were measured on the same DXA by 
the same technician (D.K.) 
-Muscle strength:  Isometric strength of back extensor muscles were measured at different joint 
angles (0; 12; and 24) using a back isometric dynamometer (Biodex b, Copyright Biodex Medical 
Systems, Inc. 2003) at baseline, six months, and at the end of the study (biodex.com).  Three reps 
were performed at each angle and the average peak torque was reported at each angle.  The 
overall average of the values at the three different angles taken at baseline, 6 months, and the end 
were used for the analysis. Subjects were measures by the same technician (R.M.) on the same 
machine. 
-Informed consent: All participants received a comprehensive explanation of the proposed study, 
its benefits, inherent risks and expected commitments with regard to time. Following the 
explanation of the proposed study, all patients were allowed a period of questioning. Individuals 
who were willing to participate in the study were required to read and sign the informed consent 
document during the first visit and prior to any experiments (Appendix 9) 
 Operationalization: The exercise group performed the abdominal and lower back 
strengthening exercises for 40 minutes, three times a week, over a period of 12 months 
minimum.  The exercises were implemented while lying on the floor in a prone or supine 
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position (strength calisthenic exercises) or while standing and leaning against a chair for support 
(weight bearing).  Participants started their exercises with a five minutes warm-up.  Stretching 
was included in some of the exercises and at the end of the session.  Women in the exercise 
group were given a descriptive list of the core/lower back strengthening exercises (Appendix 10).  
Participants in both groups were asked to maintain their regular physical activity assessed at 
baseline.   
 Exercise description: A thorough warm-up preparing the back for the exercises to come 
is completed at first.  The muscles that support the spine vary from “extensors” (back and gluteal 
muscles), to “flexors” (abdominal and iliopsoas muscles), to “obliques” or “rotators” (side 
muscles).  Trapezius, rhomboids, latissimus dorsi (LD), and erector spinae (ES) are the muscles 
that form the back.   Rectus abdominis (RA) and internal/external obliques (O) form the 
abdomen muscles (www.spine-health.com).  This pilot study focused on the LD and ES of the 
lower back, and on the RA and O of the abdomen.  The Rating of Perceived Exertion (RPE) 
scales were used as a guideline in setting the exercise intensity.  Participants were asked to start 
at a low intensity level (RPE 10-11).  A regimen was tailored according to each participant’s 
fitness level.  Subjects were recording the number of sets and reps for each movement at the end 
of each session.  Participants were instructed to gradually go up to a moderate level (RPE 12-13) 
without exceeding the intensity level of 15 till the end of the study 
 To strengthen the back muscles, 30-40 minutes of the following core/lower back 
exercises were done 3 times per week (Appendix 10):  
 Abdominal Exercise 
 1-Pelvic lift: Lie on the floor supine position with knees bent, feet shoulder-width apart, 
and arms to the side; tighten the abdominal muscles, lift the pelvis slightly off the ground 
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without bouncing, and without using buttocks or leg muscles; hold for 5 seconds, exhale, and 
slowly release the pelvis back down on the floor while inhaling.  After 3 months of exercising, 
perform the same movement on the Thera-Band Exercise Balls c, where you put your feet/heels 
on the ball instead of the floor.  Do 2 sets of 15 
 2-Core strengthening: Lie on the floor supine position with knees bent, feet shoulder-
width apart.  Grab both knees and press them against the chest.  Extend one leg out while 
exhaling and take it slowly down towards the floor, without letting it touch the floor.  The leg 
should stop from going down at the level when then lower back starts to arch.  Once at that level, 
take your leg back in and repeat with the other leg.  Do 2 sets of 10. 
 3- Standing knee lifts: Stand with right hand holding on to side of chair; raise left knee 
slowly to 90 degree angle; grab behind left knee with left hand and slowly bring the knee up to 
the chest; hold it for 5 seconds, keeping the core inwards and exhaling, then lower slowly to the 
starting position, inhaling.  Repeat the same with the other leg.  Do 2 times 15 for each leg.  
 4-Standing leg adduction: Stand with right hand holding on to side of chair. Raise one 
straight leg slowly to the side keeping the core contracted inwards; exhale, then lower slowly to 
the starting position, inhaling. Repeat the same with the other leg.  Do 2 times 15 for each leg. 
PS: Exercises 3 and 4 can be combined together in one exercise where the leg goes from forward 
bent 90 degrees position to side extended position. 
 5-Arm/Leg raises: Get down on your hands and knees and keep your core inwards and 
back in a neutral straight position (cat position); keeping your neck and back straight; slowly lift 
your right arm and the left leg to make one straight line parallel to the floor along with the back.  
Your head should be looking towards the floor keeping the neck in a neutral position.  Exhale as 
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you reach out and keep the core inwards.  Slowly go back to starting position while inhaling, and 
repeat the same routine with the other arm and its opposite leg.  Do 4 sets of 10 
 Back Exercises collated from (Hyde, 2001) with some modifications done by the 
investigator (R.M.). 
 1-Prone arm/leg exercises: Lie on stomach –prone position, face-down keeping neck 
straight with legs straight and arms straight overhead; Slowly lift the right arm along with the left 
leg, exhale, hold for 2 seconds and come down.  Repeat with left arm and right leg.  Do 4 sets of 
10.  If the participant fails to accomplish this exercise, he/she can start gradually with lifting each 
arm alone at first, then each leg, then combining both leg and arm. 
 2-Back extension: Keep the previous position.  Repeat lifting the torso slowly off the 
ground while keeping the legs on the floor and exhaling, with both arms behind the head and 
return to start position (10 times).  For a harder exercise, repeat stretching the arms out like a 
cross (10 times), and then stretching the arms forward (10 times).  The last advanced exercise 
can be given in one month from the day of the study. 
 3- Cat curls: Get down on your hands and knees and keep your core inwards and back in 
a neutral straight position.  Your head should be facing the floor.  Curve your back inwards 
making a C shape towards the floor; rise your head looking upwards while inhaling; hold for 3 
seconds; then curve your back outwards in a mountain shape while exhaling; your head should 
be looking downwards; hold for 3 seconds; go back to neutral position.  Do 2 sets of 10. 
 4-Back stretches: Lie in prone position, lifting the torso up leaning on the elbows.  Hold 
for 10 seconds.  Move backward on the bent knees, stretching the arms forward, pulling head 
between arms. Let your gluteus touch your heels.  Hold for 10 seconds.  Gently stand on the feet 
while keeping the torso down; cross the arms and grab behind the knees with the palms.  Very 
 109
gently arch the back upwards to the ceiling (C shape in the back), while grabbing behind the 
knees with the palms.  Hold for 10 seconds.  Gently roll the back all the way up.  Repeat the final 
stretch exercise 5 times.  
5.2.1. Statistical Methods 
 
 Bone density was taken at baseline (BD0) and at the end of the study (BD1).  The change 
in bone density between time 0 and time at the end of the study was calculated for all subjects 
(BD1-BD0=∆BD).  Two-way ANOVA was used to test for the differences in change in BMD 
between the two groups, while blocking for fosamax intake and taking baseline BMD as a 
covariable.  A paired TTEST was used to test the mean difference of BMI, lumbar strength, and 
lumbar BMD obtained for each group at baseline.  Muscle strength was measured at baseline, at 
the mid, and at the end of the study.  Repeated measures analysis was used to test the changes in 
isometric lumbar strength over time.  Repeated measures analysis was also used to test the 
changes in BMI values between the two groups over time.  The Least Significant Change (LSC) 
was calculated for the GE lunar prodigy DXA scan used at Ochsner.  Power analysis using non 
central t-distribution was used to estimate the sample size needed for the study to observe 




 The following pilot study need to be assessed with the following assumptions in mind: 
-Women participating in this study were assumed to accurately report their behavior concerning 
physical activity and dietary intake. 
-Women were expected to adhere to the prescribed exercise plan for the entire period of the 
study, with no loss-to-follow-up. 
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-Lumbar mineral density and back extensor muscle strength were measured on the same 
machines (DXA and Biodex, respectively) tested for their validity and reliability. 
5.3. Results 
 
 Table 5.1 displays the major similarities and differences among the postmenopausal 
women enrolled in the two groups.  All the participants were under 75 years of age based on the 
inclusion criteria.  The three women in the exercise group completed the Back-Core 
strengthening exercises; surprisingly, all of them stopped their previous physical activity such as 
walking, bike riding, and weights, and they dedicated their exercise routine to the study 
exercises.  As for the control group, one woman remained inactive, while 3 others kept their 
previous physical activity (gardening, weights, walking), and another 2 women became more 
physically active once they were enrolled in the study, where one woman started walking and 
another woman added swimming, gardening, and weights onto her aerobics routine.  The study 
lasted for about 12 to 13 months.  One woman in the exercise group started taking fosamax, after 
having been enrolled in the study and 4 women in the control group were on fosamax shortly 
before or during the study.  All women were consuming levels of calcium adequate to support 
bone formation through supplements (8 women) or through diet (1 woman).   There was no 
significant differences between the EG and the CG for any of the baseline variables (strength, 
BMI, and lumbar BMD).  No statistical difference was shown in the BMI change between the 2 
groups (Fig. 5.1).  However, significant differences were shown in the mean changes in mean 
lumbar strength (Fig. 5.2) and BMD (Fig. 5.4) in both groups.  
 At baseline, the BMI values of the 2 groups were not significantly different (TTEST= 
-0.98; P=0.36); Repeated measures analysis of the BMI changes over time (Table 5.2) showed no 
significant interaction between group and time (P=0.98) suggesting no significant departure from 
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parallelism between BMI and time.  The between subject variation (group) was not significant 
either (P=0.36) suggesting that BMI values are not far from being coincident between the 2 
groups.  Similarly, the within subject variation (time) was not significant (P=0.12) suggesting no 
time effect on the BMI. 
Table 5.1: Demographics, baseline data, and value changes for exercise and control groups 
 Exercise group (n=3) Control Group (n=6) 
Race 3/3  Caucasian 6/6  Caucasian 
Exercise Type 3/3 Back-Core 4/6 Walking-weights 
1/6 Yard 
1/6 Non active 
Fosamax 1/3 4/6 
Calcium supplements 3/3 6/6 
Baseline BMI ± SD 23.74 ± 2.35 26.275 ± 4.08 
Baseline Strength ± SD 45.507 ± 32.86 65.156 ± 35.78 
Baseline BMD ± SD 0.972 ± 0.028 0.944 ± 0.029 
∆BMI Kg/m2 ± SD -0.50 ± 0.76 -0.51± 0.704 
∆Strength ft-lbs (T2-T1) ± SD +30.03 ± 11.67* +21.75± 8.12* 
∆Strength* ft-lbs (T3-T1) ± SD +64.11 ± 14.29* +38.07 ± 9.99* 
∆BMD/yr* g/cm2 ± SD +0.019 ± 0.012 -0.029± 0.051 
* P<0.05; ∆ implies change; (T3-T1) implies (final – baseline); (T2-T1) implies (6months – baseline) 
 
 Fig. 5.2 shows that follow-up measurements at 6 months and at 12 months showed 
significant changes for mean isometric strength in both groups.  The baseline mean strength 
values were not statistically different between the 2 groups (TTEST=-0.79; P=0.45).  Repeated 
measures analysis of mean strength values over time (Table 5.3) showed no significant 
interaction between the two (P=0.36) suggesting no significant departure from parallelism 
between mean strength and time.  The baseline value of strength did not affect the change in 
response (P=0.72).  The between subject variation (group) was not significant either (P=0.24) 
suggesting that mean strength values are not far from being coincident between the 2 groups.  
However, the within subject variation (time) was significant (P=0.03) suggesting an increasing 
trend of the strength values from baseline over time in both groups, as shown in Fig5.3.  At 
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baseline, the average strength for both groups was depicted in Fig5.3 because there was no 




























Table 5.2: Type 3 of fixed effects of BMI values over time in exercise and control groups 
Effect F P 
Group 0.93 0.36 
Time 3.08 0.12 




























Fig. 5.2: Mean isometric strength values of exercise (E) (n=3) and control group (C) (n=6) at 





 Baseline lumbar BMD were not significantly different between the 2 groups 
(TTEST=0.93; P=0.38).  The training program resulted in a 0.019 ± 0.012 increase in BMD in 
the lumbar spine in the exercise group (TTEST=2.70; P=0.05; Fig. 5.4).  The 0.029± 0.051 
decrease in BMD in the lumbar spine in the control group was not statistically significant 
(TTEST=-1.39; P=0.11; Fig. 5.4).  A two-way ANOVA with exercise and fosamax being as the 
2 treatments, as well as baseline BMD taken as a covariable, was used to test the difference in 
BMD change between the two groups.    Table 5.4 shows that the one-tailed P value testing the 
difference between the two groups was not statistically significant (T value=0.9; P=0.21).  Table 
5.5 shows the steps to calculate the least significant change (LSC) for the DXA machine used.  A 
change in BMD is significant if it exceeds the LSC.  In our study, the observed changes in both 
groups were at borderline of significance and were not too far off the LSC.  This prompts the 
power calculation using non-central t-distribution as shown in Table 5.6 in order to estimate the 
sample size needed.  Given the observed variance of 0.002 and the observed difference ranging 
from 0.014 to 0.02, the number of subjects per group was generated in order to obtain a power of 
0.8.  Table 5.7 shows a descriptive comparison of the questionnaires filled at the beginning and 
at the end of the study by both groups. 
Table 5.3: Type 3 of fixed effects of mean lumbar strength values over time in E and C 
Effect F P 
Baseline Strength 0.13 0.72 
Group 1.67 0.24 
Time 7.39 0.02* 
























































Fig. 5.4: Bone mineral density (BMD) values in lumbar spine in E (n=3) and C (n=6); Values are 


































Fig. 5.5: Mean yearly change in BMD in lumbar spine in E (n=3) and C (n=6); Values are mean ± 




Table 5.4: Hypothesis testing results of the mean yearly change in BMD between the E and 
C groups by 2-way ANOVA with baseline BMD as a covariable 
TWO WAY ANOVA 
 Estimate ± SE T value P (1 tailed) 
Exercise 0.206 ± 2.233 0.09 0.46 
Control -2.166 ± 1.342 -1.61 0.09 




Table 5.5: Calculation of the Least Significant Change (LSC) of the DXA machine  
Standard Error of the machine 0.01 
Variance of one scan 0.0001 
Variance of two scans 0.0002 
SD of two scans 0.014 
Zα (1-tailed) 1.645 
Margin of Error= Zα * SD= LSC 0.0232 
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Table 5.6: Sample size calculation for observed variance of 0.002; a power of 0.8; and an 







  Power = Pr. (t ≥ t α/2, γ) 
   = 1- F (t α/2, γ; c; δ)  
  γ = degrees of freedom 
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Exercise group Control group 
Health Status 
Questionnaire 
1/3 no change 
2/3 Improvement* 
5/6 no change  
1/6 persistent low back pain 
Short Form-36 3/3 Improvement† 5/6 no change 
1/6 Deterioration‡ 
FFQ§ 3/3 no change 6/6 no change 
*Less low back pain; better performance; better health related attitudes; † Less feelings of 
tiredness; greater health expectations; increased feelings of wellness, calmness, and peacefulness;  
‡ Health limitations to do the work and social activities; pain interfering with work; bone fracture 
in a fall; §FFQ = Food Frequency Questionnaire. 
 
diff n power 
0.020 80 0.80268 
0.020 82 0.81235 
0.021 74 0.80990 
0.022 66 0.80096 
0.022 68 0.81270 
0.023 62 0.81082 
0.024 56 0.80369 
0.024 58 0.81742 
0.025 52 0.80608 
0.026 48 0.80483 
0.027 46 0.81712 
0.028 42 0.80933 
0.029 40 0.81704 
0.030 36 0.80146 
0.031 34 0.80408 
0.032 32 0.80445 
0.033 30 0.80242 
0.036 26 0.81227 
0.037 24 0.80115 




 The ideal situation was that the design would be pair matched where each pair of women 
would be matched for the different variables such as medication, physical activity, baseline 
lumbar BMD, and baseline lumbar isometric strength.  A paired TTEST would have taken care 
of the analysis nicely.  However, the actual situation was different, where it was hard to recruit 
the women into a 1-year exercise study.  Thus, the experimental design alone was not able to 
control for the differences among the participants, albeit these variations between the individuals 
were controlled with the statistical analysis to some degree.  A two-way ANOVA with baseline 
BMD taken as a covariable was run to control for the interaction of fosamax with the exercise. 
 All women in the study were asked to take 1000-1500 mg of calcium supplements 
because it has been suggested that exercise alone would not maintain or increase the bone 
mineral density if there were no calcium available from the diet or supplements.  In fact, in a 
critical review of the literature, Specker (1996) found indirect evidence that the beneficial effects 
of exercise on bone density may only happen if the daily calcium intakes exceeded 1000 mg/day.  
In a similar fashion, Wymelenberg (1994) recommended in the Harvard Health Letter that a 
woman needed to increase her daily calcium intake to 1500 mg when she approached menopause 
because this is when estrogen production starts to attenuate, thus resulting in a decrease in 
calcium absorption.  Likewise, McGarry et al (2003) have suggested that postmenopausal 
women should be taking the upper end of the range (1200-1500 mg).   
 Although the women were asked to maintain their baseline physical activity during the 
whole study, unfortunately, the opposite effect happened; women in the E group dedicated their 
commitment to the study exercises and stopped their previous habitual routine; conversely, 2 of 
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the women in the C group became more active once enrolled in the study.  This interviewer bias 
confounded the results.   
 According to Sinaki and Mikkelsen, (1984), they concluded from their controlled trial on 
postmenopausal women that flexion exercises were causing an increased number of vertebral 
fractures; whereas extension exercises as well as abdominal strengthening exercises were 
important to increase lumbar BMD.  The author Meeks (1999) also discourages the performance 
of flexion exercises (such as abdominal sit-ups) in postmenopausal women.  Based on these 
findings, our exercises were designed as such, with the exclusion of the sit-ups for the abdominal 
work-out. 
 According to Steinschneider et al., (2003), when women lose weight, the bone area might 
appear larger on the DXA scan due to the loss of muscle and fat tissue, leading to an artifact of a 
decrease in BMD.  Luckily, this pilot study showed that the numerical decrease in BMI in both 
groups was non significant with time, where the BMI remained constant in both groups (Table 
5.2).   
 Some studies have shown positive effects of different training regimens on muscle 
strength.  Rhodes et al. (2000) have shown that a one-year progressive resistance exercise 
increases dynamic muscular strength in healthy sedentary postmenopausal women (P<0.01).  
Similarly, Morganti et al. (1995) have reported a similar increase in strength in elderly women 
who performed a series of strength exercises using machines over a period of one year.  The 
findings of these studies were consistent with the present study; however, the exercises given 
here were strength exercises with no weights.  Mean isometric lumbar strength appeared to 
significantly increase from baseline in both groups.  One explanation as to why the control group 
increased in lumbar strength might be their engagement into physical activity after having been 
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enrolled in the study.   In fact, their willingness to participate in the study is a reflection of their 
interest in the exercise training.  Note that the baseline isometric strength value of the control 
group was numerically higher than the exercise group.  Yet, it became numerically lower then 
the exercise group at the end of the study.  These results suggest that the core/lower back 
strengthening exercises did increase isometric muscular strength in post-menopausal women 
with osteopenia in the lower back.   
 Our findings also suggested a borderline numerical but non-significant difference 
between the 2 groups (2.373 ± 2.625) in lumbar mineral density (P=0.21).  In a recent meta-
analysis in 2000, Wallace and Cumming found in their literature search conducted between 1977 
and 1998 that non-impact exercises (strength training with weights) had a positive effect on the 
lumbar mineral density (around 1%) in pre-and postmenopausal women.  Yet, there their search 
was limited to randomized controlled trials.  On the other hand, out pilot study did not include 
weights.  Another study that did not include weights done by Beverly et al (1989) showed that 
grip strength and BMC increased in the forearm of the exercising older women after having 
squeezed on a tennis ball as hard as possible for 30 seconds each day for 6 weeks.  This suggests 
that short period of a site-specific skeletal stress may induce osteogenesis. 
 According to Drinkwater (1994), and congruent with the findings in the case referent 
study in chapter III, the bone that has the lower BMD at baseline would show a greater response 
or increase to treatment compared to bone with a higher BMD.  Similarly, this principle applies 
to the type of bone where trabecular bone is more responsive to treatment than cortical bone. 
This can also apply to individuals, as Drinkwater (1994) had mentioned.  In our study, the 
women in the exercise group had a numerically higher lumbar BMD at baseline, as compared to 
the C group (fig.5.4).  Yet, the exercises still showed a numerical but not significant increase in 
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the lumbar mineral density in the E group as compared to the C group. 
 Another meta-analysis of randomized and non-randomized clinical trials conducted by 
Wolff et al (1999) suggested that there was a preventive effect or a reversed bone loss by almost 
1% per year caused by the exercise training, regardless of menopausal status of the women.  
Furthermore, Wolff’s findings suggested that the overall effect of the non-randomized clinical 
trials was almost double of those randomized suggesting a positive confounding bias due to the 
non-randomization.  To minimize this bias in our study, we controlled for different variables in 
the statistical analysis by including them in the model.  The diversity of the type, intensity, 
duration, and frequency of the exercises used made the development of specific 
recommendations for exercises for these women almost impossible.  In our study however, our 
exercises consisted of site-specific strengthening exercises for the core and lower back, and they 
were performed by postmenopausal women with osteopenia in the lower back at a low-to 
moderate intensity 3 times per week, 40 minutes each time.  Nevertheless, these home-based 
core/lower back strengthening exercises should serve as a complement to, rather then a surrogate 
for, the woman’s aerobic exercise routine. 
   There is a paucity of exercise studies done in early postmenopausal women, as recently 
discussed in a review article by Wallace and Cumming (2000).  Literature regarding the type of 
strengthening of exercises used in our pilot study per se is limited in early postmenopausal 
women.  Sinaki et al. conducted the closest exercise regimen to ours in 1989, where a total of 65 
healthy postmenopausal women (age 49-65 years) were randomly allocated to either an exercise 
group or a control group.  The exercise group was engaged in back strengthening exercises, for a 
frequency of once a day, 5 times a week, for 2 years.  All the women were not on 
calcium/vitamin D supplements.  The results showed no significant differences in the rate of 
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vertebral bone losses between the 2 groups.  Both groups increased in muscle strength but it was 
more significant in the exercise group.  Although the results in Sinaki et al’s study were not very 
different from our results, there are some inherent differences in the designs followed; first, the 
women enrolled in our study had osteopenia as opposed to the healthy women in Sinaki et al’s 
study; second, all of our subjects were on calcium supplements as opposed to Sinaki et al’s study 
where only 50% of the participants of both groups had an adequate dietary calcium intake in the 
range of 1200 mg.  It has already been discussed that a healthy bone would show less 
improvement than a sick bone, and that calcium supplements are the hallmark of exercise-
induced gains in bone mineral content.  On the other hand, in a study conducted on rats, Hsieh 
and Turner (2001) have found that “increasing load frequency” of an exercise is one way to 
promote osteogenesis.  On the other hand, Drinkwater (1994) talked about the “specific exercise 
overload” to the skeletal system that would create an osteogenic response in the elderly, had the 
exercise been indeed an overload.  Likewise, the literature suggests that in order for an exercise 
to meet the osteogenic criteria, the exercises should include a high-magnitude load bearing 
activities with few repetitions (Skerry, 1997).  However, this principle might be harmful to 
elderly people who may not tolerate such a strenuous exercise.  The advantage of our study is 
that the exercises implemented are safe, with low-magnitude overload, and more frequency.   
 Our proposed hypothesis to explain the expected increases in regional BMD with the 
core/lower back strengthening exercises is that the site-specific lower exercises cause the muscle 
to pull on the bone.  The importance of site-specificity of the exercises to increase the BMD in 
the targeted area has been mentioned by a plethora of researchers (Beck and Snow, 2003; Kerr et 
al., 2001; Kerr et al., 1996).  The exercises in our pilot study target opposite muscle groups (the 
abdominals and the lower back).  Thus, the same muscle is contracted when it is activated by the 
 122
exercise, and then it is stretched when the opposite muscle group is activated.  This versatile 
pulling action of the muscle in opposite directions for many sets and repetitions creates strains on 
the bone, which are than translated into biochemical signals, as suggested by Lanyon and 
Hartmen (1977) that might induce bone cell activity, leading to osteogenesis at the points of the 
pulling action.  According to Lane et al., (2003), the combination of muscle pull and direct 
impact initiate bone loading.  Additionally, findings revealed that performing the exercises for 3-
5 repetitions may create enough overload to activate the dormant muscle fibers and thus improve 
muscle strength in frail individuals (Hyatt, 1996).  In fact, Frost (1997) explained in his article 
about the “modeling threshold” principle of the bone; that is the muscle forces should induce 
strains on the bones that exceed its modeling threshold, which will lead to an increase in bone 
mass and bone strength. 
 The non-statistical significance seen in this study may be due to the small sample size.  
Given the variance estimate of the population, the expected difference, and the power, a sample 
size of 80 people per group is needed for an observed difference of 0.02 and a sample size of 22 
per group is needed for an observed difference of 0.039. 
 On another note, it has been suggested that it is unfair to judge on the effectiveness of 
these exercises by regarding the BMD increase as the sole monitoring tool.  Recent emerging 
evidence highlights that there has been no studies that show a positive correlation between BMD 
increments and patient outcomes (Crandall, 2001); additionally, the regression to the mean 
phenomenon may lead to a biased result (Cummings et al., 2000); finally, some studies have 
suggested that the reduction of fractures owing to the exercise treatment is a better reflection of 
the exercise benefit than the BMD increments (Cummings et al., 2002). 
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 According to Tomporowski (2003), physical activity is associated with psychological 
well-being.  It has been recognized in the literature that exercise promotes good health and 
longevity.  Similarly, in our pilot study, the women in the exercise group showed increased 
feelings of wellness, calmness, and peacefulness at the end of the 1-year exercise period based 
on the SF-36 questionnaire that they filled out pre- and post- the exercise study period.  They 
also reported less feelings of low back pain.  On the contrary, the control group either showed no 
change in their feelings of wellness, or even worsening.  One woman in the control group 
fractured a bone in a fall.  This suggests that the core/lower back exercises may also be beneficial 
to maintain balance and stability and this may help preventing the women from falls.  According 
to Rutherford (1999), a myriad of variables lead to the increase or a decrease of a fracture risk.  
Factors such as low bone density, increased age, muscle weakness, and poor balance might 
accentuate the risk of falling, and thus increase the risk of fracture.  Thus, as Shephard 
mentioned in 2002, the importance of physical activity in elderly is not only to increase bone 
density per se, but also to reduce the risk of falls.  Thus, it is wise to design exercises to the 
elderly population that tend to increase muscle strength as well as improve balance in order to 
control for the risk of falls and thus reduce the risk for fractures.  The site-specific core/lower 
back strengthening exercises were specifically designed for this purpose.  Our pilot study 
suggests that these site-specific exercises increase lumbar strength, and may potentially improve 
lumbar mineral density.  This may lead to a better body balance and a decreased risk of fall. 
5.4.1. Limitations 
 
 The prescribed exercise program in the current study did not completely comply with the 
ACSM exercise recommendations which states that an exercise session should comprise a warm-
up period (approximately 10 minutes), an endurance phase (20 to 60 minutes), an optional 
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recreational game, and a cool-down period (5 to 10 minutes) (ACSM, 2000).  In the present 
study, however, the primary objective was to focus on some site-specific calisthenics exercises 
for the lower back and study their effect on the lumbar bone mineral density and strength.  A 
warm-up and a stretching were always given at the beginning and at the end of each session 
respectively. 
 A second limitation is that the proposed study was a pilot study limited to Ochsner 
patients in Baton Rouge;  Due to this sampling bias, the results cannot be generalized to the 
entire population of women with low bone density.  Results should be interpreted with caution.  
Moreover, subjects provided self-reported information regarding exercise and diet, including the 
prescribed exercise they did at their home if they missed one session.  The accuracy of this 
information is subject to bias. 
 A third limitation was that neither the sampling nor the allocation of treatment was 
random.  Due to the difficulty in recruiting women to be part of the exercise study, only those 
who showed interest in being involved in the study were selected.  This accentuated the selection 
bias and might have affected the results. 
 A fourth limitation was the small sample size for this pilot study.  Again, this delineates 
the difficulty in implementing a 1-year longitudinal exercise study. 
 A fifth limitation was that some of the bone scans that were assessed at baseline might 
have been taken 3 months prior to the start of the study.  The change in BMD that might have 
occurred in these 3 months was considered negligible.   
 A sixth limitation was that one woman in the exercise group did not report consuming 






 The site-specific core/lower back strengthening exercises implemented at a low to 
moderate intensity, 3 times per week, 40 minutes each time, appear to significantly improve 
isometric lumbar strength (when complemented with calcium supplements), enhance the feelings 
of wellness.  They may potentially increase lumbar mineral density and may reduce the 
likelihood of back pain. 
5.6. Recommendations 
 
 The site-specific core/lower back exercise should be part of a woman’s weekly routine of 
physical activity since these muscles are neglected in one’s typical daily activities.  These 
exercises may improve trunk muscle strength and stability, which may reduce the risk of falls 
and increase comfort and spine BMD.  Because of the limited sample size, it is highly 
recommended that more studies need to target the design of specific exercises that can be safe, 
osteogenic, and practical to the postmenopausal women who may not be able to engage in weight 
loading activities owing to the low bone mass.   
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a. Biodex; System 3; Model number: 835-000; Dual position back extension/flexion 
attachment’s model number: 830-450.  Biodex Medical Systems Incorporation; 20 
Ramsay Road; Shirley, New York 11967-4704, USA; www.biodex.com 
b. DXA: GE Lunar Prodigy; GE Healthcare Lunar Corporation; 726 Heartland Trail, 
Madison, WI 53717 USA 







 Three projects were conducted to approach the problem of osteoporosis/osteopenia in 
postmenopausal women in Baton Rouge. 
The results of the first study (chapter 3) indicated that responding physicians displayed 
poor knowledge regarding osteoporosis prevention with gonadal steroids in hypogonadal 
patients; control of caffeine intake because of its calciuretic effect; osteoporosis diagnosis with 
X-rays; DXA scan recommendation upon glucocorticoid use; DXA scan recommendation for all 
women above 65 years of age; and the appropriate kind of exercise for osteoporosis treatment.  
Rheumatologists and endocrinologists scored globally better on osteoporosis management.  
Physicians with more years of experience were more knowledgeable of osteoporosis care. 
The results of the second study (chapter 4) indicated that osteoporosis management lied 
partly on patient adherence.  Barriers to adherence varied from physiological reactions to a 
specified treatment to a lack of motivation from the patient.  Moreover, the change in BMD 
under a specific treatment could vary from a decrease, to maintenance, or to an increase in BMD, 
without necessarily achieving the normal BMD range.  Spine, the area mostly affected, showed 
more improvement with treatment than the femur.  Bisphosphonates acted best on the spine 
statistically and on the femur numerically.  An anti-resorptive treatment may be needed if the 
disease was advanced.  Ultimately, low BMI, genetics, and history of fractures were negatively 
correlated to the increase in BMD.  Thus, these risk factors for osteoporosis are also risk factors 
for further progression of the disease as seen by decreased BMD in this study. 
 The results of the third study (chapter 5) suggested that site-specific core/lower back 
strengthening exercises could significantly improve isometric lumbar strength (when 
complemented with calcium supplements), potentially increase lumbar mineral density, enhance 
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the feelings of wellness, and may reduce the likelihood of back pain in postmenopausal women 
with osteopenia.  These exercises were implemented at a low to moderate intensity, theree times 
per week, 40 minutes each time. 
 Ultimately, for a better management of osteoporosis, physicians need to expand their 
knowledge in this arena and to be more involved in motivating their patients to improve patient 
compliance.  Although no specific recommendations for an osteogenic exercise can be developed 
from our studies, the researchers do agree however that physical activity is preferred over 
inactivity (Hertel and Trahiotis, 2001).   
It is highly recommended that more long-term studies with greater number of subjects are 
needed to target the design of specific exercises that can be safe, osteogenic, and practical to the 
postmenopausal women who may not be able to engage in weight loading activities owing to the 
low bone mass.    
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APPENDIX 1: SURVEY QUESTIONNAIRE 
Rania Mekary, B.Sc., M. Sc. Nutrition 
Ph.D. candidate at Louisiana State University 
School of Human Ecology 
Human Nutrition and Food Division 
Baton Rouge, LA. 70803 
 
Tel: (225) 772 6531 or (225) 755 4186 
Fax: (225) 755 0511 
Email: rmekar1@lsu.edu 
 
June 27, 2002 
SURVEY FOR OUR BATON ROUGE PHYSICIANS WHO TREAT OSTEOPOROSIS 
 
Dear Dr., 
 I am Rania Mekary, a PhD candidate at LSU in the Human Nutrition Division, 
conducting a survey for a research project on osteoporosis.  In advance, I am thanking you for 
taking the time to fill out this questionnaire, a necessary step towards completing my 
dissertation. 
    
This survey is a part of an important research being conducted by Louisiana State 
University’s School of Human Ecology concerning osteoporosis.  The aim of the survey is to 
determine the effectiveness of the steps physicians in the Baton Rouge area take to prevent, 
diagnose, treat, and follow-up with their patients who are at risk of - or already suffering from - 
osteoporosis.  Who should have Bone Mineral Density measurements? Who should be treated?  
What is the best-recommended treatment so far? How efficient is the treatment prescribed? Are 
there any improvements on serial test in bone density in patients’ prescribed treatments?  
Hopefully, answers to these questions will be derived once the data is gathered and analyzed 
from this questionnaire.  Subsequently, the results will be made available to you for your 
information and use.  I hope these results will be helpful to your future treatments of 
osteoporosis patients, and ultimately to the patients themselves.  
 
While I know your time is very valuable, so is your input for this survey.  These 
questions were designed to be easily answered with the minimal amount of time required.  Your 
collaboration will be highly appreciated and will be very useful to further our education in this 
endeavor.  Should you have any comments or suggestions, please feel free to contact me or e-








Important: This file is a Word Document. Please press the <Tab> button or the “up” and 
“down” arrows, or the mouse to navigate across the questions.  Refrain from using the 
<Enter> button when filling out this form. If you pressed <Enter> by mistake, click the 
“Undo” Icon form the toolbar on top of your screen to restore the form to its original format. 
Thank you. 
 
1. Today’s Date: (MM-DD-YYYY)       
 
2. Doctor’s information: 
a. Specialty:   Endocrinologist  Family Practice  Internal Medicine 
   OBGYN   Orthopedic   Rheumatologist 
   Other (Please Specify)       
b. Years of Experience                        
c. Hospital name        
 
3. Do you have or have you seen patients with osteoporosis?  
a.  If no, please stop here and submit the questionnaire as instructed at the bottom 
of the survey. 
b.  If yes, approximately how many patients per month?        
Please, continue filling out the questionnaire. 
 
4. What preventive measures do you prescribe before osteoporosis occurs? (Mark all that 
apply): 
a.  Encourage a high calcium diet and exercise to obtain optimal peak bone mass 
at young age.  
b.  Prescribe gonadal steroids in men and women who are found to be 
hypogonadal. 
c.  Control of alcohol intake and smoking 
d.  Control caffeine intake 
e.  Control salt intake 
f.  Control protein intake 
g.  Other (please specify)       
 
5. When do you suspect the presence of osteoporosis? (Please select all that apply): 
a.  Pain  
b.  Loss of height  
c.  Frailty 
d.  Curved back 
e.  Fractures 
f.  Low peak bone mass at early ages 
g.  Low body weight (thin individual) 
h.  Smoking 
i.  Family history of osteoporosis 
j.  Other (please specify)       
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6. What methods do you use to detect osteoporosis before fractures occur? 
a.  Bone density scan by dual energy x-ray absorptiometry (DEXA) 
b.  X-ray 
c.  Blood and urine tests for bone markers 
d.  Physical examination 
e.  Quantitative ultrasound for bone density 
f.  History taking 
g.  None 
h.  Other (please specify)       
 
7. When do you recommend a bone density scan? (Please check the appropriate box): 
a.  When osteoporosis is suspected, before fractures occur 
b.  When see clinical risk factors (premature menopause, amenorrhea, steroid 
therapy, overactive thyroid gland, bowel disease, anorexia nervosa, family 
history, poor diet, excessive alcohol consumption, cancer, smoking, etc.) 
c.  When fractures have already occurred 
d.  To assess the effectiveness of a treatment given for osteoporosis 
e.  Upon glucocorticoid use 
f.  All post-menopausal women 
g.  All post-menopausal women not on hormones 
h.  All women above 65 years of age 
i.  All men above 65 years of age 
j.  Other (please specify)       
 
8. If not insured, what is the % of patients who would do the bone scan anyway?      % 
 
9. When do you consider using the bone density scans (DEXA):  
a.  Always, as a screening tool 
b.  Only for women at risk of osteoporosis because DEXA is expensive 
c.  Never 
d.  Other suggestions (please specify)       
 
10. What treatment do you prescribe for osteoporosis? (Select all that apply): 
a.  Exercise. If yes, 
i. What kind? 
1.  Resistance 
2.  Swimming 
3.  Non weight bearing 
4.  Running 
5.  Walking 
6.  Physical therapy 
7.  Other (please specify)       
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ii. Frequency? 
1.  1 time/week 
2.  2 times/week 
3.  3 times/week 
4.  4 times/week 
5.  Other (please specify)       
iii. Duration each time?  
1.  10-15 minutes/time 
2.  16-30 minutes/time  
3.  31-45 minutes/time 
4.  Other (please specify)       
 
b.  Diet change.  If yes, how?  
i.  More dairy products 
ii.  More fortified milk and cereals 
iii.  Other (please specify) 
 
c.  Supplements.  If yes, what kind? 
i.  Calcium supplements 
ii.  Vitamin D supplements 
iii.  Other (please specify)       
 
d.  Hormone therapy.  If yes, what type? 
i.  Estrogen 
ii.  Progesterone 
iii.  Combination of both 
iv.  Evista 
v.  Testosterone 
vi.  Other (please specify)       
 
e.  Biphosphonates: 
i.  Fosamax 
ii.  Actonel 
iii.  Etidronate 
 
f.  Nasal Calcitonin 
 
g.  Other treatment (s) (please specify)       
 
11. How often do osteoporosis patients come back for follow-up (for another DEXA)? 
a.  Every 6 months 
b.  Every 1 year 
c.  Every 2 years 
d.  Other (please specify)       
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12. Upon follow-up, what is the approximate percentage of patients in whom you see any 
improvement in bone density? (0-100%) 
a. Diet and Supplements      % 
b. Hormones      % 
c. Biphosphonates      % 
d. Calcitonin      % 
    
13. In case of improvement, how do you describe it? (Give approximate percentage) 
a. Decrease in rate of bone loss      % 
b. Net increase in bone mass      % 
c. Maintenance of bone density      % 
d. Fracture prevention      % 
 
14. Do you think the patients follow your prescription? 
a.  Completely 
b.  Partially 
c.  No 
d.  Other (please specify)       
 
15. Which do you think is the best treatment for osteoporosis? 
a.  Supplements / Diet 
b.  Exercise 
c.  Hormone Replacement Therapy 
d.  Biphosphonates 
e.  Calcitonin 
f.  Combination of (please specify e.g. a,c,d, etc.)       
g.  Other (please specify)       
 
16. Osteoporosis patient information: 
a. What age range covers most of your patients in the last year? 
Maximum age you have seen:       Minimum age you have seen:       
 
b. What approximate percentages (%) do you characterize your patients to be? 
i. Sex:        % Male        % Female 
ii. Race:      % African American       % Native American 
       %Caucasian        % Hispanic 
 
17. When osteoporosis is diagnosed, which areas are most affected in your patients (%)? 
     % Spine      % Hip      % Wrist  
     % Other areas (please specify)       
 
 END OF SURVEY 
THANK YOU FOR YOUR COOPERATION.   
HOPE YOU HAVE A GREAT DAY! 
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APPENDIX 2: SUMMARY OF GUIDELINES FOR OSTEOPOROSIS MANAGEMENT 
BASED ON THE LITERATURE 
 
 
A.  Osteoporosis Prevention 
High calcium diet and exercise 
Control of alcohol and smoking 
Gonadal steroids in men and women if hypogonadal 
Control of caffeine intake 
Control of salt intake 
Others (calcium supplements, exercise, screening, bisphosphonates, PTH assessment)  
Control of protein intake 
 
B.  Osteoporosis Diagnosis 
B.1. Signs of Osteoporosis Presence 
Fracture 




Low Body Weight 
Frailty 
Low Peak Bone Mass (PBM) at early ages 
Pain 
Other (steroid use, white race, post-menopausal, amenorrhea) 
 




Blood and urine tests for bone markers 
Quantitative ultrasound for bone density 
 
B.3. Bone Density Scan Recommendation 
When osteoporosis is suspected, before fractures occur 
When see clinical risk factors (premature menopause…)  
To assess effectiveness of a given treatment 
When fractures have already occurred 
Upon gluco-corticoid use 
All women above 65 years of age 
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C.  Osteoporosis Treatment 
Treatment 
Supplements : 1000-1500mg calcium ; 400-800 IU vitamin D 
Exercise: walking ; resistance ; weight-bearing 
Bisphosphonates: Alendronate (Fosamax), risedronate (Actonel), and etidronate (Didronel) 
Hormone therapy: Estrogen & Progesterone 
Selective Estrogen Receptor Modulator: Raloxifene (EVISTA) 
Para-Thyroid hormone: Forteo 
Diet change: more dairy and fortified milk 
Nasal calcitonin 
 
PS: Calcium and vitamin D supplements are a must for every post-menopausal woman even if 
another treatment is given to treat osteoporosis. 
 
D.  Osteoporosis Follow-up 
1-2 years if patients are on bisphosphonates 
2-4 years if patients are on calcitonin, hormone replacement therapy, or evista. 
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APPENDIX 3: TELEPHONE SCRIPT  
Investigators: 






Subject’s Initials: Subject’s #: Date Performed: 
 
1. Good morning/afternoon/evening Mrs. _______________. 
“Hello, this is Rania Mekary.  I am a PhD candidate at LSU working with Dr Stephen Lindsey 
on a research study concerning osteoporosis treatment.   
 
You have been randomly selected among 200 patients.  I would like to ask you if you don’t mind 
answering a few questions that will shed some light on the study we are doing. 
 
--If the interviewed person gave a verbal agreement, I will document the verbal consent;   then I 
will go ahead and ask the following questions:-- 
 
Q1.  Are you taking any medication for osteoporosis? If yes, for how long? 
 
Q2.  Are you following the physician’s prescription (I would read the prescription written 
by the physician on the medical record)? If yes, skip Q3.  
 
Q3.  Why not? 
 
Q4.  What is your current level of physical activity? What type of physical activity do you 
perform? How frequent? How long do you go for? 
 
Thank you for your time and cooperation. 
Have a great day!” 
 
After the phone call, complete the form, sign and file in the participants’ study folder.  
 




APPENDIX 4: PHYSICAL ACTIVITY READINESS QUESTIONNAIRE  
Subject’s Name: Subject’s Code: 
Physical Activity Readiness Questionnaire (PAR-Q) 
Investigators: 
Lindsey/ Wood/ Hegsted/ Mekary Ochsner-LSU 
Time Performed: Date Performed: 
YES   NO  
 _____  _____  1.  Has your doctor ever said that you have a heart condition and that you   
         should only do physical activity recommended by a doctor?  
 _____  _____  2.  Do you feel pain in your chest when you do physical activity?  
 _____  _____  3.  In the past month, have you had chest pain when you were not doing   
         physical activity?  
  _____  _____  4.  Do you lose your balance because of dizziness or do you ever lose   
         consciousness?  
 _____  _____  5.  Do you have a bone or joint problem that could be made worse by a   
         change in your physical activity?  
 _____  _____  6.  Is your doctor currently prescribing drugs (for example, water pills) for your 
blood pressure or heart condition?   
  _____  _____  7.  Do you know of any other reason why you should not do physical   activity?  
  
NOTE:  1.  This questionnaire applies only to those 15 to 69 years of age.  
  
    2.  If you have temporary illness, such as a fever or cold, or are not feeling well at this  
      time, you may wish to postpone the proposed activity.  
  
    3.  If you are pregnant, you are advised to discuss the "PARmed-X for Pregnancy"   
      form with your physician before exercising.      
  
    4.  If your health changes so that you then answer YES to any of the above     
      questions, tell your fitness or health professional.  Ask whether you should    
      change your physical activity plan.  
  
I have read, understood and completed this questionnaire.  
  
SIGNATURE____________________________________  DATE__________________  
  
SIGNATURE OF PARENT______________________________________________ 
OR GUARDIAN (for participants under the age of majority)  
  
Witness________________________________________  Date__________________  
  
Informed use of the PAR-Q:  The Canadian Society for Exercise Physiology, Health Canada, and their agents 
assume no liability for persons who undertake physical activity, and if in doubt after completing this questionnaire, 




APPENDIX 5: PHYSICAL ACTIVITY QUESTIONNAIRE  
Subject’s Name: Subject’s Code: 
Physical Activity Questionnaire 
Investigators: 
Lindsey/ Wood/ Hegsted/ Mekary Ochsner-LSU 
Time Performed: Date Performed: 
 
This survey is conducted to assess lifestyle factors related to health. 
 
• Most individuals find that the questionnaire can be completed in approximately 20-30 
minutes. 
• Replies are important from all participants; exercisers or non-exercisers. 
• Be as accurate as possible, but provide your best estimate if you do not remember precisely. 
• Please provide information pertain to the previous month.  
 
If you wish to comment on any of the questions or to qualify your answers, please write in the 
























In this section we would like to ask you about your current physical activity and exercise habits 
that you perform regularly, at least once a week. Please answer as accurately as possible. Circle 




1. For the last one month, which of the following moderate or vigorous activities have you 
performed regularly? (Please circle YES for all that apply and NO if you do not perform the 





NO YES            How many sessions per week?   _________ 
How many miles (or fractions) per session? _________ 
Average duration per session?   _________ (minutes) 
 
 
What is your usual pace of walking? (Please circle one) 
CASUAL or  AVERAGE or  FAIRLY or BRISK or           
STROLLING  NORMAL   BRISK STRIDING 
(< 2 mph)  (2 to 3 mph)  (3 to 4 mph)     (4mph or faster) 
 
Stair Climbing 
NO YES           How many flights of stairs do you climb UP each day? _________ 
(1 flight = 10 steps) 
 
Jogging or Running 
NO YES  How many sessions per week?  _________ 
How many miles (or fractions) per session? _________ 
Average duration per session?                  _________ (minutes) 
 
Treadmill 
NO YES   How many sessions per week? 
Average duration per session?  _________ (minutes) Speed? 
____ (mph) Grade? ____(%) 
 
Bicycling 
NO YES   How many sessions per week?   _________ 
How many miles per session?   _________ 
Average duration per session?     _________ (minutes) 
 
Swimming laps 
NO YES  How many sessions per week?  _________ 
How many miles per session?  _________ 
(880 yds = 0.5 miles) 
Average duration per session?   _________ (minutes) 
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Aerobic Dance/Calisthenics/Floor Exercise 
NO YES  How many sessions per week?  _________ 
Average duration per session?  _________ (minutes) 
 
Moderate Sports 
(e.g. Leisure volleyball, golf (not riding), 
social dancing, doubles tennis) 
NO YES  How many sessions per week?  _________ 
Average duration per session?   _________ (minutes) 
 
Vigorous Racquet Sports 
(e.g. Racquetball, singles tennis) 
NO YES  How many sessions per week?   _________ 
Average duration per session?  _________ (minutes) 
 
Other Vigorous Sports  
or Exercise Involving 
Running (e.g. Basketball, soccer) 
NO YES  Please specify _________________________________ 
How many sessions per week?  _________ 
Average duration per session?  _________ (minutes) 
Other Activities 
NO YES  Please specify _________________________________ 
How many sessions per week?  _________ 
Average duration per session?  _________ (minutes) 
 
Weight Training 
(Machines, free weights) 
NO YES   How many sessions per week?  _________ 
Average duration per session?  _________ (minutes) 
 
Household Activities (Sweeping, vacuuming, 
washing clothes, scrubbing floors) 
NO YES  How many hours per week?   _________ 
 
Lawn Work and Gardening 
NO YES  How many hours per week?   _________ 
 
 
2. How many times a week do you engage in vigorous physical activity long enough to work up 
a sweat? _________ (times per week) 
 
THANK YOU FOR YOUR TIME!
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APPENDIX 6: FOOD FREQUENCY QUESTIONNAIRE  
Subject’s Name: Subject’s Code: 
Food Frequency Questionnaire 
Investigators: 
Lindsey/ Wood/ Hegsted/ Mekary Ochsner-LSU 
Time Performed: Date Performed: 
 
Please put a tick (♦) on the appropriate answer: 
  
I.  VITAMINS 
1.  Have you ever regularly taken multi-vitamins? 
 
? Never have 
 
? Have in the past only  
 a) for how many years did you take them in the past? 
 




? Currently take them 
 a) how many per week? 
 b) how many years have you been taking them? 
 c) what brand do you usually use? 
 




Vitamin D     Dose per day?  How long? 
? Never taken   ?less than 400 IU  ?0-1 year 
? Taken in the past only  ?400 to 600 IU  ?2-4 years 
? Yes, currently take it  ?800 IU   ?5-9 years 
     ?801 IU or more  ?≥10 years 
     ?Don’t know 
 
 
Calcium     Dose per day?  How long? 
? Never taken   ?less than 400 mg  ?0-1 year 
? Taken in the past only  ?400 to 900 mg  ?2-4 years 
? Yes, currently take it  ?901 to 1,300 mg  ?5-9 years 
     ?1,301 mg or more  ?≥10 years 
     ?Don’t know 
 









II. Milk and milk products: 
 
a) Do you drink milk? 1.  Yes________ 2.  No__________ 
b) If yes, how many? ___________ cups/week 
c) What kind? 1.  Whole__________  2.  Skim__________ 3.  Low fat______ 
d) Do you eat milk products? (e.g., yogurt, cream, ice cream, cheese, cream cheese, butter, 
etc….) 
 1.  Yes __________ 2.  No_______________ 
e) If yes, how much?  _____________ grams/week 
f) What kind? 1.  Whole_________ 2.  Skim__________ 3.  Low fat_________ 
 
III. Eggs, Meat, and Fish: 
 
a) Do you consume meat or meat products? 1.  Yes_________ 2.  No_________ 
b) If yes, how often per week? Answer by 
 1.  Always 2.  Sometimes  3.  Rarely 
 (Choose one for each) 
1. Meat (Beef, pork, or lamb)_________ 
2. Chicken__________ 




7. Processed meat (Salami, bologna, or other)___________ 
c) What kind of meat?  
 1.  Lean________ 2.  Medium fat________ 3.  High fat____________ 
 
IV. Caffeine containing beverages 
 
a) Do you drink caffeine containing beverages?1.  Yes_________ 2.  No_________ 
b) If yes, how often per week? Answer by 
 1.  Always 2.  Sometimes  3.  Rarely 
 (Choose one for each) 
1. Cola, Coke, Pepsi or Coke with caffeine_________ 
2. DIET Cola, Coke, Pepsi or Coke with caffeine __________ 
3. Tea with caffeine (not herbal)___________ 
4. Coffee with caffeine___________ 
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V.  Alcoholic beverages 
 
a) Do you drink alcoholic beverages?1.  Yes_________ 2.  No_________ 
b) If yes, how often per week? Answer by 
 1.  Always 2.  Sometimes  3.  Rarely 
 (Choose one for each) 
1.  Beer, regular_________ 
2. Beer, light__________ 
3. Red wine___________ 
4. Liquor, e.g. whiskey, gin, etc. _______________ 
 
VI. Diet changes 




? Yes  
 
physician prescribed
   
Self prescribed
 
a) If yes, for how many years? 





b) How has your use of the following foods and beverages changed over the past ten years? 
Please put a tick (♦) on the appropriate answer: 
 
Food Use has decreased Use about the same Use has increased 
Whole Milk    
Skim milk    
Cheese    
Yogurt    
Butter    
Margarine    
Eggs    
Fish    
Red meat    
Tea    
Coffee     
Alcohol    
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APPENDIX 7: SF36 HEALTH SURVEY  
Subject’s Name: Subject’s Code: 
SF36 Health Survey 
Investigators: 
Lindsey/ Wood/ Hegsted/ Mekary Ochsner-LSU 
Time Performed: Date Performed: 
INSTRUCTIONS: This set of questions asks for your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual activities. Answer every question 
by marking the answer as indicated. If you are unsure about how to answer a question please give the 
best answer you can. 
1. In general, would you say your health is: (Please tick one box.) 
Excellent   
Very Good  
Good  
Fair   
Poor   
2. Compared to one year ago, how would you rate your health in general now? (Please tick one 
box.) 
Much better than one year ago     
Somewhat better now than one year ago   
About the same as one year ago    
Somewhat worse now than one year ago   
Much worse now than one year ago   
 
3. The following questions are about activities you might do during a typical day. Does your 











3(a) Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports 
 
1 2 3 
3(b) Moderate activities, such as moving a 
table, pushing a 
vacuum cleaner, bowling, or playing golf 
1 2 3 
3(c) Lifting or carrying groceries 1 2 3 
3(d) Climbing several flights of stairs 1 2 3 
3(e) Climbing one flight of stairs 1 2 3 
3(f) Bending, kneeling, or stooping 1 2 3 
3(g) Walking more than a mile 1 2 3 
3(h) Walking several blocks 1 2 3 
3(i) Walking one block 1 2 3 
3(j) Bathing or dressing yourself 1 2 3 
 147
4. During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? 
(Please circle one number on each line.)     Yes   No 
4(a) Cut down on the amount of time you spent on work or 
other activities 
1  2 
4(b) Accomplished less than you would like 1  2 
4(c) Were limited in the kind of work or other activities 1  2 
4(d) Had difficulty performing the work or other activities (for 
example, it took extra effort) 
1  2 
 
5. During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (e.g. feeling depressed or 
anxious)? 
(Please circle one number on each line.)     Yes   No 
5(a) Cut down on the amount of time you spent on work or 
other activities 
1  2 
5(b) Accomplished less than you would like 1  2 
5(c) Didn’t do work or other activities as carefully as usual 1  2 
 
6. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered 
with your normal social activities with family, friends, neighbours, or groups? (Please tick one 
box.) 
Not at all  
Slightly  
Moderately  
Quite a bit  
Extremely  
 
7. How much physical pain have you had during the past 4 weeks? (Please tick one box.) 
None  




Very Severe  
 
8. During the past 4 weeks, how much did pain interfere with your normal work (including both 
work outside the home and housework)? (Please tick one box.) 
Not at all  
A little bit  
Moderately  




9. These questions are about how you feel and how things have been with you during the past 4 
weeks. Please give the one answer that is closest to the way you have been feeling for each 
item. 























9(a) Did you feel full of life?  
 
1  2 3 4 5 6 
9(b) Have you been a very nervous 
person? 
1  2 3 4 5 6 
9(c) Have you felt so down in the 
dumps that nothing could cheer you 
up? 
1  2 3 4 5 6 
9(d) Have you felt calm and 
peaceful? 
1  2 3 4 5 6 
9(e) Did you have a lot of energy? 1  2 3 4 5 6 
9(f) Have you felt downhearted and 
blue? 
1  2 3 4 5 6 
9(g) Did you feel worn out? 1  2 3 4 5 6 
9(h) Have you been a happy person? 1  2 3 4 5 6 
9(i) Did you feel tired? 1  2 3 4 5 6 
 
 
10. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting with friends, relatives etc.) (Please 
tick one box.) 
All of the time  
Most of the time  
Some of the time  
A little of the time  
None of the time  
 
11. How TRUE or FALSE is each of the following statements for you? 
 















11(a) I seem to get sick a little easier 
than other people 
1  2 3 4 5 
11(b) I am as healthy as anybody I 
know 
1  2 3 4 5 
11(c) I expect my health to get worse 1  2 3 4 5 




APPENDIX 8: HEALTH STATUS QUESTIONNAIRE  
Subject’s Name: Subject’s Code: 
HEALTH STATUS QUESTIONNAIRE 
Investigators: 
Lindsey/ Wood/ Hegsted/ Mekary Ochsner-LSU 
Time Performed: Date Performed: 
 
Prior to the start of any exercise program or testing a health fitness instructor must first administer to 
their client a Health Status Questionnaire. This tool will aid the personal trainer in deciding what 
course of action should be followed in regards to program recommendations. 
Code For Health Status Questionnaire 
EI = Emergency Information-must be made readily available. 
MC = Medical Clearance needed-do not allow to exercise without physician’s permission. 
SEP = Special Emergency procedure needed-do not let participant exercise alone; make sure the 
person’s exercise partner knows what to do in case of emergency. 
RF = Risk factor for CHD (educational materials and workshops needed) 
SLA = Special or Limited activities may be needed-you may want to include or exclude specific 
exercises. 
OTHER (not marked) = Personal information that may be helpful for files or research. 
 
Instructions 
Complete each question as accurately as possible. All information is confidential. 
Part 1. General information 
1. Name________________________________________ Nickname_________________ 
2. Mailing Address_______________________________ Phone (H)_________________ 
_______________________________ Phone (W)_________________ 
3. EI Personal Physician___________________________ Phone____________________ 
Physician Address_______________________________ 
_______________________________ 
4. EI Person to contact in case of emergency________________ Phone_____________ 
5. Gender (circle one): Female Male RF 
6. RF Date of birth_______/________/________ 
7. Number of hours worked per week: Less than 20 20-40 41-60 over 60 
8. SLA More than 25% of the time at your job is spent (circle all that apply) 
Sitting at desk Lifting loads Standing Walking Driving 
Part 2. Medical History 
10. RF Circle any who died of heart attack before age 50: 




11. Date of 
Last medical physical exam:______________ 
Last physical fitness test:_________________ 
 
12. Circle any operations that you have had: 
Back SLA  Heart MC  Kidney SLA  Eyes SLA  Joint SLA  Neck SLA 
Ears SLA  Hernia SLA  Lung SLA  Other________________________ 
 
13. Circle all medicine taken in last 6 months: 
Blood thinner MC  Epilepsy medication SEP  Nitroglycerin MC 
Diabetic SEP   Heart rhythm medication MC  Other______________ 
Digitalis MC   High blood pressure medication MC 
Diuretic MC   Insulin MC 
 
14. Please circle any of the following for which you have been diagnosed or treated by a 
physician or health professional: 
 
Alcoholism SEP   Diabetes SEP    Kidney problem MC 
Anemia, sickle cell SEP Emphysema SEP Mental illness SEP 
Anemia, other SEP Epilepsy SEP  Neck strain SLA 
Asthma SEP Eye problems SLA Obesity RF 
Back strain SLA   Gout SLA    Phlebitis MC 
Bleeding trait SEP   Hearing loss SLA   Rheumatoid arthritis SL 
Bronchitis, chronic SEP  Heart problems MC   Stroke MC 
Cancer SEP    High blood pressure RF Thyroid problem SEP 
Cirrhosis MC    HIV SEP    Ulcer SEP 
Concussion MC   Hypoglycemia SEP   Other________ 
Congenital defect SEP   Hyperlipidemia RF 
 
15. Any of these health symptoms that occurs frequently requires medical attention. Circle the 
number indicating how often you have each of the following: 
5= Very often 
4= Fairly often 
3= Sometimes 
2= Infrequently 
1= Practically never 
 
a. Cough up blood MC   g. Swollen joints MC 
1 2 3 4 5      1 2 3 4 5 
b. Abdominal pain MC   h. Feel faint MC 
1 2 3 4 5      1 2 3 4 5 
c. Low-back pain MC    i. Dizziness MC 
1 2 3 4 5      1 2 3 4 5 
d. Leg Pain MC    j. Breathlessness with slight exertion MC 
1 2 3 4 5      1 2 3 4 5 
e. Arm or shoulder pain MC   k. Palpitation or fast heart beat MC 
1 2 3 4 5      1 2 3 4 5 
f. Chest pain RF MC    l. Unusual fatigue with normal activity MC 
1 2 3 4 5      1 2 3 4 5 
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Part 3. Health-related behaviors 
 
16. RF Do you now smoke?  Yes   No 
17. RF If you are a smoker, indicate the number smoked per day: 
Cigarettes: 40 or more   20-39   10-19   1-9 
Cigars or pipes only: 5 or more or any inhaled   less than 5 
18. RF Do you exercise regularly?   Yes    No 
19. How many days a week do you accumulate 30 minutes of moderate activity? 
0  1  2  3  4  5 6  7   days per week 
20. How many days per week do you normally spend at least 20 minutes in vigorous exercise? 
0  1  2  3  4  5 6  7   days per week 
21. Can you walk 4 miles briskly without fatigue?  Yes   No 
22. Can you jog 3 miles at a moderate pace without discomfort?  Yes  No 
23. Weight now:___________lb.  One year ago:__________ Age 21:__________ 
Part 4. Health-related attitudes 
24. These are traits that have been associated with coronary-prone behavior. Circle the number that 
corresponds to how you feel towards the following statement: 
I am an impatient , time-conscious, hard-driving individual. 
 
Circle the number that best describes how you feel: 
6=  strongly agree 
5=  Moderately agree 
4=  Slightly agree 
3=  Slightly disagree 
2=  Moderately disagree 
1=  Strongly disagree 
 




THANK YOU FOR YOUR TIME! 
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APPENDIX 9: OCHSNER CLINIC FOUNDATION RESEARCH INFORMED CONSENT  
 
 
 THE EFFECT OF CALCIUM SUPPLEMENTS AND SITE-SPECIFIC 
STRENGTHENING EXERCISES ON LUMBAR MINERAL DENSITY AND 
MUSCLE STRENGTH IN OSTEOPENIC WOMEN: A ONE-YEAR PILOT STUDY 
  
(Sponsor’s Protocol # if exists  IRB#____.___._) 
(Louisiana State University) 
 
 
 Principal Investigator: Dr Stephen Lindsey  Sub-Investigators: Rania Mekary; Dr Bob 
Wood; Dr Maren Hegsted 
 
 
Are you in any other research studies?  Yes __________ No __________ 
      please initial your response 
You have been invited to participate in a research study. The doctors and staff at Ochsner study 
the nature of disease and attempt to improve methods of diagnosis and treatment.  This is called 
clinical research.  Understanding this study’s risks and benefits will allow you to make an 
informed judgment about whether to be part of it.  This process is called informed consent. 
 
This consent form may contain words that you do not understand.  Please ask the study doctor or 
the study staff to explain any words or information that you do not clearly understand.  You may 
take home an unsigned copy of this consent form to think about or discuss with family or friends 
before making your decision. 
 
In this consent form, “you” always refers to the subject.  If you are a legally authorized 




The purpose of this study is to determine if strength exercises for the lower back area in post-
menopausal women suffering from low bone density (BMD) have a positive effect on the bone 
density in the lower back and on the lower back muscles’ strength.  You have been asked to 
participate in this study because it is believed that specific strength lower back exercises will 




Performance Sites:  
Saint James Place, 333 Lee Drive, Baton Rouge, LA, 70808  
 
Maximum Number of Participants 
A total of 10 women will be asked to participate in this study and put into pairs. 
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Description of the study 
• During Visit One the following measurements will be obtained: 
 
A. Physical Activity Questionnaire (30 minutes) 
You will be asked to complete the Aerobic Center Longitudinal Study Physical Activity 
Questionnaire. This questionnaire will be used to measure physical activity patterns, 
including leisure and household, during the past 3 months.  
 
B.  Physical Activity Readiness questionnaire (PAR-Q) (10 minutes) 
You will be asked to complete the Physical Activity Readiness questionnaire (PAR-Q). This 
questionnaire will be used to determine if you will need to see a physician before beginning 
this exercise program. 
 
C.  Food Frequency Questionnaire (15 minutes) 
You will be asked to complete this questionnaire to identify past dietary patterns and look at 
use of calcium/vitamin D intake, including supplements, and calcium rich food, as well as 
high-protein foods, caffeine containing beverages, and alcoholic beverages. 
 
D.  Short Form 36 (20 minutes) 
You will be asked to complete the Short Form 36. This questionnaire is designed to assess 
your strength, any pain you might have with activity, and your general well-being. 
 
E.  Health Status Questionnaire (10 minutes) 
You will be asked to complete the Health Status Questionnaire. This questionnaire is 
designed to assess medical history and health related behaviors. 
 
F.  Dual Energy Xray Absorptiometry (DXA) 
DXA scan measurements for lower back will be used at the end of the study. 
 
• During Visit Two, you will be asked to perform a fitness test. 
 
A.  Isometric strength 
Isometric strength of back extensor muscles will be measured using a back isometric 
dynamometer (Biodex) at baseline, 6 months, and one year. 
 
Following the completion of the initial visits and upon selection of the n pairs, women 
randomly assigned to the treatment group (n/2) will be taught the core/lower back 
strengthening.  The Thera-Band® Exercise Ball will be introduced to the women and 
gradually incorporated into the exercise regimen for the core and lower back.  These 
exercises will be described in the following paragraph.  Some other movements will be used 
from Sara Meek’s book, who is a physical therapist who treats osteoporosis.  You will have 
to perform these exercises for a period of 1 year, 3 times a week, 40-45 minutes each time.  
The women assigned to the control group will be asked to maintain the same pattern of their 
dietary intake and physical activity throughout the study and will be asked to attend the three 




i.  Warm-up:  (5 minutes).  
A thorough warm-up preparing the back for the exercises to come is completed at first 
ii.  Strengthening 
To strengthen the back muscles, 30 minutes of the following core/lower back exercises should be 
done 3 times a week.  
iia.  Abdominal Exercises (core exercises)  
1-Pelvic lift: Lie on the floor supine position with knees bent, feet shoulder-width apart, and 
arms to the side; tighten the abdominal muscles, lift the pelvis slightly off the ground without 
bouncing, and without using buttocks or leg muscles; hold for 5 seconds and slowly release the 
pelvis back down on the floor.  After 3 months of exercising, perform the same movement on the 
Thera-Band Exercise Balls c, where you put your feet/heels on the ball instead of the floor.  Do 2 
sets of 15 
 
2-Core strengthening: Lie on the floor supine position with knees bent, feet shoulder-width apart.  
Grab both knees and press them against the chest.  Extend one leg out and take it slowly down 
towards the floor, without letting it touch the floor.  The leg should stop from going down at the 
level when then lower back starts to arch.  Once at that level, take your leg back in and repeat 
with the other leg.  Do 2 sets of 10. 
 
3- Standing knee lifts: Stand with right hand holding on to side of chair; raise left knee slowly to 
90 degree angle; grab behind left knee with left hand and slowly bring the knee up to the chest; 
hold it for 5 seconds, keeping the core inwards and exhaling, then lower slowly to the starting 
position, inhaling.  Repeat the same with the other leg.  Do 2 times 15 for each leg.  
 
4-Standing leg adduction: Stand with right hand holding on to side of chair. Raise one straight 
leg slowly to the side keeping the core contracted inwards; exhale, then lower slowly to the 
starting position, inhaling. Repeat the same with the other leg.  Do 2 times 15 for each leg. 
PS: Exercises 3 and 4 can be combined together in one exercise where the leg goes from forward 
bent 90 degrees position to side extended position. 
 
5-Arm/Leg raises: Get down on your hands and knees and keep your core inwards and back in a 
neutral straight position (cat position); keeping your neck and back straight; slowly lift your right 
arm and the left leg to make one straight line parallel to the floor along with the back.  Your head 
should be looking towards the floor keeping the neck in a neutral position.  Exhale as you reach 
out and keep the core inwards.  Slowly go back to starting position and repeat the same routine 
with the other arm and its opposite leg.  Do 4 sets of 10 
 
iib.  Back Exercises collated from (Hyde, 2001) with some modifications done by the 
investigator (R.M.). 
 1-Prone arm/leg exercises: Lie on stomach –prone position, face-down keeping neck 
straight with legs straight and arms straight overhead; Slowly lift the right arm along with the left 
leg, hold for 2 seconds and come down.  Repeat with left arm and right leg.  Do 4 sets of 10.  If 
the participant fails to accomplish this exercise, he/she can start gradually with lifting each arm 
alone at first, then each leg, then combining both leg and arm. 
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 2-Back extension: Keep the previous position.  Repeat lifting the torso slowly off the 
ground while keeping the legs on the floor, with both arms behind the head and return to start 
position (10 times).  For a harder exercise, repeat stretching the arms out like a cross (10 times), 
and then stretching the arms forward (10 times).  The last advanced exercise can be given in one 
month from the day of the study. 
 
 3- Cat curls: Get down on your hands and knees and keep your core inwards and back in 
a neutral straight position.  Your head should be facing the floor.  Curve your back inwards 
making a C shape towards the floor; rise your head looking upwards while inhaling; hold for 3 
seconds; then curve your back outwards in a mountain shape while exhaling; your head should 
be looking downwards; hold for 3 seconds; go back to neutral position.  Do 2 sets of 10. 
 
 4-Back stretches: Lie in prone position, lifting the torso up leaning on the elbows.  Hold 
for 10 seconds.  Move backward on the bent knees, stretching the arms forward, pulling head 
between arms. Let your gluteus touch your heels.  Hold for 10 seconds.  Gently stand on the feet 
while keeping the torso down; cross the arms and grab behind the knees with the palms.  Very 
gently arch the back upwards to the ceiling (C shape in the back), while grabbing behind the 
knees with the palms.  Hold for 10 seconds.  Gently roll the back all the way up.  Repeat the final 




The risks associated with low-to-moderate physical exertion are extremely low, even 
among persons with cardiovascular disease. However, there are remote risks of muscle strains, 
and other bone and joint discomforts, as well as remote risks of heart attack, stroke, and death.  
You might be subject to lose balance and fall when using the stability ball but this is rare if 
proper teaching technique is used. You should also know that your condition of osteopenia may 
not improve or may worsen, despite participation.  In the general population it would be 
expected that 1 in every 2.2 million tests would result in some heart complication requiring 
medical attention, and roughly 1 in every 3 million tests would result in death. 
 
Louisiana state law requires that participants in all clinical studies such as this one be informed 
that any study (or procedure) may also result in death, brain damage, quadriplegia (paralysis in 
all arms and legs), paraplegia (paralysis of both legs), loss of organ, loss of arm or leg, loss of 




Women with low bone density need special care and specific types of practical exercises that 
they can adhere and follow.  The idea of finding some convenient, safe, and beneficial exercises 
for the elderly women who cannot lift any weights and who cannot go to the gym is very crucial 
in adding a practical help in the life of these aged women.  This research will further determine 
whether specific strength exercise for the core and lower back with no external load and with 
more frequency have a positive effect on the lumbar mineral density and on the extensor back 
muscles’ strength. Not only the study may benefit the participant directly, but it may also benefit 
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others by providing information regarding the optimal type, intensity, and duration of exercise 
that may elicit lumbar mineral density. 
 
Regular physical exercise is shown to improve heart and blood vessel function, muscle strength 
and endurance, and bone health. Further, exercise is known to reduce the risk of serious diseases 
such as heart disease, osteoporosis, type II diabetes, and some cancers.  Lastly, regular exercise 
has also been linked to improved mood and sense of well-being. 
 
However, no promise can be made concerning the study outcome, because results from a clinical 
research study cannot be predicted.  Your physician, and those involved in this research study, 




In case of inadequate calcium intake, you will be given free calcium supplementation.  The 
fitness assessment, the muscle strength measurement, the muscle endurance measurement, and 
the training will be under no costs.  No other additional costs will be involved.  
 
PAYMENT FOR PARTICIPATION AND/OR REIMBURSEMENT OF EXPENSES 
 
Payment for participation or reimbursement of expenses will not be provided.   
 
COMPENSATION FOR INJURY 
 
If there is an injury due to the research procedures, medical treatment, if necessary for injuries or 
illness, is available.  This medical treatment and/or hospitalization is not free of charge.  If you 
think you have an injury that may be related to the research procedures, you should call Dr. 
Stephen Lindsey at (225) 761 5868 or Dr Robert Wood at Louisiana State University at 225/578-
9142 
 
AUTHORIZATION TO USE AND DISCLOSE INFORMATION FOR RESEARCH 
PURPOSES 
 
Federal regulations give you certain rights related to your health information.  These include the 
right to know who will be able to get the information and why they may be able to get it.  The 
study doctor must get your authorization (permission) to use or give out any health information 
that might identify you.  
 
What information may be used and given to others? 
If you choose to be in this study, the study doctor will get personal information about you.  This 
may include information that might identify you.  The study doctor may also get information 
about your health including:  
 
• Medical and research records 
• Records about phone calls 
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• Records about your study visits 
• Records of physical exams 
• Laboratory, x-ray, DEXA scans, and other test results 
• Diaries and questionnaires 
• Records about your calcium and vitamin D status 
 
Who may use and give out information about you? 
Information about your health may be used and given to others by the study doctor and staff. 
They might see the research information during and after the study. 
 
Who might get this information? 
Information about you and your health which might identify you may be given to:  
 
• Ochsner Clinic Foundation Institutional Review Board (IRB) 
• Ochsner Clinic Foundation Research & Compliance Offices 
• Louisiana State University Institutional Review Board (IRB) 
 
Why will this information be used and/or given to others? 
Information about you and your health that might identify you may be given to others to carry 
out the research study.   
 
The results of this research may be published in scientific journals or presented at scientific 
meetings, but your identity will not be disclosed. 
 
The Ochsner IRB may review the information.  The IRB is a group of people who perform 
independent review of research as required by regulations. The Ochsner Research & Compliance 
Offices may review this research in their oversight and auditing roles. 
 
What if I decide not to give permission to use and give out my health information? 
By signing this consent form, you are giving permission to use and give out the health 
information listed above for the purposes described above.  If you refuse to give permission, you 
will not be able to be in this research.  
 
May I review or copy the information obtained from me or created about me? 
You have the right to review and copy your health information.  However, if you decide to be in 
this study and sign this permission form, you will not be allowed to look at or copy your 
information until after the research is completed. 
 
May I withdraw or revoke (cancel) my permission? 
This permission will not stop automatically.  
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You may withdraw or take away your permission to use and disclose your health information at 
any time.  You do this by sending written notice to the study doctor.  If you withdraw your 
permission, you will not be able to continue being in this study. 
 
When you withdraw your permission, no new health information which might identify you will 
be gathered after that date.  Information that has already been gathered may still be used and 
given to others.  This would be done if it were necessary for the research to be reliable. 
 
Is my health information protected after it has been given to others? 
If you give permission to give your identifiable health information to a person or business, the 
information may no longer be protected.  There is a risk that your information will be released to 




If you have any questions concerning your participation in this study, or if at any time you feel 
you have experienced a research-related injury or a reaction to a study drug, contact: 
 Dr. Stephen Lindsey at Ochsner Clinic 
 Address: 9001 Summa Avenue, Baton Rouge, LA  
 Phone: 225-761 5868 
 
If you have questions about your rights as a research subject, you may contact: 
 
 Ochsner Clinic Foundation Institutional Review Board (OCF IRB) 
 1514 Jefferson Highway, Brent House 514 
 New Orleans, LA 70121 
 Telephone:  1-504-842-3535 
 
Do not sign this consent form unless you have had a chance to ask questions and have received 
satisfactory answers to all of your questions. 
 
If you agree to participate in this study, you will receive a signed and dated copy of this consent 
form for your records. 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
 
Participation in this study is voluntary.  You may decide not to participate in this study or you 
may withdraw from this study at any time without penalty or loss of benefits to which you are 
otherwise entitled at this site. You will be informed of any significant new findings that develop 
during the investigation that may affect your willingness to continue in the study. 
 
You should tell your study doctor about all of your past and present health conditions and 
allergies of which you are aware, and all drugs and medications which you are presently using. 
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Your participation in this study may be stopped at any time by the study doctor without your 
consent because: 
 
• the study doctor thinks it necessary for your health or safety; 
• you have not followed study instructions; 
• administrative reasons require your withdrawal. 
 
If you leave the study before the final regularly scheduled visit, you may be asked by the study 




I have read the information in this consent form (or it has been read to me).  All my questions 
about the study and my participation in it have been answered.  I freely consent to participate in 
this research study. I authorize the use and disclosure of my health information to the parties 
listed in the authorization section of this consent for the purposes described above. By signing 
this consent form I have not waived any of the legal rights which I otherwise would have as a 











Person Obtaining Consent - Signature Printed Name   Date 
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------------------------------------ Use the following only if applicable --------------------------------- 
 
If this consent form is read to the subject because the subject (or legally authorized 
representative) is unable to read the form, an impartial witness must be present for the consent 
and sign the following statement: 
 
I confirm that the information in the consent form and any other written information was 
accurately explained to, and apparently understood by, the subject (or the subject’s legally 
authorized representative).  The subject (or the subject’s legally authorized representative) freely 




Signature of Impartial Witness  Printed Name   Date 
 
Note:  This signature block cannot be used for translations into another language.  A translated 
consent form, with the translation approved by the IRB, is necessary for enrolling subjects who 
do not speak English. 
 
THANK YOU FOR YOUR TIME! 
 
 161
APPENDIX 10: CORE LOWER BACK STRENGTHENING EXERCISES  
A thorough warm-up preparing the back for the exercises to come is completed for the first five 
minutes.  To strengthen the back muscles, 30-40 minutes of the following core/lower back 
exercises should be done 3threetimes a week.  
 
CORE EXERCISES 
1-Pelvic Lift: Lie on the floor supine position with knees bent, feet shoulder-width apart, and 
arms to the side; tighten the abdominal muscles, lift the pelvis slightly off the ground without 
bouncing, and without using buttocks or leg muscles; hold for 5 seconds, exhale, then slowly 
release the pelvis back down on the floor.  After three months of exercising, perform the same 
movement on the Thera-Band Exercise Balls, where you put your feet/heels on the ball instead of 
the floor.  Do 2 sets of 15 
 
 
2-Core Strengthening: Lie on the floor supine position with knees bent, feet shoulder-width 
apart.  Grab both knees and press them against the chest.  Extend one leg out while exhaling and 
take it slowly down towards the floor, without letting it touch the floor.  The leg should stop 
from going down at the level when then lower back starts to arch.  Once at that level, take your 
leg back in and repeat with the other leg.  Do 2 sets of 10 
 
 
3- Standing Knee Lifts: Stand with right hand holding on to side of chair; raise left knee slowly 
to 90 degree angle; grab behind left knee with left hand and slowly bring the knee up to the 
chest; hold it for 5 seconds, keeping the core inwards and exhaling, then lower slowly to the 




4-Standing Leg Adduction: Stand with right hand holding on to side of chair. Raise one straight 
leg slowly to the side keeping the core contracted inwards; exhale, then lower slowly to the 
starting position, inhaling. Repeat the same with the other leg.  Do 2 times 15 for each leg. 
 PS: Exercises 3 and 4 can be combined together in one exercise where 
the leg goes from forward bent 90 degrees position to side extended position 
 
5-Arm/Leg Raises: Get down on your hands and knees and keep your core inwards and back in 
a neutral straight position (cat position); keeping your neck and back straight; slowly lift your 
right arm and the left leg to make one straight line parallel to the floor along with the back.  Your 
head should be looking towards the floor keeping the neck in a neutral position.  Exhale as you 
reach out and keep the core inwards.  Slowly go back to starting position and repeat the same 
routine with the other arm and its opposite leg.  Do 4 sets of 10 
 
 
BACK EXERCISES collated from (Hyde, 2001) with some modifications done by the 
investigator (R.M.) 
 
1-Prone Arm/Leg Exercises: Lie on stomach –prone position, face-down keeping neck straight 
with legs straight and arms straight overhead; Slowly lift the right arm along with the left leg, 
exhale, hold for 2 seconds and come down.  Repeat with left arm and right leg.  Do 4 sets of 10.  
If the participant fails to accomplish this exercise, he/she can start gradually with lifting each arm 








2-Back Extension: Keep the previous position.  Repeat lifting the torso slowly off the ground 
while keeping the legs on the floor and exhaling, with both arms behind the head and return to 
start position (10 times).  For a harder exercise, repeat stretching the arms out like a cross (10 
times), and then stretching the arms forward (10 times).  The last advanced exercise can be given 
in one month from the day of the study. 
 
 
3- Cat Curls: Get down on your hands and knees and keep your core inwards and back in a 
neutral straight position.  Your head should be facing the floor.  Curve your back inwards 
making a C shape towards the floor; rise your head looking upwards while inhaling; hold for 3 
seconds; then curve your back outwards in a mountain shape while exhaling; your head should 




4-Back Stretches: Lie in prone position, lifting the torso up leaning on the elbows.  Hold for 10 
seconds.  Move backward on the bent knees, stretching the arms forward, pulling head between 
arms. Let your gluteus touch your heels.  Hold for 10 seconds.  Gently stand on the feet while 
keeping the torso down; cross the arms and grab behind the knees with the palms.  Very gently 
arch the back upwards to the ceiling (C shape in the back), while grabbing behind the knees with 
the palms.  Hold for 10 seconds.  Gently roll the back all the way up.  Repeat the final stretch 
exercise 5 times.  
 
 
THANK YOU FOR YOUR TIME TO COMPLETE THE EXERCISES! 
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